Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" ABCC5 "EST277145, MOAT-C, MRP5, SMRP" ENSG00000114770 "ATP binding cassette subfamily C member 5" O15440 3 183919934-184018015 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044067, HPA052295" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA044067: , HPA052295: " "unprognostic (9.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.83e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-2)" "unprognostic (2.07e-1)" "prognostic unfavourable (6.78e-8)" "unprognostic (4.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.02e-1)" "unprognostic (5.91e-3)" "prognostic unfavourable (3.40e-4)" "unprognostic (1.10e-1)" "unprognostic (9.05e-3)" "unprognostic (1.64e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-2)" 7.9 11.2 24.7 9.6 26.2 12.0 6.7 42.8 28.6 7.7 11.4 12.0 13.4 6.8 14.1 7.0 17.1 6.1 11.6 16.0 19.1 13.7 12.8 3.6 9.4 7.3 20.5 18.5 11.8 4.9 22.4 20.5 10.8 21.7 10.6 14.4 31.1 7.4 9.3 41.0 14.5 8.5 10.5 12.9 16.3 48.5 9.4 20.9 9.3 5.5 7.3 7.4 18.1 12.7 4.2 3.5 15.8 4.5 5.0 7.0 4.5 7.3 4.0 9.3 11.1 9.3 10.6 14.4 5.9 4.7 5.3 5.8 6.3 5.6 7.9 14.0 5.6 29.5 11.4 6.5 7.0 8.6 11.1 16.7 10.1 5.7 3.8 5.1 13.1 16.9 6.6 5.7 3.8 6.2 15.5 11.0 9.1 19.3 13.9 5.8 9.6 7.8 9.7 3.1 4.7 19.4 47.5 17.0 10.1 6.1 33.6 10.0 20.2 1.6 7.1 6.2 6.1 7.9 8.1 4.2 8.2 7.3 4.6 10.2 6.3 10.7 4.5 7.7 7.0 2.1 4.5 3.2 4.0 3.1 3.5 4.2 4.6 6.3 15.8 5.0 3.5 1.3 5.0 4.5 24.7 26.2 42.8 28.6 19.1 13.7 20.5 18.5 21.7 20.9 ABLIM3 KIAA0843 ENSG00000173210 "Actin binding LIM protein family member 3" O94929 5 149141483-149260542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 58.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 25.2;HHSteC: 25.8;HSkMC: 29.7;hTERT-HME1: 29.7;TIME: 32.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003245 Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA003245: AB_1078083" "unprognostic (1.07e-1)" "unprognostic (1.31e-1)" "unprognostic (9.87e-2)" "unprognostic (1.75e-1)" "unprognostic (8.74e-2)" "unprognostic (4.19e-2)" "unprognostic (9.48e-3)" "unprognostic (4.37e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "prognostic unfavourable (1.28e-4)" "unprognostic (3.12e-2)" "unprognostic (8.10e-2)" "unprognostic (2.45e-3)" "unprognostic (1.20e-1)" 45.9 6.0 7.9 3.5 9.8 1.2 35.0 29.7 12.5 9.1 4.7 11.6 7.0 2.9 4.9 8.9 15.6 5.8 6.1 58.4 8.5 10.2 17.0 48.1 9.1 4.8 9.9 5.9 2.6 2.4 39.3 3.1 26.1 14.3 6.5 4.7 7.7 3.0 9.9 24.3 3.5 3.7 8.7 14.0 5.0 2.7 2.3 3.3 0.1 4.2 8.9 4.5 8.8 14.6 0.0 0.6 2.2 0.3 0.0 0.0 6.8 7.3 1.5 0.0 0.0 13.1 25.2 0.0 5.1 14.3 2.9 5.2 0.0 5.1 0.0 0.8 6.4 0.1 0.0 6.0 5.8 0.0 0.0 0.0 0.3 0.1 25.8 0.0 0.0 29.7 1.6 10.5 29.7 13.1 0.0 2.3 17.1 2.8 0.0 0.0 0.0 20.2 0.0 0.0 0.0 16.4 5.0 2.0 0.0 1.0 0.3 2.8 0.4 0.0 32.9 6.2 1.4 6.4 8.6 0.0 0.0 0.0 10.8 0.0 17.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 6.8 7.9 9.8 29.7 12.5 8.5 10.2 9.9 5.9 14.3 3.3 AC004922.1 ENSG00000284292 7 99325879-99394653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA004334 Uncertain Approved "Cell Junctions,Cytosol" "Cell Junctions" Cytosol "HPA004334: AB_1078215" 6.0 5.2 4.2 9.4 6.2 6.9 7.8 3.2 9.1 5.3 6.6 4.6 5.6 13.8 5.8 3.8 5.3 5.0 4.5 4.9 7.1 4.1 6.3 4.6 8.1 3.2 6.0 3.9 6.4 3.0 4.1 5.2 6.2 5.0 3.1 4.9 3.3 5.4 4.6 2.4 9.6 4.2 3.0 6.5 7.0 3.9 3.2 2.9 6.0 6.4 4.4 4.6 4.1 7.9 13.0 18.1 16.3 5.1 11.9 18.0 4.1 3.9 0.4 1.0 0.5 2.8 5.0 3.3 1.8 3.0 3.1 7.1 5.8 4.4 10.8 3.4 2.8 1.2 3.7 0.6 2.1 7.4 2.5 2.9 1.9 0.9 2.7 3.1 2.6 1.1 3.1 1.2 4.3 3.8 4.0 2.1 7.8 4.8 1.2 2.6 11.8 2.1 1.1 1.5 0.6 2.0 1.1 1.0 2.8 4.6 8.3 2.1 1.7 2.9 4.8 2.6 7.1 4.2 0.0 2.2 4.7 2.9 4.1 5.7 9.2 15.5 18.1 7.1 16.3 5.1 7.3 7.0 6.9 13.0 7.9 6.1 6.1 13.9 5.1 15.0 8.9 11.9 18.0 ACOT13 "HT012, THEM2" ENSG00000112304 "Acyl-CoA thioesterase 13" Q9NPJ3 6 24667035-24705065 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 41.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019881 Approved Approved "Cell Junctions" "Cell Junctions" "HPA019881: AB_1857978" "unprognostic (3.61e-1)" "unprognostic (1.62e-1)" "unprognostic (6.02e-2)" "unprognostic (1.80e-2)" "unprognostic (9.57e-2)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.71e-1)" "prognostic favourable (2.53e-6)" "unprognostic (3.67e-2)" "unprognostic (1.64e-2)" "unprognostic (7.16e-2)" "unprognostic (5.97e-2)" "unprognostic (4.86e-2)" "unprognostic (1.50e-1)" "unprognostic (2.13e-2)" 10.0 9.7 13.5 7.0 14.5 4.7 7.9 8.2 13.1 5.8 12.8 5.6 5.9 9.4 5.2 6.2 5.4 5.9 9.9 24.2 11.1 11.6 26.3 41.7 7.0 7.1 13.8 10.6 6.4 9.7 8.9 12.2 6.3 12.3 9.8 11.0 4.0 7.4 6.4 15.7 8.2 8.6 5.5 10.1 6.8 8.1 19.8 8.8 10.5 8.7 8.5 5.2 6.9 4.7 12.8 8.7 11.5 10.5 7.8 12.0 8.8 4.3 5.6 5.7 10.2 8.1 10.2 3.2 3.6 4.3 2.6 4.2 7.5 5.5 8.1 12.2 4.1 4.8 5.0 7.2 4.1 12.5 4.6 7.5 5.8 5.1 4.1 4.8 3.5 5.9 7.1 3.5 7.0 6.2 12.0 4.2 5.2 4.4 8.6 9.3 3.8 4.5 7.5 5.0 10.1 8.8 4.0 11.4 4.0 4.2 14.2 10.0 9.8 4.0 7.1 4.7 2.7 1.3 3.3 8.1 20.7 8.1 5.0 17.4 14.1 6.9 10.2 6.4 8.8 10.5 12.0 12.8 9.9 10.0 8.7 8.7 11.7 10.2 11.5 7.8 9.9 7.0 9.5 8.8 13.5 14.5 8.2 13.1 11.1 11.6 13.8 10.6 12.3 8.8 ADAM22 MDC2 ENSG00000008277 "ADAM metallopeptidase domain 22" Q9P0K1 7 87934143-88202889 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.9" "Cell line enhanced" "Detected in many" "Karpas-707: 35.5;SH-SY5Y: 33.8;U-266/84: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050325, CAB079064" Supported Approved "Cell Junctions" "Intracellular and membrane" 78000 "Cell Junctions" "CAB079064: , HPA050325: " "unprognostic (1.20e-2)" "unprognostic (8.61e-2)" "unprognostic (3.38e-1)" "unprognostic (1.94e-2)" "unprognostic (2.89e-2)" "unprognostic (3.09e-1)" "unprognostic (7.84e-3)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-1)" "unprognostic (3.71e-3)" "unprognostic (1.69e-1)" "unprognostic (3.47e-2)" "unprognostic (4.13e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-4)" "unprognostic (4.70e-2)" 2.9 11.7 10.9 1.5 15.7 1.5 2.1 46.9 36.4 8.6 2.3 6.2 1.6 1.3 6.3 11.2 1.6 3.7 3.7 3.0 14.0 10.6 5.5 0.8 2.0 2.9 8.8 14.4 5.6 1.8 4.5 3.7 0.9 17.0 14.5 2.3 2.9 1.5 7.1 3.3 1.8 1.9 5.0 8.2 2.9 1.4 2.7 5.7 2.8 4.5 0.0 1.9 2.1 2.9 0.4 1.2 1.9 0.0 0.5 1.6 0.1 1.0 0.3 2.1 2.5 0.6 0.1 1.5 0.0 0.2 0.1 0.2 2.1 3.5 3.1 0.8 0.0 0.0 3.0 0.0 0.0 8.5 3.9 2.3 2.2 0.6 0.0 2.8 0.0 0.3 0.0 0.0 0.1 0.2 0.1 35.5 0.1 2.8 3.6 0.5 5.0 1.1 2.1 8.2 4.5 0.0 1.7 11.3 33.8 1.7 0.0 0.3 1.5 0.3 0.0 2.1 1.5 0.4 1.5 8.2 13.6 2.5 1.8 6.0 3.1 1.9 0.0 0.0 1.0 0.0 0.1 0.4 0.3 1.0 0.0 0.3 1.6 1.2 0.2 0.5 0.0 1.2 0.0 0.1 10.9 15.7 46.9 21.8 14.0 10.6 8.8 14.4 17.0 5.7 ADGRL2 "KIAA0786, LEC1, LPHH1, LPHN2" ENSG00000117114 "Adhesion G protein-coupled receptor L2" O95490 1 81306160-81992436 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 62.8;hTEC/SVTERT24-B: 31.2;NTERA-2: 26.3;SH-SY5Y: 42.1;U-2197: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043447 Approved "Plasma membrane,Cell Junctions" 280000 "Plasma membrane, Cell Junctions" "HPA043447: AB_2678486" "unprognostic (2.54e-2)" "unprognostic (6.29e-3)" "unprognostic (2.57e-1)" "prognostic unfavourable (1.33e-4)" "unprognostic (3.22e-1)" "unprognostic (1.61e-1)" "prognostic unfavourable (9.92e-4)" "unprognostic (3.55e-2)" "unprognostic (9.84e-2)" "unprognostic (2.42e-1)" "unprognostic (7.81e-2)" "unprognostic (8.01e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (3.00e-4)" "unprognostic (2.76e-1)" "unprognostic (3.38e-3)" "unprognostic (1.41e-2)" 8.9 10.5 21.1 3.6 20.9 0.0 8.8 1.5 45.8 7.5 7.0 1.4 1.2 2.7 6.1 8.6 12.0 12.0 11.5 17.6 12.2 6.6 10.9 18.7 32.7 3.5 3.5 22.8 18.8 4.9 20.3 11.8 24.4 6.2 15.6 5.4 9.4 19.1 10.1 2.0 6.3 6.1 6.0 3.2 10.0 7.6 2.0 3.3 0.6 22.4 15.0 5.0 6.5 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 2.3 62.8 0.0 7.8 8.9 0.8 1.5 3.5 0.6 0.7 0.0 0.0 0.0 17.2 8.0 2.5 5.0 6.6 0.5 0.1 10.2 0.0 1.8 4.4 2.9 0.0 0.1 7.6 0.4 31.2 3.1 10.3 0.0 0.0 0.8 0.0 0.0 0.0 26.3 1.8 0.0 8.6 0.0 14.3 0.9 3.1 42.1 0.0 1.7 0.0 0.1 18.5 6.7 6.4 7.3 28.7 2.2 0.0 0.0 0.0 3.6 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 20.9 1.5 45.8 12.2 6.6 3.5 22.8 6.2 3.3 AGO2 "CASC7, EIF2C2, hAGO2, LINC00980, Q10" ENSG00000123908 "Argonaute 2, RISC catalytic component" Q9UKV8 8 140520156-140635619 "Enzymes, Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019309, HPA058075" Approved Supported "Nucleoplasm,Cell Junctions" 35000000 "Nucleoplasm, Cell Junctions" "CAB019309: , HPA058075: " "unprognostic (2.75e-2)" "unprognostic (1.79e-3)" "unprognostic (1.27e-1)" "prognostic unfavourable (1.21e-4)" "unprognostic (2.46e-1)" "unprognostic (2.15e-1)" "unprognostic (1.49e-3)" "unprognostic (8.86e-2)" "unprognostic (2.21e-1)" "unprognostic (8.50e-2)" "unprognostic (3.47e-2)" "unprognostic (2.73e-1)" "prognostic unfavourable (1.82e-5)" "unprognostic (1.32e-1)" "unprognostic (2.77e-1)" "unprognostic (1.32e-1)" "unprognostic (3.02e-1)" 11.2 6.6 7.7 9.9 13.1 16.2 25.0 9.9 11.4 7.5 9.2 12.1 12.8 5.3 10.2 10.4 10.6 8.6 8.8 12.4 8.8 5.3 6.9 7.4 13.2 12.5 13.4 5.0 11.8 8.4 13.2 8.8 9.9 10.7 7.5 6.9 5.6 8.1 12.6 37.1 14.1 7.5 15.0 11.7 6.9 10.0 5.9 12.7 11.1 8.6 8.2 8.9 10.4 18.4 2.5 2.1 6.4 2.6 2.4 3.0 1.5 12.6 10.5 10.8 12.3 7.1 8.4 9.1 8.0 5.8 3.6 4.5 11.6 3.8 14.6 10.1 7.7 8.6 18.2 8.6 8.0 8.2 9.5 17.1 18.0 7.4 6.4 7.0 5.8 5.7 7.8 10.0 10.4 8.3 17.8 9.2 11.7 19.2 12.1 5.6 8.0 18.3 12.5 9.1 6.6 4.6 13.2 12.7 9.2 12.5 4.3 8.9 11.0 10.3 11.6 6.3 17.5 9.8 12.8 8.2 2.6 10.3 4.6 12.8 9.2 1.8 2.6 0.7 2.7 2.3 3.0 1.3 2.6 2.3 2.1 2.5 2.7 2.7 6.4 2.4 2.3 1.5 2.1 1.5 7.7 13.1 9.9 11.4 8.8 5.3 13.4 5.0 10.7 12.7 AL358113.1 ENSG00000285130 9 69035750-69255187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HaCaT: 2.8;HUVEC TERT2: 2.1;REH: 9.6;U-2 OS: 2.2" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "dendritic cells: 1.3;monocytes: 2.8;T-cells: 2.6" "HPA001813, HPA068304, HPA070714" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA001813: AB_1080764, HPA068304: , HPA070714: " 1.6 4.3 2.5 1.9 2.1 2.6 2.8 3.6 2.5 1.6 2.8 3.0 2.7 1.6 2.2 1.6 1.6 3.4 1.6 5.8 1.3 2.1 8.8 2.1 3.2 2.8 1.7 3.7 9.4 1.6 1.7 1.6 2.4 4.0 1.6 2.9 2.8 3.2 7.5 1.6 3.0 4.5 1.6 3.1 3.1 3.4 2.1 0.0 2.6 2.0 2.1 2.4 1.3 0.1 1.3 0.1 2.8 0.0 2.6 0.4 0.4 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.7 0.3 2.8 0.2 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 2.1 0.1 0.0 0.2 0.0 1.2 0.2 0.8 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.4 0.0 0.3 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.2 2.6 0.2 0.1 1.3 0.1 1.0 0.1 0.6 0.3 0.1 0.0 2.8 1.3 2.6 0.4 AL645922.1 ENSG00000244255 6 31927698-31952048 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 115.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.3;Hep G2: 1.5;Karpas-707: 2.4;U-266/84: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000951, HPA001817, HPA001832" Approved Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" "Endoplasmic reticulum, Vesicles" "Cell Junctions" "HPA000951: , HPA001817: AB_1078779, HPA001832: AB_1078778" "unprognostic (7.68e-2)" "unprognostic (1.86e-2)" 5.3 0.9 0.6 2.9 0.7 0.3 3.9 0.6 0.7 0.7 3.7 0.3 0.0 0.8 0.9 3.0 0.9 1.1 0.8 4.4 0.7 0.6 10.8 115.5 15.8 9.7 0.7 0.0 1.5 0.7 0.3 0.7 5.0 0.6 0.8 0.6 1.1 0.8 0.3 0.8 0.7 4.3 1.5 0.8 9.7 1.3 1.3 0.0 0.3 0.7 0.0 1.3 1.5 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.7 0.6 0.7 0.7 0.6 0.7 0.0 0.6 0.0 AMOTL1 JEAP ENSG00000166025 "Angiomotin like 1" Q8IY63 11 94706431-94876753 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 78.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 36.0;WM-115: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3;NK-cell: 2.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001196 Approved Approved "Cell Junctions,Cytosol" 11000 Cytosol "Cell Junctions" "HPA001196: AB_1078147" "unprognostic (2.21e-1)" "unprognostic (5.25e-2)" "unprognostic (4.23e-2)" "unprognostic (5.43e-2)" "unprognostic (7.58e-2)" "unprognostic (3.29e-2)" "unprognostic (1.05e-1)" "unprognostic (2.40e-1)" "unprognostic (2.09e-1)" "unprognostic (7.97e-2)" "unprognostic (1.85e-1)" "unprognostic (5.95e-2)" "prognostic favourable (5.03e-6)" "unprognostic (7.47e-3)" "unprognostic (1.39e-1)" "unprognostic (1.68e-2)" "unprognostic (1.29e-2)" 14.4 5.7 3.3 6.9 4.0 0.6 9.2 3.7 4.8 12.8 15.4 2.7 9.1 2.2 16.4 11.4 19.3 7.5 10.9 10.1 3.1 3.9 4.4 4.8 10.0 2.5 3.2 2.5 7.3 10.8 13.5 13.9 25.4 3.5 18.7 4.0 11.3 8.9 13.6 78.2 11.7 4.8 32.8 2.6 6.2 8.1 7.1 1.8 12.9 8.6 21.9 10.1 24.4 9.5 2.3 1.0 0.0 0.7 2.3 0.1 0.5 18.0 5.1 13.8 0.0 14.9 12.9 6.6 10.0 17.5 4.6 5.4 9.4 0.5 0.8 4.9 13.5 23.5 6.5 36.0 4.8 1.4 5.0 9.7 5.4 0.0 3.4 2.1 0.0 7.6 22.3 15.7 26.3 9.5 24.5 0.9 10.8 5.2 6.6 1.3 2.0 3.4 0.0 25.1 1.5 6.5 7.6 10.5 12.7 0.6 13.9 3.6 0.7 3.0 8.7 12.6 9.3 0.2 6.8 0.5 0.0 5.1 3.5 0.0 34.4 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.6 2.3 0.0 0.0 0.0 2.3 0.2 1.0 0.0 0.5 3.3 4.0 3.7 3.0 3.1 3.9 3.2 2.5 3.5 1.8 AMOTL2 LCCP ENSG00000114019 "Angiomotin like 2" Q9Y2J4 3 134355874-134375479 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063027 Approved "Cell Junctions" "Cell Junctions" "HPA063027: " "unprognostic (2.23e-1)" "unprognostic (2.55e-2)" "unprognostic (7.01e-3)" "prognostic unfavourable (1.94e-4)" "unprognostic (6.09e-2)" "unprognostic (1.57e-2)" "unprognostic (9.84e-2)" "unprognostic (4.40e-2)" "unprognostic (2.32e-1)" "unprognostic (3.02e-1)" "unprognostic (2.85e-2)" "unprognostic (1.49e-1)" "unprognostic (8.09e-2)" "unprognostic (3.59e-1)" "unprognostic (7.67e-2)" "unprognostic (3.85e-1)" "unprognostic (1.17e-2)" 49.4 9.5 9.2 8.8 22.6 0.6 29.0 6.1 19.3 25.7 13.5 47.7 7.9 6.9 24.2 10.2 19.4 19.1 18.2 14.0 13.1 7.6 21.4 10.4 20.4 8.5 25.5 15.1 12.6 21.3 11.1 3.4 27.6 16.6 21.0 4.9 20.3 13.8 14.8 11.5 19.8 8.2 27.8 17.7 15.9 12.6 7.6 28.1 0.1 18.6 15.9 8.6 15.1 31.8 0.0 0.0 0.2 0.0 0.0 0.2 0.0 24.9 10.7 7.6 8.1 7.8 10.3 67.5 25.3 14.8 24.5 12.0 33.7 7.6 0.0 33.2 17.3 19.1 4.9 6.8 10.0 0.0 0.5 0.0 5.8 3.5 15.9 0.0 0.0 14.4 21.4 9.2 9.9 11.4 0.2 0.0 15.1 7.9 0.0 0.0 9.9 4.4 0.0 10.2 0.0 14.6 5.8 1.1 3.2 20.6 24.1 17.0 22.9 0.2 19.2 16.1 14.2 10.7 15.6 0.0 0.0 0.0 5.8 0.0 17.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.2 22.6 6.1 19.3 13.1 7.6 25.5 15.1 16.6 28.1 ANKRA2 ENSG00000164331 "Ankyrin repeat family A member 2" Q9H9E1 5 73552335-73565686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003968, HPA065263" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA003968: , HPA065263: " "unprognostic (1.75e-1)" "unprognostic (5.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-1)" "unprognostic (3.31e-1)" "unprognostic (3.89e-2)" "unprognostic (5.68e-2)" "unprognostic (6.19e-2)" "unprognostic (3.47e-2)" "unprognostic (1.09e-1)" "unprognostic (1.06e-2)" "unprognostic (1.79e-1)" "unprognostic (9.80e-3)" "unprognostic (3.36e-1)" "unprognostic (3.31e-1)" "unprognostic (6.65e-2)" "unprognostic (1.13e-3)" 13.0 19.4 11.9 9.2 17.1 18.7 20.9 22.8 18.3 15.7 13.5 16.6 13.1 15.0 20.0 21.0 13.3 18.5 15.0 12.2 18.1 15.8 9.6 15.9 20.7 13.9 20.6 12.3 23.3 19.7 11.4 30.2 15.4 23.1 19.8 16.4 17.5 19.0 14.3 14.5 13.4 15.3 17.8 30.7 13.0 16.2 10.3 15.8 18.1 22.2 4.5 14.7 14.9 13.3 10.7 5.9 16.9 7.4 7.0 15.5 7.3 5.1 3.9 5.7 6.0 10.5 16.0 17.5 7.0 10.5 6.1 9.2 1.1 7.9 4.8 5.7 6.9 3.7 2.7 12.5 8.8 10.0 4.7 4.2 3.0 5.4 8.2 2.5 8.3 16.5 16.9 7.4 7.6 6.8 4.1 8.1 7.0 3.1 4.3 6.4 3.1 2.9 2.6 6.2 6.6 4.8 6.4 7.7 6.0 5.3 4.3 8.3 6.4 4.1 8.5 2.5 3.0 3.9 5.0 15.8 11.4 4.1 6.2 4.1 7.1 16.9 5.7 11.3 8.7 4.6 10.5 10.7 10.2 12.1 4.9 8.4 15.5 14.2 9.0 7.0 7.4 5.9 11.7 7.3 11.9 17.1 22.8 18.3 18.1 15.8 20.6 12.3 23.1 15.8 APOC3 ENSG00000110245 "Apolipoprotein C3" P02656 11 116829706-116833072 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 714.1" "Group enriched" "Detected in some" 19 "CACO-2: 27.8;Hep G2: 75.2" "Cancer enriched" "Detected in many" 643 "liver cancer: 4021.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065365, HPA073918" Supported Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Secreted to blood" 88520000000 97000000000 Nucleoplasm "Nucleoli, Cell Junctions" "HPA065365: , HPA073918: " "prognostic favourable (3.77e-4)" "unprognostic (2.33e-1)" "prognostic unfavourable (6.87e-5)" "unprognostic (1.60e-2)" "unprognostic (5.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 38.7 0.1 0.1 31.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.4 714.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 91.3 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 27.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 75.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.6 0.9 0.0 0.0 0.3 1.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 AQP4 MIWC ENSG00000171885 "Aquaporin 4" P55087 18 26852038-26865818 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 185.1;lung: 53.5" "Cell line enhanced" "Detected in some" "AF22: 6.7;Karpas-707: 2.0;RPTEC TERT1: 3.8;U-87 MG: 1.7" "Cancer enriched" "Detected in some" 22 "glioma: 223.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005079, HPA014784, CAB058689" Enhanced Supported Approved "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "CAB005079: AB_2274338, CAB058689: , HPA014784: AB_1844967" "unprognostic (7.23e-5)" "unprognostic (1.55e-1)" "unprognostic (3.19e-8)" "unprognostic (3.68e-1)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.34e-1)" "unprognostic (5.38e-3)" "unprognostic (1.64e-3)" "unprognostic (8.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.14e-2)" "unprognostic (1.35e-1)" "unprognostic (4.10e-2)" 1.7 1.7 60.7 1.6 57.1 1.6 1.8 21.8 185.1 1.9 1.6 41.3 0.0 1.6 1.6 2.0 1.9 2.1 1.6 2.7 64.3 27.1 2.7 2.0 53.5 1.7 39.8 36.4 2.8 1.7 2.9 0.8 1.6 39.1 1.8 1.6 0.0 1.8 1.7 25.4 1.6 1.6 1.6 67.2 1.8 6.1 1.7 42.2 0.0 8.4 0.1 1.6 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.2 0.9 0.0 0.0 0.0 0.0 3.8 0.0 1.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 57.1 21.8 31.7 64.3 27.1 39.8 36.4 39.1 42.2 ARL15 "ARFRP2, FLJ20051" ENSG00000185305 "ADP ribosylation factor like GTPase 15" Q9NXU5 5 53883945-54310582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044604, HPA063820" Uncertain Approved "Golgi apparatus,Plasma membrane,Cell Junctions" "Golgi apparatus" "Plasma membrane, Cell Junctions" "HPA044604: AB_10960542, HPA063820: " "unprognostic (2.18e-1)" "unprognostic (4.32e-2)" "unprognostic (1.82e-2)" "unprognostic (2.41e-2)" "unprognostic (1.08e-1)" "unprognostic (3.70e-1)" "unprognostic (8.52e-3)" "unprognostic (1.16e-2)" "unprognostic (3.05e-2)" "unprognostic (6.56e-2)" "unprognostic (4.26e-3)" "unprognostic (3.86e-1)" "unprognostic (2.48e-3)" "unprognostic (1.35e-1)" "unprognostic (9.15e-2)" "unprognostic (5.60e-2)" "unprognostic (1.08e-1)" 22.0 19.9 13.4 13.1 10.5 2.2 20.1 15.7 22.4 29.9 15.6 5.9 8.7 13.9 32.2 9.9 13.2 12.7 20.5 20.1 19.7 13.2 23.9 12.8 14.4 13.9 11.3 11.2 9.8 7.8 3.5 28.0 31.4 12.3 14.3 15.4 15.3 19.6 12.1 5.2 16.9 12.7 26.7 15.1 15.2 11.1 14.2 10.5 17.4 13.4 13.9 10.8 19.1 13.6 2.0 5.0 7.4 3.5 1.4 4.8 2.3 1.9 3.8 5.9 9.9 5.9 5.2 7.4 6.2 9.4 6.2 13.3 14.6 4.8 17.1 10.2 6.0 4.7 8.9 10.2 8.7 2.2 9.2 23.6 5.5 1.2 1.4 2.2 27.7 7.4 7.0 10.2 7.1 15.0 21.2 2.7 4.1 4.1 4.3 2.2 2.0 2.5 3.9 6.3 0.4 8.7 20.7 7.5 3.9 7.9 4.4 5.0 4.7 2.9 7.6 3.9 6.0 2.9 4.5 1.1 1.1 19.6 5.9 6.3 6.3 2.7 3.5 4.6 2.9 3.2 1.7 2.0 2.0 2.1 5.0 1.6 2.1 1.7 7.4 1.4 2.3 0.7 4.8 2.3 13.4 10.5 15.7 22.4 19.7 13.2 11.3 11.2 12.3 10.5 ARPC1A "Arc40, SOP2Hs, SOP2L" ENSG00000241685 "Actin related protein 2/3 complex subunit 1A" Q92747 7 99325910-99366262 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA004334 Approved Approved "Cell Junctions,Cytosol" 2400000 "Cell Junctions" Cytosol "HPA004334: AB_1078215" "unprognostic (1.31e-1)" "unprognostic (1.58e-1)" "unprognostic (6.22e-3)" "unprognostic (1.93e-2)" "unprognostic (8.38e-3)" "unprognostic (1.95e-2)" "prognostic unfavourable (4.70e-4)" "unprognostic (2.52e-2)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.89e-2)" "unprognostic (7.88e-2)" "unprognostic (4.45e-2)" "unprognostic (9.15e-2)" "unprognostic (7.07e-2)" "unprognostic (1.83e-1)" 36.6 39.8 40.2 25.2 41.0 18.7 49.1 32.3 55.9 40.0 43.6 32.3 37.9 50.1 30.4 45.9 58.3 43.3 32.1 65.3 45.9 43.5 30.6 41.2 29.6 32.2 38.6 39.7 47.2 41.9 30.9 31.4 31.8 40.6 28.2 44.2 33.9 31.7 36.7 20.9 46.1 55.0 31.9 27.9 26.8 53.1 28.6 25.1 23.7 44.4 41.8 31.6 31.5 33.9 11.1 16.1 33.2 29.1 10.9 12.6 9.9 45.4 24.8 28.2 12.9 26.3 44.8 24.0 32.7 38.4 33.4 33.3 27.8 52.5 15.9 48.4 39.7 19.3 36.9 47.5 40.4 7.9 31.1 8.5 18.5 22.4 29.0 10.0 11.2 41.6 26.6 43.0 46.0 54.6 21.3 18.5 51.2 66.5 16.7 13.4 26.4 56.1 9.9 19.5 19.5 24.8 27.6 29.1 24.9 32.0 46.0 43.6 23.0 14.8 42.3 42.8 38.4 75.4 52.1 7.2 13.2 22.6 37.0 22.5 56.1 33.2 18.9 31.9 9.8 28.6 7.6 11.0 9.3 12.6 16.1 11.1 12.1 9.1 23.8 10.9 29.1 11.7 12.1 9.9 40.2 41.0 32.3 55.9 45.9 43.5 38.6 39.7 40.6 25.1 ARPC5 "ARC16, dJ127C7.3, p16-Arc" ENSG00000162704 "Actin related protein 2/3 complex subunit 5" O15511 1 183620846-183635757 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 154.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022013, HPA031972" Approved Approved "Vesicles,Plasma membrane,Cell Junctions,Cytosol" 15000000 "Vesicles, Plasma membrane, Cell Junctions, Cytosol" "HPA022013: AB_1845045, HPA031972: " "unprognostic (3.82e-1)" "unprognostic (8.78e-2)" "unprognostic (1.43e-1)" "unprognostic (2.36e-2)" "unprognostic (1.74e-1)" "unprognostic (1.85e-2)" "prognostic unfavourable (3.63e-4)" "unprognostic (5.90e-3)" "unprognostic (3.84e-2)" "unprognostic (3.17e-3)" "unprognostic (1.14e-1)" "unprognostic (1.29e-1)" "prognostic unfavourable (1.21e-10)" "unprognostic (3.03e-2)" "unprognostic (4.66e-2)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" 46.6 25.1 24.9 57.5 24.3 25.2 28.9 13.8 24.8 26.6 42.3 26.5 18.6 40.8 39.0 26.7 44.5 29.3 24.6 36.8 28.2 22.3 28.8 29.7 52.3 58.3 28.4 18.7 27.3 21.5 12.4 18.2 84.8 20.0 23.2 29.2 17.0 25.4 16.5 16.4 25.2 47.3 32.8 46.0 79.9 35.6 21.7 23.5 61.2 27.5 22.7 52.8 30.6 30.8 27.4 68.9 154.0 96.6 30.7 40.7 124.3 50.8 28.2 24.3 16.7 20.1 28.7 58.2 69.9 53.9 30.5 24.9 25.5 36.1 46.8 79.6 40.2 35.4 17.1 23.8 16.1 67.4 15.3 28.3 38.4 22.0 32.7 41.0 55.2 34.7 25.4 36.9 29.4 35.7 21.5 38.8 39.5 20.9 38.2 11.0 23.2 10.8 35.6 21.6 45.2 17.1 26.4 10.5 28.3 72.9 31.5 27.0 31.6 36.7 79.5 44.6 23.2 49.8 67.3 46.3 51.1 32.0 35.1 29.6 34.2 79.3 80.0 124.1 34.8 89.8 27.7 27.4 34.2 35.5 68.9 24.4 37.1 37.6 154.0 30.7 96.6 32.5 40.7 124.3 24.9 24.3 13.8 21.1 28.2 22.3 28.4 18.7 20.0 23.5 ASGR1 CLEC4H1 ENSG00000141505 "Asialoglycoprotein receptor 1" P07306 17 7173431-7179564 "Predicted intracellular proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 171.0" "Cell line enriched" "Detected in some" 30 "Hep G2: 102.0" "Cancer enriched" "Detected in many" 90 "liver cancer: 131.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7" "Group enriched" "Detected in many" 13 "dendritic cells: 13.7;monocytes: 39.1" "Region enriched" "Detected in many" 9 "cerebellum: 49.4" "Not detected" "Not detected" "HPA011954, HPA012852" Enhanced Supported "Vesicles,Cell Junctions" "Intracellular and membrane" Vesicles "Cell Junctions" "HPA011954: AB_1845079, HPA012852: AB_1845080" "unprognostic (3.56e-3)" "unprognostic (3.57e-1)" "unprognostic (8.76e-2)" "unprognostic (4.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-2)" "unprognostic (5.37e-2)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (8.55e-5)" "unprognostic (1.55e-1)" "unprognostic (8.33e-11)" "unprognostic (1.45e-1)" "unprognostic (2.00e-1)" "unprognostic (1.73e-3)" "unprognostic (4.46e-3)" 0.2 0.1 0.8 0.9 0.6 0.6 0.2 2.8 1.8 0.1 0.2 0.2 0.2 0.5 0.2 0.1 0.1 0.1 0.7 0.1 0.8 0.8 0.1 171.0 0.7 0.3 0.4 1.2 0.1 0.3 0.9 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.3 0.7 0.3 0.3 0.3 0.5 0.2 2.9 0.2 0.1 1.4 0.1 0.1 0.3 0.1 0.2 13.7 2.1 39.1 0.1 0.3 10.1 0.0 0.1 2.0 0.9 0.0 0.0 0.1 0.1 0.1 0.2 0.3 3.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.3 102.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 1.8 0.2 0.1 0.1 0.0 0.1 0.2 0.3 0.1 0.1 0.7 0.0 0.0 0.1 0.1 0.8 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 2.1 39.1 0.1 0.1 17.9 0.3 0.1 0.0 0.0 13.7 0.2 0.1 0.1 1.1 0.1 4.5 0.6 0.1 10.1 0.8 0.6 2.8 1.8 0.8 0.8 0.4 1.2 0.7 0.2 BORCS8-MEF2B MEF2BNB-MEF2B ENSG00000064489 "BORCS8-MEF2B readthrough" 19 19145567-19192158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 10.9;U-266/70: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA004734 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (2.74e-1)" "unprognostic (5.77e-3)" "unprognostic (8.67e-2)" "unprognostic (3.88e-1)" "unprognostic (1.46e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.75e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (6.23e-2)" "unprognostic (1.25e-1)" "unprognostic (2.33e-1)" "unprognostic (7.78e-2)" "unprognostic (5.29e-2)" 4.8 3.5 7.0 5.8 7.4 7.4 4.6 5.6 8.6 5.4 5.4 8.1 6.7 3.2 6.7 7.4 5.4 10.5 7.2 3.4 6.8 6.2 7.5 5.9 4.8 7.1 8.0 5.5 9.8 7.8 5.5 4.9 5.0 7.3 5.7 5.5 6.2 5.6 7.2 5.3 8.8 4.0 8.9 5.9 5.8 5.0 5.5 5.8 5.6 5.9 4.9 7.5 5.8 5.8 0.0 0.4 0.6 0.1 0.0 0.3 0.0 1.6 0.0 0.7 1.2 1.0 2.4 1.3 1.1 1.0 1.5 1.5 0.0 3.1 3.3 0.5 0.0 0.6 0.6 0.6 0.3 0.4 2.4 1.1 0.1 0.3 2.2 0.0 0.2 0.0 2.3 0.7 3.7 0.4 0.2 1.9 0.6 3.1 0.7 0.4 0.0 10.9 3.3 0.9 0.9 0.0 0.2 0.0 1.1 1.9 0.0 0.9 0.3 0.5 0.3 0.7 1.2 5.6 0.4 11.1 1.7 5.5 2.3 2.6 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.1 0.0 7.0 7.4 5.6 8.6 6.8 6.2 8.0 5.5 7.3 5.8 BRK1 "C3orf10, HSPC300, MDS027" ENSG00000254999 "BRICK1, SCAR/WAVE actin nucleating complex subunit" Q8WUW1 3 10115592-10127190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060391 Approved "Nuclear speckles,Cell Junctions" 130000 "Nuclear speckles" "Cell Junctions" "HPA060391: " "unprognostic (4.99e-2)" "unprognostic (3.48e-2)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (2.91e-1)" "unprognostic (9.60e-2)" "prognostic unfavourable (5.76e-5)" "unprognostic (2.49e-2)" "unprognostic (2.89e-1)" "unprognostic (1.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.37e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-1)" "unprognostic (9.40e-2)" "unprognostic (4.35e-2)" "unprognostic (7.75e-3)" 67.1 47.6 53.4 40.4 57.1 52.4 62.9 33.4 69.5 52.8 58.6 36.1 47.3 37.9 63.2 68.3 73.0 59.4 70.8 54.4 42.6 45.3 66.8 57.3 49.3 53.2 43.3 53.6 62.7 57.8 38.8 39.2 44.4 40.7 60.8 51.8 41.5 84.2 53.1 62.7 57.0 46.5 74.3 37.2 47.0 57.2 65.2 34.2 50.2 83.3 62.4 64.8 63.0 61.0 67.4 89.7 76.1 75.4 47.2 61.0 89.1 30.1 36.2 38.6 20.0 64.6 70.6 91.4 44.9 44.8 42.2 42.0 24.8 35.5 34.8 21.4 51.6 15.8 27.7 45.5 46.3 38.3 38.4 48.0 41.8 36.9 36.8 45.6 36.4 46.3 44.1 47.2 34.4 58.8 31.1 40.8 63.6 66.3 29.5 36.5 44.4 45.9 28.6 39.7 37.8 55.5 50.1 15.0 26.1 36.1 31.5 36.3 51.2 40.0 53.1 42.5 32.6 49.7 40.0 23.5 63.0 78.5 61.5 62.7 34.9 54.1 75.4 75.9 56.5 72.4 50.3 67.4 55.0 53.1 84.3 67.4 50.1 54.4 76.1 47.2 70.9 89.7 61.0 89.1 53.4 57.1 33.4 69.5 42.6 45.3 43.3 53.6 40.7 34.2 BUB1B-PAK6 ENSG00000259288 "BUB1B-PAK6 readthrough" 15 40217428-40276396 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031124 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.83e-1)" "unprognostic (1.29e-3)" "unprognostic (1.32e-1)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-2)" 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 C17orf62 "FLJ90469, MGC4368" ENSG00000178927 "Chromosome 17 open reading frame 62" Q9BQA9 17 82442589-82450829 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045696 Uncertain Approved "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "HPA045696: " "unprognostic (1.87e-2)" "unprognostic (6.92e-3)" "unprognostic (2.25e-1)" "unprognostic (2.15e-3)" "unprognostic (5.75e-2)" "unprognostic (2.05e-3)" "unprognostic (3.81e-3)" "unprognostic (4.86e-2)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-3)" "unprognostic (7.99e-2)" "prognostic unfavourable (6.83e-11)" "unprognostic (1.47e-1)" "unprognostic (5.51e-2)" "unprognostic (7.78e-2)" "unprognostic (9.14e-3)" 19.9 17.3 16.8 35.8 25.2 16.4 20.0 8.6 20.4 16.2 16.2 20.8 10.5 12.1 16.5 13.1 17.1 16.0 22.9 12.1 15.2 12.1 17.5 29.1 20.2 48.3 26.8 12.4 17.6 21.3 12.9 15.7 14.9 20.6 19.5 13.6 12.2 14.7 12.7 6.5 13.9 21.1 20.2 19.0 53.7 16.4 8.3 20.9 26.0 13.8 8.2 42.3 29.2 13.3 30.6 33.0 74.9 44.2 24.2 25.9 34.6 14.0 20.5 11.3 18.6 17.9 18.8 11.0 12.7 15.4 18.7 22.3 7.6 14.3 35.7 11.7 17.9 14.2 7.7 9.5 12.9 25.4 6.3 9.7 6.7 8.9 18.6 10.9 28.7 21.7 13.8 16.0 9.0 24.2 8.1 26.8 15.7 15.6 45.2 9.2 8.6 11.0 34.6 6.8 27.4 13.8 17.9 9.7 18.4 22.9 26.8 16.3 27.5 43.9 8.3 14.6 14.3 23.9 13.4 49.0 16.3 26.3 19.0 17.8 12.8 43.8 34.1 44.0 25.9 44.2 20.0 30.2 23.9 25.0 31.4 30.6 20.2 19.6 74.9 24.2 39.6 33.0 24.8 34.6 16.8 25.2 8.6 20.4 15.2 12.1 26.8 12.4 20.6 20.9 C8orf37 "BBS21, CORD16, FLJ30600, RP64" ENSG00000156172 "Chromosome 8 open reading frame 37" Q96NL8 8 95244919-95269201 "Disease related genes, Predicted intracellular proteins" "Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease mutation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024198 Approved Approved "Plasma membrane,Cell Junctions,Cytosol" Cytosol "Plasma membrane, Cell Junctions" "HPA024198: AB_1845775" "unprognostic (7.90e-2)" "unprognostic (1.98e-2)" "unprognostic (5.68e-2)" "prognostic unfavourable (4.63e-4)" "unprognostic (2.72e-3)" "unprognostic (4.20e-3)" "unprognostic (2.04e-2)" "unprognostic (8.94e-2)" "unprognostic (1.81e-1)" "unprognostic (1.76e-1)" "unprognostic (6.11e-3)" "unprognostic (2.32e-1)" "unprognostic (1.09e-1)" "unprognostic (6.72e-3)" "unprognostic (2.02e-1)" "unprognostic (1.33e-2)" "unprognostic (3.29e-1)" 4.8 5.6 7.9 5.8 9.9 2.4 6.4 9.8 8.0 6.7 3.1 10.5 2.9 2.6 6.5 8.6 3.3 10.5 4.0 7.0 8.7 7.1 6.6 4.9 4.3 5.6 7.4 6.9 13.0 3.8 10.1 9.9 4.9 7.9 5.6 2.8 4.6 4.3 7.1 2.9 4.2 3.3 6.2 9.2 4.4 3.2 4.5 9.5 3.8 6.7 1.6 5.1 4.0 4.4 3.9 1.9 2.3 1.4 2.7 2.3 0.8 4.1 6.7 5.6 2.9 2.0 5.2 1.6 1.8 4.1 2.4 3.1 1.0 9.1 8.3 4.4 3.0 3.4 2.3 4.6 5.2 2.6 2.1 6.5 4.1 3.0 2.2 1.4 3.6 5.2 2.2 2.8 7.8 3.5 3.3 4.9 3.0 3.2 6.9 1.6 1.8 4.6 3.6 3.0 2.1 5.2 1.8 5.4 5.3 3.7 0.8 3.1 6.5 1.3 3.0 2.9 3.8 2.5 1.8 4.5 4.3 5.6 5.6 3.1 3.6 1.3 1.4 0.6 1.2 0.9 2.1 1.9 1.4 1.3 1.9 3.9 1.4 2.3 2.3 2.7 0.7 0.9 0.5 0.8 7.9 9.9 9.8 8.0 8.7 7.1 7.4 6.9 7.9 9.5 C9orf3 "AOPEP, AP-O, APO, C90RF3, FLJ14675" ENSG00000148120 "Chromosome 9 open reading frame 3" Q8N6M6 9 94726701-95087218 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 20.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004633, HPA072729" Approved Approved "Cell Junctions" "Cell Junctions" "HPA004633: AB_1078362, HPA072729: " "unprognostic (4.25e-2)" "unprognostic (1.07e-3)" "unprognostic (6.29e-2)" "unprognostic (1.71e-1)" "unprognostic (1.12e-1)" "unprognostic (2.75e-2)" "unprognostic (9.59e-2)" "unprognostic (4.24e-2)" "unprognostic (2.99e-2)" "unprognostic (1.34e-1)" "unprognostic (2.60e-2)" "unprognostic (2.80e-1)" "prognostic favourable (6.33e-5)" "unprognostic (2.31e-1)" "unprognostic (2.56e-1)" "unprognostic (3.29e-2)" "unprognostic (3.37e-2)" 6.2 8.5 6.8 9.1 12.7 2.4 11.3 10.5 10.3 14.0 17.8 24.6 24.1 5.1 28.8 15.0 20.2 16.0 17.9 29.9 8.9 5.9 12.7 28.1 10.9 3.1 11.3 6.1 11.7 24.7 25.0 11.1 24.4 11.3 22.1 6.8 11.4 13.1 17.6 29.8 39.1 8.1 32.2 11.6 6.8 10.8 6.4 11.4 3.3 11.6 23.7 7.8 12.9 25.1 5.4 5.8 2.1 3.6 3.4 3.6 1.8 4.5 20.4 2.2 3.8 2.3 3.0 8.7 4.4 2.0 4.6 2.8 4.3 6.0 1.3 3.7 7.4 18.0 4.1 4.2 2.3 9.5 3.2 1.3 18.5 3.8 4.7 1.2 1.0 3.1 17.5 4.0 2.7 2.6 2.1 1.9 8.4 6.7 1.7 1.4 2.9 8.5 2.7 7.1 1.7 8.1 4.1 4.5 6.8 7.4 6.9 1.6 7.6 0.9 2.0 2.0 2.0 8.3 2.3 1.6 2.1 0.7 6.9 1.0 3.6 0.3 3.6 2.1 3.6 2.5 2.3 2.4 3.0 3.3 5.8 5.4 2.3 2.7 1.3 3.4 1.7 5.2 1.9 1.8 6.8 12.7 10.5 10.3 8.9 5.9 11.3 6.1 11.3 11.4 CABLES2 "C20orf150, dJ908M14.2, ik3-2" ENSG00000149679 "Cdk5 and Abl enzyme substrate 2" Q9BTV7 20 62388632-62407285 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052138 Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" "Nuclear bodies" "Nucleoplasm, Cell Junctions" "HPA052138: " "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (2.25e-1)" "prognostic unfavourable (5.26e-5)" "unprognostic (1.45e-2)" "unprognostic (1.51e-1)" "unprognostic (2.71e-2)" "unprognostic (5.07e-2)" "unprognostic (5.37e-3)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.09e-2)" "prognostic unfavourable (1.24e-6)" "unprognostic (1.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.67e-1)" "unprognostic (2.94e-2)" 2.3 3.3 5.9 5.6 5.6 8.3 2.8 15.1 10.2 3.4 4.4 3.6 1.3 3.6 3.7 3.6 3.7 4.7 3.0 10.5 4.3 5.5 2.6 3.6 2.9 5.7 4.9 5.3 4.3 3.7 4.1 5.8 4.3 7.2 4.1 4.1 3.1 3.6 4.2 5.4 5.2 4.9 4.3 3.5 4.1 3.8 34.9 5.4 5.1 5.7 2.6 5.2 4.1 3.2 1.4 1.1 1.0 1.1 1.5 4.1 0.5 9.5 7.2 12.5 12.7 1.9 2.7 1.7 5.4 5.4 15.2 7.1 25.9 5.5 9.6 4.7 3.5 6.1 7.6 3.6 6.0 4.3 4.2 11.2 3.7 6.2 3.4 4.5 5.8 1.7 4.1 4.3 1.6 3.5 2.8 8.4 3.4 11.7 11.8 3.6 4.1 8.3 16.5 10.5 4.2 2.2 6.3 6.8 10.3 8.0 10.6 2.1 7.2 6.9 3.6 14.1 4.3 18.5 5.6 8.1 6.6 11.4 12.6 5.2 7.3 0.0 0.9 0.2 2.7 1.1 1.5 1.4 1.9 2.1 1.1 1.1 1.0 1.2 1.0 1.5 1.1 0.9 4.1 0.5 5.9 5.6 15.1 10.2 4.3 5.5 4.9 5.3 7.2 5.4 CAMK2A "CAMKA, CaMKIINalpha, KIAA0968" ENSG00000070808 "Calcium/calmodulin dependent protein kinase II alpha" Q9UQM7 5 150219491-150290291 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "brain: 105.7;skeletal muscle: 50.1" "Cell line enhanced" "Detected in some" "HaCaT: 2.6;SCLC-21H: 9.5;U-87 MG: 8.0" "Cancer enriched" "Detected in single" 13 "glioma: 6.0" "Group enriched" "Detected in all" 6 "amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1" "Low region specificity" "Detected in all" "CAB004330, HPA051783, HPA051785, HPA053973" Supported Approved "Plasma membrane,Cell Junctions,Cytosol" 21000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB004330: AB_626788, HPA051783: , HPA051785: , HPA053973: " "unprognostic (7.20e-3)" "unprognostic (6.47e-3)" "unprognostic (6.16e-3)" "unprognostic (4.85e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-3)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (3.07e-1)" "unprognostic (1.05e-1)" "unprognostic (4.49e-2)" "unprognostic (1.41e-2)" "unprognostic (2.00e-8)" "unprognostic (2.71e-4)" "unprognostic (1.68e-1)" "unprognostic (1.70e-2)" "unprognostic (1.36e-3)" 1.3 1.7 60.7 1.3 50.6 1.3 1.1 1.4 105.7 1.8 1.3 3.7 0.0 1.2 2.1 1.4 1.9 1.7 1.3 3.7 74.6 10.5 1.6 1.2 1.5 1.2 5.1 39.8 1.3 1.1 1.1 0.4 1.3 2.4 1.6 1.3 0.0 1.2 1.4 50.1 1.6 1.3 2.5 1.7 1.2 1.3 1.2 2.3 0.0 1.2 0.0 1.1 1.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.6 0.0 0.5 1.3 0.8 0.7 0.0 0.1 0.0 0.2 0.6 2.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 0.5 0.2 1.7 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.0 9.5 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 8.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 60.7 50.6 1.4 99.6 74.6 10.5 5.1 39.8 2.4 2.3 CAMK2B "CAM2, CAMK2, CAMKB" ENSG00000058404 "Calcium/calmodulin dependent protein kinase II beta" Q13554 7 44217150-44334577 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 41.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006849, HPA026307, HPA051783, HPA051785, HPA053973" Enhanced Supported Supported "Plasma membrane,Cell Junctions,Cytosol" 680000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB006849: , HPA026307: AB_1845941, HPA051783: , HPA051785: , HPA053973: " "unprognostic (1.88e-3)" "unprognostic (4.49e-2)" "unprognostic (3.55e-3)" "unprognostic (1.36e-2)" "unprognostic (5.25e-2)" "unprognostic (2.90e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-1)" "unprognostic (1.17e-2)" "unprognostic (1.60e-2)" "unprognostic (5.23e-7)" "unprognostic (7.04e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (3.95e-2)" 1.4 8.1 20.6 1.4 46.7 1.2 2.0 60.1 81.9 1.2 1.4 4.0 0.7 1.7 1.3 18.8 2.0 1.8 1.2 39.2 36.5 18.0 1.7 3.5 1.2 1.8 10.3 21.3 1.1 3.3 5.6 9.9 1.1 13.4 3.0 1.4 2.7 1.8 2.2 70.7 1.8 1.6 1.2 4.1 1.3 2.4 2.3 4.8 0.0 7.7 2.4 2.0 1.1 0.0 1.3 1.0 3.2 1.2 3.2 1.2 0.8 0.0 0.3 0.2 0.3 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.8 0.2 0.1 0.2 0.7 0.0 1.0 2.4 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 5.2 0.0 0.2 0.1 2.3 0.1 0.9 0.1 0.0 0.0 41.0 2.2 0.2 0.0 0.0 1.9 0.1 0.2 0.2 0.3 0.2 0.0 0.5 0.4 0.1 0.1 0.0 0.2 3.2 0.7 1.0 0.8 0.9 1.2 1.1 1.0 0.5 0.5 1.3 1.2 1.1 2.0 3.2 1.2 1.0 0.9 0.8 20.6 46.7 60.1 42.4 36.5 18.0 10.3 21.3 13.4 4.8 CAMK2D CAMKD ENSG00000145349 "Calcium/calmodulin dependent protein kinase II delta" Q13557 4 113451032-113761927 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026281, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" 140000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA026281: AB_1845944, HPA051783: , HPA051785: , HPA053973: " "unprognostic (2.14e-2)" "unprognostic (3.17e-1)" "unprognostic (2.13e-1)" "unprognostic (7.49e-2)" "unprognostic (2.19e-1)" "unprognostic (5.09e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (2.26e-1)" "unprognostic (2.62e-1)" "unprognostic (7.81e-2)" "unprognostic (7.91e-3)" "unprognostic (2.62e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-2)" "unprognostic (1.87e-1)" "unprognostic (1.90e-2)" 22.8 12.9 47.7 18.3 13.0 2.8 23.5 50.2 30.6 11.0 18.2 7.4 28.6 13.6 11.6 9.4 15.6 9.6 14.8 77.1 17.9 21.4 9.6 17.6 14.7 17.5 14.0 23.8 12.9 7.4 33.7 7.0 9.3 12.5 16.3 19.0 9.9 9.4 48.3 48.5 10.8 19.2 26.2 16.0 8.4 17.6 9.4 8.5 11.2 11.6 9.8 14.5 21.5 22.6 18.5 11.2 0.6 8.8 6.4 9.7 5.2 1.0 14.3 15.8 5.3 34.6 66.2 5.6 33.5 22.4 13.2 11.4 9.6 4.0 20.5 4.9 23.3 0.5 9.8 5.2 13.5 7.8 2.5 0.0 5.2 11.0 17.5 0.0 0.0 42.3 7.2 10.2 25.3 11.7 0.8 9.2 24.8 3.8 2.0 0.8 2.2 5.3 4.0 18.5 0.1 13.5 9.7 4.3 4.3 4.5 6.8 4.5 0.1 5.5 7.0 34.9 8.2 14.8 6.6 7.1 3.6 17.6 18.0 1.2 16.4 0.0 8.8 0.0 5.1 5.1 9.7 8.0 5.0 5.6 11.2 18.5 5.8 4.9 0.6 6.4 1.7 0.0 9.3 5.2 47.7 13.0 50.2 25.6 17.9 21.4 14.0 23.8 12.5 8.5 CAMK2G CAMKG ENSG00000148660 "Calcium/calmodulin dependent protein kinase II gamma" Q13555 10 73812501-73874591 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.0" "Cell line enhanced" "Detected in all" "PC-3: 45.4;SK-BR-3: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "granulocytes: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040656, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" 170000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA040656: , HPA051783: , HPA051785: , HPA053973: " "unprognostic (8.63e-3)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (3.46e-3)" "unprognostic (4.27e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-2)" "unprognostic (2.36e-1)" "unprognostic (2.48e-1)" "unprognostic (6.25e-2)" "unprognostic (2.92e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (2.48e-1)" "unprognostic (8.28e-2)" "unprognostic (9.64e-2)" "unprognostic (4.62e-2)" 9.1 8.8 27.4 9.4 20.7 17.4 6.8 22.2 53.8 9.0 37.3 13.3 9.7 19.7 20.1 9.1 20.6 13.2 10.6 6.7 22.8 24.4 11.6 5.9 10.7 8.9 26.8 31.2 6.4 5.7 8.0 6.0 15.8 38.6 18.5 15.5 8.5 12.4 29.8 73.0 9.1 18.1 29.6 29.8 11.0 14.2 3.8 13.4 4.4 6.4 7.6 8.7 26.5 10.8 4.2 7.1 39.8 5.6 9.8 9.2 5.0 10.9 7.9 7.1 13.6 5.2 8.6 8.4 7.5 12.9 10.4 8.5 12.2 11.8 8.1 7.9 9.7 17.0 5.6 6.4 8.3 7.3 6.7 5.5 6.1 5.5 2.6 7.5 9.3 4.5 5.8 10.3 7.2 8.8 6.0 12.1 5.7 7.6 12.5 11.2 5.2 45.4 11.4 7.5 4.3 5.4 15.9 3.7 8.6 4.3 57.2 3.7 10.7 4.7 10.8 7.7 12.4 4.2 10.1 3.7 4.4 7.5 8.3 21.5 2.7 8.5 5.6 39.8 7.5 2.3 9.2 4.2 8.4 8.0 7.1 3.9 8.1 7.9 36.4 9.8 4.0 2.4 8.1 5.0 27.4 20.7 22.2 53.8 22.8 24.4 26.8 31.2 38.6 13.4 CCDC107 MGC31967 ENSG00000159884 "Coiled-coil domain containing 107" Q8WV48 9 35658290-35661511 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016857, HPA050442" Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA016857: AB_10669751, HPA050442: " "unprognostic (3.70e-3)" "unprognostic (7.07e-3)" "unprognostic (3.60e-2)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.09e-2)" "unprognostic (4.13e-1)" "unprognostic (1.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.33e-2)" "unprognostic (1.89e-1)" "unprognostic (5.15e-1)" "unprognostic (1.96e-1)" "unprognostic (5.75e-2)" 42.1 23.4 11.1 15.4 10.3 5.4 50.3 17.2 12.9 17.5 35.2 8.5 18.1 15.0 24.9 28.6 22.4 18.2 31.5 31.3 10.2 11.0 13.0 15.0 14.0 14.1 9.7 7.9 15.3 80.2 7.6 10.5 10.8 8.4 22.8 13.7 11.5 14.6 24.5 29.3 9.6 16.0 44.8 9.7 13.5 24.2 9.2 8.8 19.3 14.0 8.8 10.9 38.9 24.1 20.7 32.5 7.6 11.0 16.4 46.9 18.3 7.9 7.2 6.0 7.5 30.3 19.5 3.5 13.5 12.2 8.7 8.1 3.3 2.4 5.2 6.0 17.7 2.7 4.4 6.5 6.4 15.3 7.1 2.4 11.0 8.1 7.2 3.8 9.5 11.5 7.8 9.2 7.2 6.0 3.2 10.1 10.8 5.1 4.2 5.6 4.4 22.3 6.1 1.4 4.1 28.7 4.3 3.9 6.6 7.0 9.8 6.6 5.1 4.7 7.5 13.9 7.7 10.0 12.3 4.5 6.7 10.4 25.7 6.1 12.1 7.6 10.6 5.1 36.1 11.0 46.9 20.7 31.7 31.4 11.8 20.1 15.5 21.3 2.1 16.4 6.4 32.5 35.2 18.3 11.1 10.3 17.2 12.9 10.2 11.0 9.7 7.9 8.4 8.8 CCDC170 "bA282P11.1, C6orf97, FLJ23305" ENSG00000120262 "Coiled-coil domain containing 170" Q8IYT3 6 151494030-151621193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 19.4;fallopian tube: 33.0" "Group enriched" "Detected in some" 5 "MCF7: 13.8;T-47d: 8.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 16.1" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027114, HPA027185" Enhanced Approved "Golgi apparatus,Cell Junctions" "Golgi apparatus" "Cell Junctions" "HPA027114: AB_2732435, HPA027185: AB_2672151" "unprognostic (7.46e-2)" "unprognostic (3.54e-2)" "unprognostic (6.93e-2)" "prognostic favourable (3.64e-4)" "unprognostic (2.13e-1)" "unprognostic (8.79e-3)" "unprognostic (2.74e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (2.18e-2)" "unprognostic (3.56e-2)" "unprognostic (1.40e-2)" "unprognostic (3.93e-2)" "unprognostic (2.17e-1)" "unprognostic (5.21e-2)" 3.0 6.2 2.1 1.4 6.7 0.3 4.0 0.4 2.4 3.9 0.9 6.5 0.3 2.6 5.2 19.4 0.6 33.0 1.5 3.3 3.7 3.6 1.6 1.5 9.7 3.6 1.3 1.4 14.4 0.5 0.3 1.5 1.6 16.1 1.2 0.7 3.9 0.5 0.6 0.8 0.6 1.2 1.5 1.2 2.9 1.8 5.9 1.5 0.7 5.7 0.6 0.8 1.7 1.2 0.1 1.8 8.6 4.1 0.1 0.1 0.9 0.0 0.2 0.5 0.0 0.5 0.4 0.0 0.1 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.1 0.1 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 8.1 0.1 0.8 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.5 3.1 8.6 0.1 4.1 0.1 0.1 0.0 0.0 1.8 0.1 0.1 0.1 2.9 0.1 3.7 0.1 0.1 0.9 2.1 6.7 0.4 2.4 3.7 3.6 1.3 1.4 16.1 1.5 CCDC66 DKFZp686C0433 ENSG00000180376 "Coiled-coil domain containing 66" A2RUB6 3 56557161-56621818 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044185, HPA051937" Approved Supported "Cell Junctions,Midbody ring,Centriolar satellite,Cytosol" "Centriolar satellite" "Cell Junctions, Midbody ring, Cytosol" "HPA044185: AB_10965852, HPA051937: " "unprognostic (2.28e-2)" "unprognostic (7.74e-2)" "unprognostic (7.37e-2)" "unprognostic (2.90e-1)" "unprognostic (5.28e-2)" "unprognostic (1.72e-2)" "unprognostic (7.26e-3)" "unprognostic (1.68e-3)" "unprognostic (2.05e-2)" "unprognostic (1.27e-1)" "unprognostic (3.05e-3)" "unprognostic (5.48e-3)" "unprognostic (6.85e-3)" "unprognostic (1.81e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-1)" "unprognostic (6.81e-3)" 8.4 7.5 9.3 7.6 11.7 6.5 12.0 31.0 15.1 11.7 11.0 9.6 7.6 5.9 12.7 12.7 6.7 12.9 7.6 8.4 9.8 6.4 9.2 4.6 7.7 10.1 10.8 10.6 14.7 7.1 10.1 32.9 7.6 11.0 9.7 9.4 7.8 9.1 10.9 11.9 5.7 7.7 11.1 11.2 8.7 8.0 8.6 12.9 11.9 12.1 5.7 10.2 11.0 9.7 2.6 1.1 7.0 2.2 5.0 14.1 2.7 5.4 1.9 6.1 3.6 9.2 5.4 4.8 7.0 6.4 9.2 8.1 4.2 4.3 15.2 1.6 3.7 3.0 3.4 6.4 10.3 5.4 4.1 9.5 8.4 4.8 6.5 12.1 3.6 5.3 9.3 7.6 5.4 5.8 8.8 2.4 7.1 4.4 9.7 7.7 9.9 7.5 3.3 5.2 8.2 5.5 1.9 2.3 4.2 8.4 5.4 5.1 1.9 5.3 3.1 6.9 5.4 6.4 9.5 4.9 5.2 8.1 5.1 13.9 5.4 7.0 1.5 3.3 4.3 1.9 5.6 2.6 7.4 5.3 1.1 1.7 8.6 6.2 0.3 5.0 2.2 1.0 14.1 2.7 9.3 11.7 31.0 15.1 9.8 6.4 10.8 10.6 11.0 12.9 CCDC85C ENSG00000205476 "Coiled-coil domain containing 85C" A6NKD9 14 99500180-99604026 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058346 Uncertain Approved "Nuclear speckles,Cell Junctions" "Nuclear speckles, Cell Junctions" "HPA058346: " "unprognostic (7.17e-2)" "unprognostic (2.23e-2)" "unprognostic (3.64e-1)" "prognostic unfavourable (1.44e-4)" "unprognostic (5.70e-2)" "unprognostic (2.61e-1)" "unprognostic (1.68e-3)" "unprognostic (4.80e-2)" "unprognostic (1.45e-2)" "unprognostic (8.75e-2)" "unprognostic (3.30e-1)" "unprognostic (1.68e-3)" "prognostic favourable (2.60e-5)" "unprognostic (4.14e-2)" "unprognostic (1.95e-1)" "unprognostic (8.74e-3)" "unprognostic (9.81e-3)" 3.5 12.0 13.9 3.3 15.5 7.2 6.1 45.2 11.8 11.3 15.3 11.7 16.6 15.4 8.7 12.6 24.0 10.0 13.9 11.4 11.6 7.6 7.8 32.3 6.7 1.9 10.3 5.9 6.9 15.3 10.4 10.0 7.1 9.1 15.8 9.5 19.9 20.8 14.8 15.2 13.6 27.0 15.4 8.4 3.0 10.5 8.1 8.1 2.7 9.5 9.3 8.7 13.7 17.9 0.3 0.1 0.7 0.0 0.4 2.0 0.6 17.3 15.9 19.8 11.8 0.2 0.0 18.4 5.9 6.0 11.9 6.9 19.3 18.4 0.1 23.4 6.6 23.4 14.6 14.1 7.4 28.5 8.6 0.9 15.8 13.0 1.6 0.2 1.8 0.0 7.5 3.4 9.8 3.7 4.2 2.6 1.4 29.0 7.7 2.3 7.2 16.6 11.6 8.3 3.9 8.4 6.9 9.8 12.3 15.0 8.0 3.6 17.5 3.5 8.3 2.3 19.8 8.4 5.8 4.2 5.5 0.1 0.4 1.5 1.6 0.7 0.0 0.0 0.6 0.0 0.8 0.2 1.9 1.3 0.0 0.3 2.0 1.1 0.6 0.4 0.0 0.1 2.0 0.6 13.9 15.5 45.2 11.8 11.6 7.6 10.3 5.9 9.1 8.1 CD34 ENSG00000174059 "CD34 molecule" P28906 1 207880972-207911402 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 31.8;MOLT-4: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000018, HPA036722, HPA036723" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" 69000000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB000018: AB_2063006, HPA036722: , HPA036723: " "unprognostic (3.82e-1)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.09e-1)" "unprognostic (1.24e-1)" "prognostic favourable (5.93e-5)" "unprognostic (1.25e-2)" "unprognostic (7.74e-2)" "unprognostic (7.65e-2)" "unprognostic (3.53e-1)" "unprognostic (1.37e-3)" "unprognostic (6.95e-2)" "prognostic unfavourable (8.47e-4)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (1.60e-1)" "unprognostic (1.01e-2)" 61.9 8.8 4.6 12.8 7.6 1.9 37.5 3.1 6.7 38.3 15.9 5.2 20.5 5.0 41.4 40.3 33.8 22.3 20.6 51.2 5.4 4.9 18.8 2.2 25.0 11.9 8.1 6.7 20.7 8.6 7.8 3.6 78.9 6.3 21.0 7.4 12.8 12.4 20.5 39.7 21.2 12.1 42.3 4.7 9.2 11.3 23.1 4.7 3.5 25.8 35.9 11.0 33.6 33.1 0.6 1.7 1.6 0.3 0.6 0.5 1.5 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.2 1.1 0.3 0.9 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 31.8 0.0 0.0 0.8 0.0 31.4 0.1 0.2 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 1.1 0.0 4.8 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.6 0.2 0.3 0.5 0.2 0.5 0.3 0.3 0.2 0.2 0.6 0.3 0.3 1.1 0.6 0.3 1.7 0.2 1.5 4.6 7.6 3.1 6.7 5.4 4.9 8.1 6.7 6.3 4.7 CDH24 CDH11L ENSG00000139880 "Cadherin 24" Q86UP0 14 23047062-23057538 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065233 Approved "Nucleoplasm,Cell Junctions,Centriolar satellite,Cytosol" "Nucleoplasm, Centriolar satellite" "Cell Junctions, Cytosol" "HPA065233: " "unprognostic (2.30e-1)" "unprognostic (3.06e-2)" "unprognostic (4.15e-3)" "unprognostic (6.21e-2)" "unprognostic (1.27e-1)" "unprognostic (9.18e-2)" "unprognostic (6.68e-3)" "unprognostic (2.71e-2)" "unprognostic (5.97e-3)" "unprognostic (3.55e-1)" "unprognostic (4.18e-2)" "unprognostic (5.97e-2)" "prognostic unfavourable (1.15e-4)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.37e-2)" "unprognostic (8.85e-2)" 5.8 4.7 8.0 4.3 9.3 2.9 5.0 13.0 12.6 6.2 4.5 4.0 6.1 3.0 13.4 3.2 5.8 5.8 10.1 3.8 10.5 5.1 4.6 1.1 4.7 3.4 4.4 4.8 3.8 3.5 8.3 3.1 5.7 5.3 4.6 4.5 7.9 4.7 4.5 1.8 7.2 5.0 10.2 4.0 5.2 4.1 3.4 6.6 7.8 6.8 3.8 4.1 7.3 6.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 2.5 2.5 10.6 12.0 2.6 1.3 5.9 4.8 3.1 4.0 5.2 3.2 3.5 0.2 3.9 5.2 14.6 4.5 4.0 3.3 3.9 3.8 0.5 6.5 1.0 2.9 7.3 0.2 10.2 1.3 4.4 2.9 6.6 1.5 6.3 3.5 7.2 0.5 4.9 2.6 5.9 12.7 3.5 4.7 1.1 2.1 30.8 8.2 11.2 6.0 0.6 5.3 1.0 6.1 4.0 15.5 1.6 3.5 2.0 0.6 0.1 4.2 2.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.0 9.3 13.0 12.6 10.5 5.1 4.4 4.8 5.3 6.6 CDH3 "CDHP, PCAD" ENSG00000062038 "Cadherin 3" P22223 16 68636189-68722616 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.0;retina: 40.5" "Cell line enhanced" "Detected in some" "A-431: 24.4;HaCaT: 67.7;HBEC3-KT: 32.6;hTCEpi: 26.1;hTERT-HME1: 19.9;RPTEC TERT1: 29.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 10 "pons and medulla: 16.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA001767, CAB002487" Enhanced Supported "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "CAB002487: AB_563446, HPA001767: AB_1078376" "unprognostic (1.55e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-1)" "unprognostic (4.38e-3)" "unprognostic (6.73e-2)" "unprognostic (1.55e-2)" "unprognostic (1.85e-2)" "prognostic unfavourable (8.53e-4)" "unprognostic (1.22e-1)" "unprognostic (3.45e-2)" "prognostic unfavourable (8.43e-4)" "unprognostic (4.30e-2)" "unprognostic (2.41e-5)" "unprognostic (2.11e-1)" "unprognostic (1.09e-1)" "unprognostic (1.33e-3)" "unprognostic (8.56e-2)" 2.2 0.1 1.0 2.5 1.2 0.0 8.7 1.5 1.1 10.5 1.0 2.2 3.0 0.3 9.4 10.3 23.5 8.9 1.4 0.4 1.1 0.8 8.3 0.2 3.6 2.1 0.6 0.4 32.6 0.4 0.5 3.6 6.4 16.0 11.7 0.5 40.5 9.3 4.4 0.1 21.2 0.4 4.1 1.5 10.0 0.7 2.2 0.1 44.0 2.0 26.1 20.1 2.5 6.7 0.9 0.6 1.4 0.5 0.6 0.8 0.2 24.4 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 14.6 9.1 0.0 0.1 0.0 67.7 0.6 32.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 26.1 0.0 19.9 0.0 0.0 0.0 0.0 12.7 0.0 0.0 1.2 2.0 0.0 0.0 0.0 29.3 11.0 0.1 0.0 0.2 0.0 11.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.5 0.2 0.4 0.2 0.3 0.6 0.5 0.4 0.1 0.9 0.6 0.8 1.4 0.6 0.2 0.6 0.2 0.2 1.0 1.2 1.5 1.1 1.1 0.8 0.6 0.4 16.0 0.1 CERCAM "CEECAM1, CerCAM, GLT25D3" ENSG00000167123 "Cerebral endothelial cell adhesion molecule" Q5T4B2 9 128411751-128437351 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.1" "Cell line enhanced" "Detected in many" "ASC diff: 55.3;ASC TERT1: 59.0;fHDF/TERT166: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021657, HPA051595" Uncertain Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Intracellular and membrane" "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA021657: AB_1846507, HPA051595: " "unprognostic (2.87e-2)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" "unprognostic (2.19e-1)" "unprognostic (4.68e-3)" "unprognostic (7.79e-3)" "unprognostic (3.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (5.22e-4)" "unprognostic (1.59e-1)" "unprognostic (5.93e-2)" "prognostic unfavourable (3.33e-16)" "unprognostic (1.34e-2)" "unprognostic (1.04e-1)" "unprognostic (6.05e-3)" "prognostic unfavourable (3.30e-5)" 12.7 5.1 40.0 7.2 65.5 1.6 9.0 10.0 62.1 19.1 6.9 61.2 5.0 4.8 11.4 10.9 8.2 6.0 17.3 8.8 72.8 34.7 4.9 1.8 5.3 2.3 59.5 28.1 14.1 18.8 15.8 21.6 27.4 31.4 11.1 5.2 3.5 13.2 13.6 4.3 8.9 6.0 27.7 78.1 3.3 5.4 5.2 62.1 0.0 6.7 2.4 2.7 15.1 6.6 0.3 2.0 0.3 1.6 1.1 5.3 2.2 9.4 6.1 6.8 7.3 55.3 59.0 5.9 30.7 29.0 8.0 6.0 2.2 0.4 0.0 12.6 50.1 6.5 3.0 4.0 3.1 2.4 4.8 0.5 5.5 3.3 16.9 1.1 17.2 32.7 2.1 8.7 2.1 9.1 2.7 7.5 10.4 18.0 0.4 11.6 0.4 4.6 0.9 4.8 1.3 3.7 3.6 1.0 1.9 6.9 8.4 3.5 6.8 2.3 10.0 21.4 5.8 29.4 4.7 8.8 6.9 0.1 20.3 3.3 4.2 0.3 1.1 0.1 3.8 1.6 0.3 0.3 0.3 4.7 1.5 0.1 0.1 5.3 0.3 1.1 0.1 2.0 0.0 2.2 40.0 65.5 10.0 24.5 72.8 34.7 59.5 28.1 31.4 62.1 CFAP206 "C6orf165, dJ382I10.1, FLJ25974" ENSG00000272514 "Cilia and flagella associated protein 206" Q8IYR0 6 87407983-87464465 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 17.7;testis: 60.5" "Cell line enhanced" "Detected in some" "MCF7: 4.4;RPTEC TERT1: 5.3;T-47d: 9.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "HPA044891, HPA072261" Approved Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA044891: AB_10960832, HPA072261: " "unprognostic (4.31e-1)" "unprognostic (8.75e-3)" "unprognostic (2.40e-1)" "unprognostic (2.31e-1)" "unprognostic (5.51e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (4.68e-3)" "unprognostic (3.13e-2)" "unprognostic (3.99e-3)" "unprognostic (9.08e-3)" "unprognostic (4.22e-2)" "unprognostic (1.46e-1)" "unprognostic (8.54e-2)" "unprognostic (2.26e-2)" 0.2 0.5 1.3 0.3 3.0 0.2 0.5 0.3 2.2 0.9 0.3 3.0 0.2 0.3 0.7 3.4 0.2 17.7 0.4 0.3 2.1 2.0 1.5 0.3 2.4 0.2 0.7 1.4 2.7 0.3 0.8 2.6 0.4 8.1 0.5 0.2 0.3 0.3 0.5 0.2 0.3 0.2 0.3 0.5 0.2 0.2 60.5 0.6 0.0 1.4 0.0 0.2 0.4 0.1 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.9 0.5 2.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.2 1.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.9 0.0 0.2 0.0 0.1 0.8 4.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 1.2 1.1 0.6 0.4 0.5 0.3 9.0 0.2 0.0 0.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.3 3.0 0.3 2.2 2.1 2.0 0.7 1.4 8.1 0.6 CFB "BF, BFD, H2-Bf" ENSG00000243649 "Complement factor B" P00751 6 31945650-31952084 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "liver: 461.5" "Cell line enhanced" "Detected in some" "ASC diff: 6.0;ASC TERT1: 5.8;CAPAN-2: 6.9;fHDF/TERT166: 11.3;HSkMC: 18.7" "Cancer enhanced" "Detected in all" "liver cancer: 78.3" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "HPA000951, HPA001817, HPA001832, CAB016381" Supported Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" "Secreted to blood" 878700000 180000000000 "Endoplasmic reticulum, Vesicles" "Cell Junctions" "CAB016381: AB_627562, HPA000951: , HPA001817: AB_1078779, HPA001832: AB_1078778" "prognostic favourable (2.76e-5)" "unprognostic (1.02e-1)" "unprognostic (1.44e-1)" "unprognostic (7.94e-2)" "unprognostic (1.82e-2)" "unprognostic (8.56e-2)" "unprognostic (8.08e-3)" "unprognostic (8.81e-2)" "unprognostic (3.51e-1)" "unprognostic (2.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.57e-2)" "prognostic unfavourable (1.53e-5)" "unprognostic (1.36e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-2)" "unprognostic (3.68e-2)" 9.3 1.0 0.3 4.1 0.4 0.3 2.4 0.2 0.4 1.3 9.0 0.4 0.9 3.2 0.5 3.7 2.2 4.0 8.9 3.3 0.2 0.0 16.1 461.5 2.5 2.1 0.7 0.1 2.8 5.8 0.4 1.0 4.0 1.0 4.0 1.6 2.6 3.1 0.3 0.5 0.5 4.7 2.6 0.6 0.8 4.1 1.4 0.3 0.3 1.8 0.5 1.7 1.6 0.4 0.1 1.6 0.0 0.8 0.0 0.2 0.0 0.0 1.8 0.1 0.1 6.0 5.8 0.0 0.0 0.3 1.5 0.6 0.0 6.9 0.1 5.1 11.3 0.0 0.0 1.9 1.4 0.4 0.3 0.4 0.3 0.5 0.0 0.7 0.1 18.7 0.1 0.9 0.6 0.2 0.2 0.7 0.1 0.1 0.1 0.4 0.3 0.1 0.2 0.4 0.2 1.6 0.0 0.0 0.0 0.5 1.2 0.2 0.0 0.2 0.0 0.2 0.5 0.3 0.3 0.5 1.9 0.5 3.1 0.5 0.5 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.3 0.4 0.2 0.3 0.2 0.0 0.7 0.1 1.0 0.3 CHCHD7 "COX23, MGC2217" ENSG00000170791 "Coiled-coil-helix-coiled-coil-helix domain containing 7" Q9BUK0 8 56211686-56218798 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050783 Approved Approved "Cell Junctions,Aggresome" "Cell Junctions" Aggresome "HPA050783: " "unprognostic (1.64e-2)" "unprognostic (3.23e-2)" "unprognostic (3.18e-2)" "prognostic unfavourable (1.39e-6)" "unprognostic (4.46e-2)" "unprognostic (2.43e-1)" "unprognostic (5.04e-2)" "unprognostic (8.38e-3)" "unprognostic (1.62e-1)" "unprognostic (9.03e-2)" "unprognostic (2.24e-1)" "unprognostic (1.15e-1)" "prognostic favourable (9.47e-5)" "unprognostic (1.94e-1)" "unprognostic (5.07e-1)" "unprognostic (1.77e-2)" "unprognostic (2.50e-1)" 16.6 14.8 24.1 19.6 29.4 17.6 18.9 27.1 23.3 17.6 20.7 18.3 22.8 22.5 13.1 34.3 15.7 17.6 12.3 27.0 21.0 19.5 23.4 18.0 19.4 24.4 27.0 16.0 36.3 20.0 22.5 48.3 13.3 26.7 19.2 21.3 19.2 34.5 18.0 23.2 14.6 26.2 14.8 32.0 33.0 17.7 7.6 24.8 27.4 19.8 18.3 24.9 15.5 16.4 31.0 33.6 26.2 20.6 24.2 31.1 17.3 18.8 6.0 13.5 4.4 36.0 25.6 14.0 13.5 12.7 10.8 8.1 15.4 23.1 17.8 11.9 7.9 10.6 14.0 20.7 13.4 7.7 26.9 27.2 14.4 21.3 18.3 23.2 17.5 30.5 19.1 7.6 34.2 11.2 13.3 11.7 25.3 9.4 23.1 34.4 11.9 8.7 26.6 4.1 14.8 19.8 20.4 3.5 2.3 7.1 11.0 10.0 11.5 13.0 16.2 5.7 12.1 18.3 12.6 12.4 12.6 29.7 16.0 34.5 9.7 21.5 20.6 26.2 23.2 19.0 22.5 31.0 26.0 23.6 22.8 26.4 31.1 27.8 7.9 24.2 16.6 33.6 29.7 17.3 24.1 29.4 27.1 23.3 21.0 19.5 27.0 16.0 26.7 24.8 CMTR2 "AFT, FLJ11171, FTSJD1, MTr2" ENSG00000180917 "Cap methyltransferase 2" Q8IYT2 16 71281389-71289715 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041700, HPA048265" Uncertain Approved "Nuclear speckles,Cell Junctions" "Cell Junctions" "Nuclear speckles" "HPA041700: , HPA048265: " "unprognostic (1.27e-1)" "unprognostic (2.49e-2)" "unprognostic (2.94e-3)" "unprognostic (1.43e-1)" "unprognostic (6.30e-2)" "unprognostic (3.82e-2)" "unprognostic (1.93e-3)" "unprognostic (2.86e-2)" "unprognostic (7.93e-2)" "unprognostic (3.41e-1)" "unprognostic (1.85e-2)" "unprognostic (7.39e-2)" "prognostic favourable (4.97e-5)" "unprognostic (9.55e-2)" "unprognostic (5.99e-2)" "unprognostic (1.54e-1)" "unprognostic (5.34e-2)" 10.4 14.9 7.1 11.7 9.0 5.4 15.9 5.3 9.1 10.6 13.4 11.5 15.6 14.1 12.5 16.4 20.4 8.8 11.0 9.0 8.5 6.9 13.5 18.2 10.7 14.7 12.4 3.4 16.2 12.2 12.7 24.3 17.4 9.0 11.9 10.5 10.6 13.6 14.1 8.4 9.9 16.1 9.4 9.5 17.5 8.9 16.0 9.3 20.9 14.3 7.6 15.4 9.6 14.2 11.2 10.3 11.0 8.0 13.1 11.2 8.6 11.3 7.9 11.4 11.3 12.9 11.2 6.4 9.3 9.1 10.5 10.1 4.7 15.8 6.1 11.2 7.3 11.2 7.0 8.3 12.9 6.3 4.7 17.0 4.6 5.9 16.1 10.0 23.3 8.1 15.9 7.7 10.4 11.9 7.3 4.6 17.4 10.1 12.1 16.9 7.1 4.7 16.4 7.3 13.2 12.9 7.7 7.5 8.5 10.5 9.2 10.2 13.7 7.3 11.4 11.9 11.0 12.1 7.2 8.6 8.9 10.9 8.9 10.2 10.2 11.0 7.2 7.1 9.8 8.0 11.2 11.2 9.2 10.3 10.3 10.2 10.5 10.3 0.4 13.1 5.2 3.6 8.0 8.6 7.1 9.0 5.3 9.1 8.5 6.9 12.4 3.4 9.0 9.3 COBL KIAA0633 ENSG00000106078 "Cordon-bleu WH2 repeat protein" O75128 7 51016212-51316818 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.7" "Cell line enhanced" "Detected in many" "BEWO: 15.9;HeLa: 28.3;RPMI-8226: 21.8;SK-BR-3: 12.7;U-266/84: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 4.6" "Lineage enriched" "Detected in single" 46 "dendritic cells: 4.6" "Low region specificity" "Detected in many" "HPA019033, HPA019167" Enhanced Approved "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA019033: AB_2083648, HPA019167: AB_1847070" "unprognostic (8.09e-2)" "unprognostic (1.08e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-3)" "unprognostic (3.13e-1)" "unprognostic (5.33e-3)" "unprognostic (2.90e-1)" "unprognostic (5.29e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.92e-2)" "prognostic favourable (5.21e-12)" "unprognostic (7.64e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (5.41e-3)" 1.8 1.3 27.5 1.8 26.1 0.7 9.5 12.5 23.8 3.9 11.6 27.9 2.2 11.6 2.0 4.4 9.5 12.7 5.8 32.8 27.7 14.5 8.3 12.3 8.8 0.7 23.8 13.8 2.6 11.4 24.7 5.2 3.4 10.8 9.4 7.3 2.8 26.9 3.7 68.7 10.7 20.7 2.2 25.0 0.8 7.4 2.5 16.8 0.0 5.5 12.2 3.1 1.0 2.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 5.8 4.3 0.0 0.1 0.0 0.0 15.9 0.0 0.0 0.0 0.0 10.4 9.4 0.0 0.4 0.0 10.9 6.0 0.0 0.0 0.0 4.6 0.0 28.3 2.2 0.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 3.0 0.1 0.0 3.6 0.0 0.0 4.2 3.6 0.0 0.2 21.8 8.5 0.0 5.7 0.1 2.0 12.7 1.8 9.1 0.0 0.0 0.0 5.2 0.1 0.4 0.0 16.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 27.5 26.1 12.5 19.0 27.7 14.5 23.8 13.8 10.8 16.8 COBLL1 KIAA0977 ENSG00000082438 "Cordon-bleu WH2 repeat protein like 1" Q53SF7 2 164653624-164843679 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 154.2" "Cell line enhanced" "Detected in many" "Karpas-707: 28.8;RPTEC TERT1: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 17 "memory B-cell: 15.5;naive B-cell: 9.2;plasmacytoid DC: 5.5" "Group enriched" "Detected in many" 18 "B-cells: 15.5;dendritic cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044933, HPA053344" Enhanced Approved "Cell Junctions" "Cell Junctions" "HPA044933: AB_2679148, HPA053344: AB_2682123" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.38e-2)" "unprognostic (3.65e-2)" "unprognostic (1.03e-1)" "unprognostic (4.49e-3)" "unprognostic (1.10e-3)" "unprognostic (1.70e-1)" "unprognostic (2.76e-2)" "unprognostic (3.65e-2)" "unprognostic (1.77e-1)" "prognostic favourable (5.27e-13)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (2.47e-1)" "unprognostic (1.42e-1)" 14.3 35.7 3.3 4.1 4.0 1.1 9.3 1.4 4.0 8.1 7.0 3.3 17.7 4.3 5.3 11.2 16.3 2.9 9.7 3.7 4.1 3.2 35.6 43.4 10.8 4.7 4.5 2.9 7.1 23.4 4.9 8.9 154.2 5.2 11.9 3.1 8.8 8.0 22.6 2.6 8.2 5.8 9.7 3.9 4.6 12.6 3.0 2.6 1.2 7.6 9.6 6.9 13.0 11.1 15.5 5.5 0.0 0.0 0.5 0.0 0.3 4.6 1.1 2.9 0.0 3.3 0.6 5.3 15.8 6.4 2.7 2.6 3.9 2.0 0.4 3.1 1.4 17.0 11.8 9.9 2.8 1.3 4.5 4.4 4.6 15.9 4.8 0.0 0.0 0.8 9.2 0.4 13.0 9.9 0.0 28.8 3.4 5.2 0.1 0.0 1.4 5.3 0.6 11.4 4.7 29.1 16.1 6.5 2.5 6.9 6.7 2.2 5.0 0.0 4.2 5.1 4.3 2.0 3.6 10.8 4.0 1.5 2.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.5 0.0 5.5 0.0 0.3 3.3 4.0 1.4 4.0 4.1 3.2 4.5 2.9 5.2 2.6 COLEC12 "CL-P1, SCARA4, SRCL" ENSG00000158270 "Collectin subfamily member 12" Q5KU26 18 316740-500722 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 40.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.3;BJ: 8.4;HSkMC: 14.3;U-2197: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047917, HPA071056" Enhanced Approved "Golgi apparatus,Vesicles,Cell Junctions" 550000 "Golgi apparatus, Vesicles" "Cell Junctions" "HPA047917: , HPA071056: " "unprognostic (8.67e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (3.60e-2)" "unprognostic (6.94e-2)" "unprognostic (1.09e-2)" "unprognostic (1.14e-4)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "unprognostic (4.86e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (2.61e-1)" "unprognostic (2.24e-3)" "unprognostic (1.52e-2)" "prognostic unfavourable (8.10e-4)" "unprognostic (3.01e-3)" 14.2 3.7 6.9 4.6 9.7 1.2 9.4 3.5 6.4 40.8 8.0 7.7 5.1 3.4 13.1 9.9 7.5 6.6 8.1 13.5 7.0 6.3 2.7 1.4 18.7 13.9 8.1 5.8 6.8 2.4 1.5 1.5 32.0 10.5 9.6 5.0 23.5 4.8 3.5 6.3 4.4 5.0 14.3 5.2 1.2 5.0 5.0 4.7 0.7 7.6 3.8 4.9 15.0 7.3 0.9 0.9 3.3 0.8 0.7 0.5 0.3 0.0 0.0 1.5 0.0 1.6 17.3 0.6 8.4 2.9 1.2 2.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.0 4.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.3 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.8 0.4 0.5 0.3 0.3 0.5 0.5 0.4 0.2 0.9 0.4 0.4 3.3 0.7 0.5 0.9 0.3 0.3 6.9 9.7 3.5 6.4 7.0 6.3 8.1 5.8 10.5 4.7 COLQ EAD ENSG00000206561 "Collagen like tail subunit of asymmetric acetylcholinesterase" Q9Y215 3 15450133-15521751 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Neurotransmitter degradation" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.8;lymphoid tissue: 19.6" "Group enriched" "Detected in some" 5 "BEWO: 16.9;HDLM-2: 5.5;U-937: 8.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 11.4" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 31.8" "Lineage enriched" "Detected in single" 35 "T-cells: 31.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045876 Approved "Plasma membrane,Cell Junctions" "Secreted to blood" "Plasma membrane" "Cell Junctions" "HPA045876: " "unprognostic (4.08e-3)" "unprognostic (2.61e-2)" "unprognostic (2.13e-3)" "unprognostic (2.37e-1)" "unprognostic (2.11e-1)" "unprognostic (4.62e-2)" "unprognostic (1.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (1.28e-3)" "unprognostic (4.68e-1)" "unprognostic (7.00e-5)" "unprognostic (6.58e-2)" "unprognostic (1.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.30e-4)" 2.7 0.7 0.9 0.7 1.1 1.3 0.9 11.4 2.1 2.4 2.3 0.4 0.2 0.8 3.2 2.7 1.3 8.8 1.8 15.9 1.5 1.2 0.5 0.9 2.1 19.6 0.9 1.1 2.3 0.6 10.0 1.1 0.5 2.1 2.0 0.5 2.0 1.1 1.4 14.3 0.9 1.4 1.1 1.5 3.8 1.5 2.0 0.4 3.8 1.0 0.6 3.3 1.3 1.4 0.0 0.2 0.0 0.4 0.9 31.8 1.7 0.1 0.5 2.0 1.1 1.4 1.0 16.9 0.3 0.5 0.4 0.6 0.0 0.3 0.1 0.7 0.2 0.2 0.3 0.4 0.5 5.5 1.2 0.6 0.7 0.1 0.2 0.4 1.1 0.8 0.4 0.8 0.3 0.3 0.0 0.5 0.8 0.3 0.6 1.8 0.2 0.6 0.8 0.2 0.4 0.4 0.4 0.6 1.7 0.2 0.1 0.4 1.2 0.8 0.1 0.1 1.0 1.8 0.6 1.6 1.5 0.1 0.1 8.5 0.1 0.0 0.4 0.0 5.5 0.0 31.8 0.0 2.7 3.9 0.0 0.0 0.3 0.3 0.0 0.9 0.0 0.2 0.1 1.7 0.9 1.1 11.4 2.1 1.5 1.2 0.9 1.1 2.1 0.4 CTNNBIP1 "ICAT, MGC15093" ENSG00000178585 "Catenin beta interacting protein 1" Q9NSA3 1 9848276-9910336 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 116.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042617, HPA067089" Enhanced Approved "Plasma membrane,Cell Junctions,Mitochondria" "Plasma membrane, Cell Junctions, Mitochondria" "HPA042617: , HPA067089: " "unprognostic (2.71e-1)" "unprognostic (4.46e-2)" "unprognostic (1.94e-1)" "prognostic favourable (5.68e-6)" "unprognostic (3.08e-1)" "unprognostic (2.63e-2)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" "unprognostic (2.23e-2)" "unprognostic (2.62e-1)" "unprognostic (2.17e-2)" "unprognostic (1.77e-1)" "unprognostic (1.24e-3)" "unprognostic (3.62e-2)" "unprognostic (3.22e-2)" "unprognostic (8.63e-2)" "unprognostic (4.37e-2)" 12.6 4.0 10.1 4.3 8.1 7.7 18.3 21.4 14.8 16.6 5.8 10.1 10.9 7.4 4.8 31.3 49.0 5.2 4.8 13.7 10.1 9.5 5.6 4.8 15.2 4.0 8.4 11.3 5.5 14.1 4.0 6.6 11.0 13.7 9.9 4.2 13.3 15.5 16.5 13.1 116.5 5.8 4.5 9.2 3.3 8.8 11.8 6.5 4.8 7.9 33.9 13.5 5.6 21.7 1.9 6.8 12.9 5.4 8.8 2.9 2.3 25.8 3.8 23.8 18.1 3.6 6.0 7.6 5.1 9.0 7.6 4.9 1.8 33.0 8.0 14.9 6.6 13.2 2.7 30.5 3.5 20.1 4.2 5.2 1.2 24.1 7.5 3.8 3.0 6.7 30.2 9.6 9.9 20.4 9.1 3.8 4.6 15.8 8.6 14.4 12.6 6.7 9.8 7.0 5.1 3.9 8.9 26.2 16.5 11.7 10.6 15.5 13.0 9.5 13.3 4.9 6.0 7.4 11.2 8.3 10.8 9.3 1.8 19.8 19.5 2.7 5.4 12.9 2.9 1.9 1.7 1.9 1.5 2.4 6.8 1.6 1.4 1.4 4.0 8.8 1.2 2.1 1.2 2.3 10.1 8.1 21.4 14.8 10.1 9.5 8.4 11.3 13.7 6.5 CTNND2 "GT24, NPRAP" ENSG00000169862 "Catenin delta 2" Q9UQB3 5 10971840-11904043 "Disease related genes, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 74.3" "Cell line enhanced" "Detected in some" "AF22: 17.7;MCF7: 8.0;SK-BR-3: 5.3;U-266/84: 15.1" "Cancer enriched" "Detected in many" 16 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015077, CAB037339" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" "Nucleoplasm, Golgi apparatus, Cell Junctions" "CAB037339: , HPA015077: " "unprognostic (7.32e-2)" "unprognostic (1.51e-3)" "unprognostic (2.23e-1)" "unprognostic (5.16e-2)" "unprognostic (5.66e-2)" "unprognostic (2.06e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-2)" "unprognostic (9.13e-2)" "unprognostic (9.86e-2)" "unprognostic (8.95e-3)" "unprognostic (2.66e-1)" "unprognostic (9.55e-4)" "unprognostic (5.87e-2)" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (4.76e-2)" 1.7 2.4 30.9 1.8 26.3 1.4 2.8 21.6 74.3 1.7 1.8 16.6 0.0 1.7 1.6 1.9 1.6 1.7 4.8 6.0 26.0 17.7 1.5 1.7 2.4 1.6 22.8 20.2 2.1 12.5 1.5 5.7 1.9 11.0 2.6 1.9 2.6 1.7 1.7 1.6 1.5 2.0 1.6 13.3 5.7 1.9 4.2 14.7 0.0 1.7 0.0 1.5 1.6 0.1 0.0 0.0 0.8 0.4 0.0 0.3 0.6 0.0 0.1 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.0 0.0 0.0 2.7 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 15.1 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.6 30.9 26.3 21.6 29.1 26.0 17.7 22.8 20.2 11.0 14.7 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924485-7926166 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 91.1" "Cell line enhanced" "Detected in many" "AN3-CA: 33.2;HEK 293: 23.1;NTERA-2: 25.2;REH: 19.1;SCLC-21H: 19.6;SH-SY5Y: 32.9" "Cancer enhanced" "Detected in all" "ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 2.1 4.8 47.7 2.5 91.1 1.6 2.1 0.0 74.2 5.2 6.1 5.0 3.6 2.6 17.5 5.1 2.4 16.4 1.8 1.6 49.4 16.8 3.1 1.5 3.0 1.6 15.7 20.1 2.7 2.1 2.3 6.5 2.0 4.0 5.5 2.1 0.0 2.1 16.5 1.6 2.8 2.1 7.1 1.5 2.0 2.2 6.1 8.3 0.0 1.8 0.0 1.6 2.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 2.7 7.1 33.2 0.0 0.1 1.6 2.9 0.8 1.4 0.8 0.8 1.7 0.0 5.6 0.7 12.1 1.6 0.3 0.0 1.0 23.1 0.2 1.9 0.5 0.3 0.5 0.6 0.0 0.9 0.5 0.3 1.8 7.0 0.1 0.1 13.4 6.1 4.5 25.2 11.7 19.1 0.0 2.1 5.1 0.5 19.6 32.9 1.7 0.9 3.0 7.3 0.2 2.8 0.7 11.7 1.3 1.6 0.2 0.3 1.5 2.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 91.1 0.0 63.8 49.4 16.8 15.7 20.1 4.0 8.3 DCAF13 "DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1" ENSG00000164934 "DDB1 and CUL4 associated factor 13" Q9NV06 8 103414714-103443453 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Ubl conjugation pathway" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044504 Uncertain Supported "Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol" "Nucleoplasm, Nucleoli" "Cell Junctions, Centrosome, Cytosol" "HPA044504: " "prognostic unfavourable (4.06e-4)" "unprognostic (4.39e-2)" "unprognostic (1.70e-1)" "unprognostic (4.46e-3)" "unprognostic (3.57e-2)" "unprognostic (7.86e-3)" "prognostic unfavourable (8.05e-6)" "unprognostic (5.92e-3)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.54e-3)" "unprognostic (2.31e-2)" "prognostic unfavourable (2.85e-4)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (8.63e-2)" 18.4 20.5 13.8 18.1 15.7 10.6 20.2 11.3 14.3 16.0 16.7 13.0 12.9 13.1 18.1 16.7 24.0 15.3 10.7 15.9 12.4 11.8 35.2 26.5 12.4 18.4 16.5 12.1 20.9 28.9 15.7 34.6 21.2 16.2 16.4 18.5 7.4 15.9 11.3 21.1 13.7 16.8 15.3 13.9 20.4 14.7 25.3 15.0 26.4 17.1 22.6 24.3 16.9 15.5 28.6 26.4 10.3 22.1 24.0 27.2 20.2 27.5 24.8 23.2 23.6 16.9 19.6 17.4 20.6 15.8 19.6 20.1 24.4 27.0 38.4 35.3 21.5 20.8 31.4 26.3 38.0 36.6 22.3 53.1 14.9 27.7 19.3 21.7 22.9 15.9 18.2 28.8 48.0 27.2 35.6 16.9 29.8 22.5 41.1 22.8 35.5 38.8 26.8 28.2 39.6 28.5 23.1 29.6 28.1 12.9 20.2 23.3 31.1 14.9 17.8 20.0 32.1 25.7 27.5 18.7 32.5 54.3 26.9 47.5 25.5 8.6 18.6 10.3 18.4 22.1 25.2 28.6 19.8 19.7 26.4 22.1 19.8 20.2 2.0 24.0 16.0 13.7 27.2 20.2 13.8 15.7 11.3 14.3 12.4 11.8 16.5 12.1 16.2 15.0 DCP2 NUDT20 ENSG00000172795 "Decapping mRNA 2" Q8IU60 5 112976702-113020970 "Enzymes, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 52.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011677, HPA057676" Approved Approved "Nucleoplasm,Cell Junctions,Cytoplasmic bodies" "Nucleoplasm, Cytoplasmic bodies" "Cell Junctions" "CAB011677: AB_731858, HPA057676: " "unprognostic (2.76e-1)" "unprognostic (3.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.09e-1)" "unprognostic (1.28e-1)" "unprognostic (3.86e-3)" "prognostic unfavourable (4.84e-4)" "unprognostic (1.87e-1)" "unprognostic (3.64e-2)" "unprognostic (6.26e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-2)" "prognostic unfavourable (2.66e-5)" "unprognostic (8.39e-2)" "unprognostic (2.84e-1)" "unprognostic (3.25e-2)" "unprognostic (5.75e-2)" 8.0 7.5 8.1 16.3 9.5 22.9 15.0 16.8 10.9 9.1 6.6 6.4 6.6 6.3 10.5 6.8 7.4 8.0 6.5 6.1 8.1 8.9 8.1 8.1 13.2 19.8 6.9 6.1 12.8 6.2 7.0 12.2 40.2 8.3 8.1 7.3 6.5 9.6 8.6 8.3 9.8 8.7 7.3 7.4 19.9 6.7 6.8 6.5 52.9 7.0 4.1 20.0 8.7 9.1 5.1 6.5 16.3 8.3 3.9 5.9 3.2 3.6 3.1 14.1 11.3 2.8 3.1 22.8 3.3 2.7 4.2 6.1 14.6 7.8 19.1 5.3 1.9 4.5 16.2 4.5 5.1 5.1 7.1 17.9 2.7 5.8 3.2 10.9 9.3 2.9 3.1 5.1 5.1 7.1 13.2 7.5 3.8 4.6 16.0 11.6 12.2 1.9 15.7 13.4 7.1 6.5 9.3 3.3 7.0 4.6 5.2 6.7 15.4 14.6 4.6 4.7 8.4 2.4 5.0 5.1 11.2 14.6 2.7 15.3 3.6 12.2 7.2 5.5 4.0 7.1 5.5 5.1 4.9 4.2 6.5 3.6 4.6 4.7 16.3 3.9 8.3 3.5 5.9 3.2 8.1 9.5 16.8 10.9 8.1 8.9 6.9 6.1 8.3 6.5 DDB2 "DDBB, FLJ34321, UV-DDB2, XPE" ENSG00000134574 "Damage specific DNA binding protein 2" Q92466 11 47214465-47239240 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" DNA-binding "Cancer-related genes, Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025912, HPA058406" Enhanced Supported "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "CAB025912: , HPA058406: " "prognostic favourable (7.29e-4)" "prognostic favourable (1.58e-4)" "unprognostic (1.49e-1)" "prognostic favourable (1.20e-4)" "unprognostic (4.29e-2)" "unprognostic (2.04e-2)" "unprognostic (2.96e-2)" "unprognostic (6.18e-2)" "unprognostic (2.25e-1)" "unprognostic (3.58e-3)" "unprognostic (3.53e-1)" "unprognostic (1.94e-1)" "unprognostic (4.57e-3)" "unprognostic (1.21e-2)" "unprognostic (4.25e-2)" "unprognostic (9.82e-3)" "unprognostic (1.07e-1)" 12.2 22.2 5.3 13.3 8.6 8.1 11.3 11.0 8.2 16.8 13.5 7.3 13.4 6.0 18.2 14.1 25.4 14.3 13.0 6.1 4.7 2.9 6.6 20.8 11.3 16.1 15.0 5.0 9.8 15.6 6.1 8.6 5.5 6.3 20.9 12.3 8.1 17.6 14.8 6.3 36.9 11.0 19.0 17.6 15.1 9.1 7.6 7.6 23.3 6.6 16.7 26.0 17.3 15.2 11.4 6.1 11.5 11.0 7.4 27.0 9.0 8.2 22.3 9.3 7.0 6.0 12.2 11.0 9.1 21.3 11.6 13.7 3.6 4.8 19.9 1.9 8.3 14.6 5.3 18.5 5.8 4.9 10.0 4.7 21.3 16.5 5.9 5.4 12.4 16.3 21.0 5.8 13.0 34.0 1.2 9.7 19.0 15.6 20.7 2.6 3.0 8.1 10.4 2.3 10.7 4.9 8.2 4.9 6.1 11.1 3.2 2.9 20.4 1.8 14.6 35.7 16.3 7.8 4.2 10.2 7.7 4.4 13.4 6.9 12.8 5.9 8.1 11.5 12.1 11.0 11.7 11.4 12.7 11.7 6.1 7.4 9.4 10.1 2.2 7.4 9.2 0.1 27.0 9.0 5.3 8.6 11.0 8.2 4.7 2.9 15.0 5.0 6.3 7.6 DDR1 "CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6" ENSG00000204580 "Discoidin domain receptor tyrosine kinase 1" Q08345 6 30876421-30900156 "CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lactation, Pregnancy" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 31.2;HBEC3-KT: 24.0;RT4: 31.9;T-47d: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010162, CAB025656, HPA057194" Approved Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" 2100000 "Nucleoplasm, Cell Junctions" "CAB010162: AB_2092090, CAB025656: , HPA057194: " "unprognostic (2.11e-2)" "unprognostic (9.31e-2)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (7.75e-3)" "unprognostic (6.43e-2)" "unprognostic (1.92e-1)" "unprognostic (1.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.50e-1)" "unprognostic (4.41e-2)" "prognostic favourable (3.31e-10)" "unprognostic (1.42e-1)" "unprognostic (2.53e-1)" "unprognostic (5.49e-3)" "unprognostic (4.09e-2)" 6.7 11.3 23.5 7.9 36.2 2.2 12.5 6.8 42.2 9.7 25.2 57.4 17.6 16.8 7.7 10.5 30.5 31.7 18.9 8.7 27.8 20.8 19.8 3.5 13.2 3.1 55.7 19.8 11.3 20.9 28.2 14.6 13.3 34.7 17.7 14.9 4.0 28.3 20.5 9.1 41.3 32.1 3.1 43.2 5.1 52.2 5.1 37.0 8.7 20.9 10.5 7.6 16.3 16.6 1.8 0.4 0.0 0.2 0.0 1.8 0.9 19.3 6.4 9.1 1.9 0.6 0.8 5.6 0.5 0.1 0.2 0.0 8.6 10.3 0.1 10.8 1.7 31.2 1.9 24.0 0.1 10.7 3.4 0.0 5.8 2.2 1.8 0.0 0.4 1.2 12.4 0.1 0.2 0.7 5.6 0.2 1.3 12.2 0.6 0.0 1.5 1.3 1.3 6.8 0.7 4.6 31.9 1.6 0.8 1.8 14.4 7.0 35.8 0.2 1.4 4.5 4.2 0.4 4.5 0.2 0.0 0.8 2.9 0.0 3.9 0.0 0.2 0.0 1.1 0.0 0.8 0.4 0.2 0.7 0.4 1.8 1.2 1.8 0.0 0.0 0.0 0.4 0.0 0.9 23.5 36.2 6.8 25.0 27.8 20.8 55.7 19.8 34.7 37.0 DHRS7B "CGI-93, DKFZp566O084, MGC8916, SDR32C1" ENSG00000109016 "Dehydrogenase/reductase 7B" Q6IAN0 17 21123364-21193265 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012132, HPA016873" Uncertain Approved "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions, Cytosol" "HPA012132: AB_1847658, HPA016873: AB_1847657" "unprognostic (1.90e-1)" "unprognostic (3.16e-2)" "unprognostic (2.71e-1)" "prognostic favourable (1.98e-8)" "unprognostic (9.83e-2)" "unprognostic (1.18e-1)" "unprognostic (3.46e-1)" "unprognostic (1.45e-1)" "unprognostic (5.02e-3)" "unprognostic (2.76e-1)" "unprognostic (1.70e-1)" "unprognostic (2.81e-1)" "prognostic favourable (3.95e-5)" "unprognostic (1.20e-2)" "unprognostic (6.26e-2)" "unprognostic (9.20e-2)" "unprognostic (3.97e-1)" 15.9 17.8 14.0 10.3 14.5 2.5 16.2 11.1 15.2 17.6 14.2 11.9 16.7 14.4 13.5 25.3 12.8 15.4 16.3 17.9 11.8 13.2 23.1 18.4 13.9 14.0 14.5 14.8 11.8 18.9 31.2 11.4 14.2 12.9 14.8 15.2 16.5 17.5 10.5 23.7 15.7 18.3 12.7 11.1 11.5 14.7 30.5 9.1 8.0 19.7 15.8 10.9 10.7 12.8 4.2 11.7 15.0 20.4 4.1 5.7 7.5 10.0 11.9 4.4 9.5 11.6 8.0 7.6 9.6 5.4 7.0 12.9 15.0 10.6 4.2 14.7 8.2 14.3 6.4 15.7 10.0 8.1 20.6 5.8 8.8 12.8 6.4 3.2 4.3 6.2 10.5 9.0 13.7 6.8 3.5 5.3 8.2 20.7 3.5 12.7 6.0 5.1 5.9 11.5 7.4 23.4 12.2 2.4 5.1 11.9 10.6 10.3 7.1 6.7 3.4 5.9 4.1 17.6 10.8 2.9 4.5 7.9 9.2 12.0 8.7 9.7 18.9 15.0 3.8 17.9 3.4 4.2 3.8 2.5 11.7 3.6 4.1 3.6 13.5 4.1 20.4 5.0 5.7 7.5 14.0 14.5 11.1 15.2 11.8 13.2 14.5 14.8 12.9 9.1 DONSON "B17, C21orf60, C2TA, DKFZP434M035" ENSG00000159147 "Downstream neighbor of SON" Q9NYP3 21 33559542-33588708 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039558, HPA049033" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cell Junctions" Cytosol "HPA039558: , HPA049033: " "unprognostic (9.90e-3)" "unprognostic (1.01e-3)" "unprognostic (6.58e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-1)" "unprognostic (1.93e-2)" "prognostic unfavourable (8.22e-4)" "unprognostic (4.00e-2)" "unprognostic (5.93e-3)" "prognostic favourable (2.17e-4)" "unprognostic (1.25e-1)" "unprognostic (4.10e-3)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.77e-2)" "unprognostic (1.66e-1)" "unprognostic (2.07e-1)" "unprognostic (8.83e-2)" 6.4 3.5 4.1 9.2 8.0 9.4 10.2 7.8 5.6 6.8 7.1 3.3 3.5 6.1 6.7 5.8 8.3 6.3 5.9 7.5 5.5 4.4 5.6 16.2 5.2 11.1 4.7 4.0 13.5 5.7 11.7 6.9 12.2 8.1 5.7 7.4 4.4 4.8 4.3 5.9 9.1 9.3 5.4 5.2 8.2 5.8 24.0 3.0 26.4 5.0 8.1 10.7 4.5 9.7 0.7 0.5 0.1 0.9 0.4 1.4 0.3 27.0 6.3 13.3 11.6 4.2 7.7 10.4 21.6 9.3 16.6 18.8 17.8 7.4 14.7 5.6 10.7 8.1 17.9 7.7 18.2 14.7 15.5 27.6 13.9 16.1 3.0 14.6 6.7 5.5 2.5 18.7 4.6 10.6 26.3 25.7 14.2 5.5 13.3 5.2 13.8 7.8 12.0 27.6 15.7 7.4 7.3 14.5 6.0 32.4 10.4 9.5 13.6 7.4 6.1 15.8 11.0 11.5 15.2 23.3 22.9 24.2 8.8 19.5 17.8 0.0 0.3 0.1 1.4 0.9 0.7 0.2 1.4 0.6 0.2 0.7 0.8 0.1 0.0 0.4 0.0 0.5 0.6 0.3 4.1 8.0 7.8 5.6 5.5 4.4 4.7 4.0 8.1 3.0 EDA2R "EDA-A2R, EDAA2R, TNFRSF27, XEDAR" ENSG00000131080 "Ectodysplasin A2 receptor" Q9HAV5 X 66595637-66639298 "Predicted membrane proteins" Differentiation "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 14.2;BJ hTERT+: 13.6;HSkMC: 19.3;LHCN-M2: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;naive B-cell: 1.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA054522 Approved "Cell Junctions" "Cell Junctions" "HPA054522: " "unprognostic (1.31e-3)" "unprognostic (3.17e-3)" "unprognostic (2.19e-1)" "unprognostic (8.49e-3)" "unprognostic (4.15e-3)" "unprognostic (3.63e-3)" "unprognostic (2.48e-2)" "unprognostic (3.37e-2)" "unprognostic (2.82e-1)" "unprognostic (7.17e-2)" "unprognostic (6.04e-2)" "unprognostic (2.74e-1)" "unprognostic (1.01e-1)" "unprognostic (2.12e-2)" "unprognostic (8.23e-2)" "unprognostic (4.92e-2)" "unprognostic (3.08e-1)" 4.7 9.4 2.3 1.9 3.2 0.0 5.6 1.2 3.0 9.7 3.7 5.7 4.6 0.4 13.5 6.3 3.6 6.5 4.8 2.8 2.9 1.2 3.0 1.2 3.7 0.6 5.7 1.1 12.9 4.9 7.4 16.0 4.8 4.5 14.5 7.6 5.5 6.1 8.3 11.0 2.5 1.8 7.5 8.2 2.0 1.6 2.7 4.0 1.5 8.2 1.9 1.2 6.3 7.4 1.1 0.3 0.0 0.5 0.0 1.1 0.0 0.0 9.1 8.4 0.0 12.2 14.2 0.1 12.5 13.6 1.2 1.9 0.0 0.0 4.5 0.0 8.1 0.0 0.0 4.8 4.1 0.0 4.3 0.0 0.2 5.9 2.1 0.0 0.0 19.3 11.3 9.4 8.6 0.3 0.4 4.7 17.8 1.0 0.2 0.0 3.1 0.0 0.0 1.1 0.0 0.9 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.1 9.5 0.0 6.8 0.0 0.1 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.3 1.1 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 2.3 3.2 1.2 2.6 2.9 1.2 5.7 1.1 4.5 4.0 EFCAB11 C14orf143 ENSG00000140025 "EF-hand calcium binding domain 11" Q9BUY7 14 89794669-89954777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA051209 Approved "Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "HPA051209: " "unprognostic (1.03e-1)" "unprognostic (6.10e-3)" "unprognostic (2.36e-2)" "unprognostic (2.00e-3)" "unprognostic (2.39e-1)" "unprognostic (3.74e-3)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (1.00e-2)" "unprognostic (3.37e-2)" "unprognostic (1.77e-1)" "unprognostic (2.24e-1)" "unprognostic (3.84e-7)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (8.45e-2)" 4.7 5.8 10.2 6.2 8.1 5.3 9.3 5.7 7.6 5.6 5.2 10.4 6.7 5.1 4.9 6.9 6.2 11.0 4.9 3.7 7.8 6.6 7.6 5.8 3.2 3.3 8.6 5.7 5.2 4.8 8.3 8.2 8.4 7.7 5.4 5.6 6.1 5.6 5.4 2.4 3.7 3.6 6.3 8.4 6.7 4.4 36.9 6.2 2.5 7.9 3.3 6.3 5.2 4.1 2.6 2.1 12.8 5.3 3.3 1.6 0.8 4.9 7.6 6.6 8.2 4.1 4.4 18.7 7.2 6.6 9.9 6.9 8.9 17.5 7.7 13.8 4.8 10.8 5.7 14.4 14.3 8.6 3.6 5.5 6.5 14.5 0.9 7.0 13.4 3.0 3.6 6.4 7.4 8.2 5.8 7.6 11.7 25.5 5.2 9.5 2.8 13.7 6.0 10.5 5.5 9.1 13.7 2.8 4.7 9.1 17.0 8.5 13.8 5.1 6.9 5.4 7.4 5.6 7.0 4.6 13.1 13.3 7.8 3.3 9.7 12.8 1.3 3.4 0.6 3.0 0.3 2.6 1.0 1.0 2.1 2.6 1.6 1.4 4.0 3.3 5.3 1.8 1.3 0.8 10.2 8.1 5.7 7.6 7.8 6.6 8.6 5.7 7.7 6.2 ELFN1 PPP1R28 ENSG00000225968 "Extracellular leucine rich repeat and fibronectin type III domain containing 1" P0C7U0 7 1688119-1747954 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 13.3" "Cell line enhanced" "Detected in some" "REH: 19.1;U-138 MG: 12.0;U-2 OS: 17.6;U-2197: 20.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066382 Approved "Nucleoplasm,Cell Junctions" 11000 "Nucleoplasm, Cell Junctions" "HPA066382: " "unprognostic (8.45e-2)" "unprognostic (3.39e-3)" "unprognostic (6.54e-4)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "prognostic favourable (9.68e-4)" "unprognostic (4.60e-3)" "unprognostic (1.63e-3)" "unprognostic (6.60e-2)" "unprognostic (4.14e-3)" "unprognostic (1.11e-2)" "unprognostic (2.31e-2)" "unprognostic (7.47e-3)" "unprognostic (8.63e-2)" "unprognostic (2.78e-1)" "unprognostic (4.07e-1)" 1.8 0.8 2.2 0.6 1.4 0.0 0.6 0.0 4.2 3.2 0.3 0.2 2.2 0.3 0.3 0.8 0.8 3.3 1.8 2.2 2.8 13.3 0.3 0.1 2.7 0.0 0.2 0.2 0.2 0.7 0.6 0.0 0.5 0.2 1.2 0.6 0.3 0.5 1.7 1.7 0.2 0.7 0.2 0.0 0.5 0.9 0.5 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 2.9 6.2 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.1 0.3 0.0 3.0 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.5 0.0 2.8 1.2 0.7 19.1 0.0 1.9 0.0 0.0 2.8 1.3 0.1 0.1 0.0 0.0 0.2 0.0 12.0 17.6 20.5 0.0 0.0 0.2 5.1 0.0 0.0 1.5 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.5 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.0 ELMO3 "CED-12, CED12, ELMO-3, FLJ13824" ENSG00000102890 "Engulfment and cell motility 3" Q96BJ8 16 67199111-67204029 "Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 16.7;CAPAN-2: 24.5;HaCaT: 23.2;T-47d: 22.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 6.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA021484 Approved Approved "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA021484: AB_1848129" "unprognostic (4.49e-3)" "unprognostic (2.04e-1)" "unprognostic (1.10e-2)" "unprognostic (8.08e-2)" "unprognostic (1.39e-1)" "unprognostic (6.16e-3)" "unprognostic (3.14e-1)" "unprognostic (8.17e-3)" "unprognostic (1.73e-1)" "unprognostic (8.06e-2)" "unprognostic (3.40e-2)" "unprognostic (6.95e-3)" "prognostic favourable (2.77e-5)" "unprognostic (3.47e-1)" "unprognostic (2.66e-1)" "unprognostic (1.84e-1)" "unprognostic (1.97e-2)" 1.1 0.8 0.6 7.8 1.8 2.5 4.6 6.7 1.4 2.8 30.3 0.5 32.0 18.9 2.6 9.8 13.1 4.8 16.0 0.9 0.7 0.8 13.3 3.9 6.9 1.4 0.5 0.5 1.2 26.6 6.5 28.7 13.7 1.0 13.2 5.1 0.9 25.1 28.8 0.5 19.1 37.7 1.7 0.5 2.8 12.8 8.7 0.6 1.1 18.2 9.7 9.2 6.8 6.0 1.2 0.8 2.1 0.4 0.4 1.0 0.1 10.6 1.2 1.2 1.5 0.2 0.3 16.7 0.6 0.3 0.8 0.7 7.0 24.5 1.5 0.8 0.3 23.2 1.1 10.7 0.1 0.7 1.4 1.5 1.9 2.3 0.5 0.9 3.8 0.2 7.9 0.6 0.6 0.8 1.4 0.7 0.4 8.9 0.9 4.5 1.6 0.9 2.2 1.1 2.3 1.0 1.4 8.2 1.8 1.5 7.3 0.7 22.9 1.6 1.4 1.9 2.3 1.1 1.1 2.5 0.8 2.8 0.9 2.1 0.9 0.0 0.4 1.0 1.0 0.0 0.1 1.2 0.8 0.1 0.5 1.1 0.6 0.2 2.1 0.4 0.1 0.8 0.5 0.1 0.6 1.8 6.7 1.4 0.7 0.8 0.5 0.5 1.0 0.6 ELOC "SIII, TCEB1" ENSG00000154582 "Elongin C" Q15369 8 73939169-73972287 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078113 Approved "Nucleoli,Vesicles,Cell Junctions" 250000 Vesicles "Nucleoli, Cell Junctions" "HPA078113: " "prognostic unfavourable (6.48e-4)" "unprognostic (1.60e-1)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" "unprognostic (2.46e-2)" "unprognostic (8.02e-3)" "unprognostic (5.84e-3)" "unprognostic (2.19e-2)" "unprognostic (1.77e-1)" "unprognostic (6.99e-3)" "unprognostic (4.02e-3)" "unprognostic (3.33e-2)" "unprognostic (2.77e-3)" "unprognostic (3.84e-2)" "unprognostic (5.33e-2)" "unprognostic (1.67e-1)" "unprognostic (8.95e-2)" 27.0 29.5 39.1 19.2 37.6 35.4 24.2 25.6 43.3 17.5 19.6 12.2 21.0 13.4 18.2 31.7 24.5 17.2 17.9 50.1 33.9 29.5 28.2 36.1 21.2 35.2 32.5 28.4 17.9 25.5 17.6 20.0 25.7 27.3 19.2 20.6 12.1 16.3 21.0 62.5 16.6 14.5 24.4 33.9 18.7 18.5 51.0 18.8 19.7 19.6 31.9 27.9 19.3 16.7 38.9 55.3 51.7 35.4 32.5 44.9 26.4 44.6 36.6 33.6 24.3 25.7 33.6 24.1 44.4 36.3 43.6 44.8 32.5 39.0 22.8 36.0 39.3 32.1 37.0 44.3 57.7 26.2 30.7 39.7 39.1 51.5 33.6 25.4 29.8 34.0 35.6 39.4 51.0 40.5 34.9 30.6 57.2 33.1 65.3 45.7 30.5 59.3 23.8 21.1 21.6 47.5 39.2 31.7 30.0 18.6 101.5 41.4 37.4 27.4 30.9 31.7 35.8 34.6 44.5 34.8 42.4 42.0 38.1 27.8 38.4 51.7 32.2 38.2 31.2 35.4 34.0 38.9 37.5 34.8 34.2 34.0 34.3 34.4 37.7 32.5 33.8 55.3 44.9 26.4 39.1 37.6 25.6 43.3 33.9 29.5 32.5 28.4 27.3 18.8 ERCC4 "FANCQ, RAD1, XPF" ENSG00000175595 "ERCC excision repair 4, endonuclease catalytic subunit" Q92889 16 13920157-13952345 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cockayne syndrome, Disease mutation, Dwarfism, Fanconi anemia, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000156, HPA045828" Approved Supported "Nucleoplasm,Nuclear bodies,Cell Junctions" "Nucleoplasm, Nuclear bodies" "Cell Junctions" "CAB000156: , HPA045828: " "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.12e-3)" "unprognostic (9.41e-2)" "unprognostic (3.35e-1)" "unprognostic (1.40e-2)" "unprognostic (1.64e-2)" "unprognostic (2.26e-1)" "unprognostic (3.59e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (5.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (6.30e-2)" "unprognostic (5.88e-4)" 8.4 12.7 8.6 7.0 11.3 5.3 6.4 8.9 9.7 8.1 6.7 9.9 6.0 4.1 8.5 6.8 6.7 8.5 6.8 7.8 7.2 7.1 6.9 7.2 6.9 6.8 10.5 8.8 9.9 7.6 13.3 13.0 5.9 9.6 8.3 5.4 7.1 6.4 7.0 31.3 6.9 5.7 8.5 10.3 7.7 6.6 14.2 8.9 13.7 9.7 5.6 6.4 9.1 7.8 8.4 7.9 8.3 6.8 8.9 7.4 2.6 5.4 7.0 6.4 9.2 10.7 10.1 5.0 7.2 7.7 6.5 8.3 2.4 5.4 9.1 10.4 6.3 6.9 9.5 4.9 10.1 12.3 5.6 4.5 7.8 6.0 9.8 6.0 5.1 7.6 6.9 8.6 7.3 8.6 7.0 10.7 9.1 4.5 8.0 4.1 4.7 3.7 9.2 13.0 11.2 4.0 3.7 5.3 6.3 8.8 7.2 6.7 9.1 4.6 9.7 9.6 7.1 8.6 6.3 9.5 11.1 6.3 9.2 7.3 9.7 8.3 6.2 5.4 6.8 6.8 7.4 6.2 6.4 5.1 5.5 8.4 6.4 6.9 7.2 8.9 5.7 7.9 5.8 2.6 8.6 11.3 8.9 9.7 7.2 7.1 10.5 8.8 9.6 8.9 ERMN "ERMIN, JN, KIAA1189" ENSG00000136541 Ermin Q8TAM6 2 157318625-157327713 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 106.7" "Cell line enriched" "Detected in some" 6 "HAP1: 20.8" "Group enriched" "Detected in some" 12 "endometrial cancer: 2.2;glioma: 9.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038295, HPA038296" Enhanced Approved "Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "HPA038295: AB_10805353, HPA038296: AB_10796217" "unprognostic (7.89e-2)" "unprognostic (9.06e-3)" "unprognostic (2.71e-2)" "prognostic favourable (6.93e-6)" "unprognostic (1.06e-1)" "unprognostic (2.02e-2)" "unprognostic (9.14e-2)" "unprognostic (1.79e-1)" "unprognostic (4.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.07e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-3)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (9.97e-3)" "unprognostic (5.76e-2)" 1.6 1.4 29.1 2.9 50.5 9.7 1.6 2.7 106.7 1.4 1.8 52.4 0.0 1.8 1.6 1.5 1.7 1.4 1.9 1.6 40.9 21.4 1.5 1.5 2.0 3.1 75.1 18.4 1.5 1.6 1.4 0.1 1.4 54.5 1.5 1.9 4.3 2.4 1.5 1.7 1.9 1.9 1.6 100.9 2.5 2.2 1.7 69.5 0.0 1.6 0.0 2.7 1.7 0.1 1.7 1.3 3.9 1.6 2.4 2.1 0.7 0.1 0.3 0.3 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 1.2 0.0 1.9 0.3 20.8 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.2 2.8 0.4 0.2 0.7 2.3 0.3 0.5 0.0 0.4 0.5 0.0 1.0 0.4 0.6 0.0 0.1 0.0 0.7 1.2 0.0 0.2 0.1 0.2 0.6 3.4 1.9 0.5 1.8 0.9 1.0 2.6 1.6 1.1 2.1 1.2 1.0 0.7 0.8 0.6 0.6 1.7 1.5 1.6 3.9 2.4 1.0 1.3 0.9 0.7 29.1 50.5 2.7 27.9 40.9 21.4 75.1 18.4 54.5 69.5 ESCO2 "EFO2, RBS" ENSG00000171320 "Establishment of sister chromatid cohesion N-acetyltransferase 2" Q56NI9 8 27771949-27812640 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027243, HPA053679" Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" "Nucleoplasm, Golgi apparatus" "Cell Junctions" "HPA027243: , HPA053679: " "unprognostic (7.86e-2)" "unprognostic (1.50e-2)" "prognostic favourable (1.04e-4)" "unprognostic (5.13e-3)" "unprognostic (9.50e-2)" "unprognostic (8.67e-3)" "unprognostic (7.30e-4)" "unprognostic (5.24e-3)" "unprognostic (2.24e-2)" "unprognostic (2.54e-2)" "unprognostic (7.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.65e-14)" "unprognostic (6.65e-3)" "unprognostic (5.32e-1)" "unprognostic (5.85e-2)" "unprognostic (4.06e-1)" 1.0 1.7 0.5 7.1 0.5 5.5 1.0 0.4 0.6 1.2 9.6 0.1 0.5 11.9 0.6 1.0 5.0 0.3 1.8 1.1 0.7 0.5 1.6 1.4 1.1 4.2 0.5 0.6 0.6 1.0 0.3 0.3 1.5 0.5 0.5 4.5 0.1 1.4 1.4 0.4 1.1 23.2 0.4 0.8 4.7 2.4 10.3 0.2 39.8 0.5 5.3 5.7 1.0 1.8 1.3 1.9 0.8 1.5 0.9 4.6 0.8 24.8 18.9 8.5 10.3 1.1 1.8 4.7 15.0 6.3 13.9 15.9 6.7 4.9 9.2 7.9 3.9 13.8 10.3 4.1 21.2 7.1 4.4 10.9 8.5 7.0 0.1 5.5 10.2 0.3 0.4 8.1 2.0 5.1 8.7 14.1 8.0 4.8 22.3 2.5 5.7 6.4 9.9 25.4 6.7 4.5 15.1 3.7 5.4 7.5 9.1 3.8 6.2 6.1 2.2 8.6 17.8 17.3 11.7 1.9 5.0 11.4 4.7 9.3 11.9 0.1 0.7 0.4 0.3 1.5 0.1 1.3 0.7 1.0 1.9 0.1 0.5 0.4 0.8 0.9 0.4 0.2 4.6 0.8 0.5 0.5 0.4 0.6 0.7 0.5 0.5 0.6 0.5 0.2 FAM13A "ARHGAP48, FAM13A1, KIAA0914" ENSG00000138640 "Family with sequence similarity 13 member A" O94988 4 88725955-89111398 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.7;monocytes: 6.5;T-cells: 5.2" "Low region specificity" "Detected in all" "HPA038108, HPA038109" Uncertain Approved "Nucleoli,Cell Junctions,Cytosol" "Cell Junctions, Cytosol" Nucleoli "HPA038108: , HPA038109: AB_10672619" "unprognostic (1.14e-1)" "unprognostic (1.53e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.81e-1)" "unprognostic (8.20e-2)" "unprognostic (1.75e-1)" "unprognostic (1.46e-3)" "unprognostic (6.36e-2)" "unprognostic (4.71e-1)" "unprognostic (3.49e-3)" "unprognostic (1.90e-2)" "unprognostic (7.44e-2)" "prognostic favourable (4.28e-4)" 58.6 10.8 9.1 11.0 9.3 6.5 19.0 17.9 18.5 15.5 41.0 3.7 7.4 30.5 10.9 12.0 9.3 14.8 10.7 8.8 9.6 5.7 14.0 22.9 13.3 5.3 10.0 6.8 17.8 23.5 45.5 11.2 20.7 11.4 15.9 9.3 11.5 13.3 8.0 8.4 17.5 30.5 15.6 19.4 4.9 13.4 11.1 12.9 3.2 20.4 16.1 4.0 30.4 23.8 0.1 5.7 1.4 6.5 0.7 5.2 2.6 2.4 3.7 5.5 7.2 32.2 13.3 9.1 5.7 6.9 2.2 2.1 3.1 5.7 0.1 2.3 4.0 1.5 8.1 4.1 5.1 0.3 5.6 4.0 5.1 0.4 9.4 3.3 0.5 12.7 3.3 5.7 2.1 3.8 10.5 0.4 4.9 0.1 0.3 1.5 6.8 3.8 5.5 9.4 2.1 4.2 12.0 14.0 3.7 1.4 4.4 5.4 3.1 0.1 1.4 6.4 3.5 3.1 3.2 1.9 1.1 0.0 9.5 0.3 3.3 0.1 6.5 0.1 1.8 3.2 1.3 0.1 4.7 0.6 5.7 0.1 5.2 1.3 1.4 0.7 1.0 1.9 2.5 2.6 9.1 9.3 17.9 18.5 9.6 5.7 10.0 6.8 11.4 12.9 FBLN7 "FLJ37440, TM14" ENSG00000144152 "Fibulin 7" Q53RD9 2 112138385-112188216 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 17.4;BJ hTERT+: 12.4;SCLC-21H: 11.2;SH-SY5Y: 9.0;U-2197: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory CD4 T-cell: 18.5;naive CD4 T-cell: 16.2;T-reg: 17.4" "Lineage enriched" "Detected in single" 36 "T-cells: 18.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034992 Approved "Plasma membrane,Cell Junctions" "Secreted to extracellular matrix" 27000 "Plasma membrane" "Cell Junctions" "HPA034992: AB_10601469" "unprognostic (1.72e-1)" "unprognostic (1.47e-1)" "unprognostic (5.88e-2)" "unprognostic (4.88e-3)" "unprognostic (1.24e-1)" "unprognostic (1.70e-3)" "unprognostic (4.34e-2)" "unprognostic (4.80e-2)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (7.91e-2)" "unprognostic (2.02e-2)" "unprognostic (2.35e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-2)" "unprognostic (1.21e-2)" "unprognostic (9.33e-2)" 7.5 5.8 2.9 9.0 3.4 1.1 10.4 10.3 16.4 12.4 2.3 1.6 4.1 1.7 6.5 8.2 2.9 10.5 7.1 3.3 4.0 3.8 2.5 6.6 3.7 11.8 6.9 4.2 2.8 3.4 16.7 27.4 13.6 10.5 4.7 2.0 14.7 3.9 9.0 1.9 7.1 3.8 3.2 2.2 7.3 4.1 2.0 1.1 8.7 14.9 5.5 9.5 3.6 10.4 0.0 0.5 0.0 0.0 0.0 18.5 3.5 0.0 0.1 17.4 0.0 1.9 1.4 0.0 3.8 12.4 4.2 6.6 0.0 0.1 0.0 0.1 5.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.3 0.8 0.9 0.0 0.0 1.3 0.1 7.0 0.0 1.0 0.0 0.0 1.4 0.0 0.4 0.0 0.4 0.3 0.0 0.0 4.4 0.2 0.0 11.2 9.0 0.0 0.0 0.5 0.4 0.1 3.6 0.6 0.5 18.0 0.5 0.0 0.0 0.0 0.5 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.7 0.0 18.5 0.2 0.0 0.0 16.2 0.5 0.0 0.0 0.0 0.5 17.4 3.5 2.9 3.4 10.3 16.4 4.0 3.8 6.9 4.2 10.5 1.1 FIGN ENSG00000182263 "Fidgetin, microtubule severing factor" Q5HY92 2 163593396-163736012 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 54 "basophil: 5.4" "Lineage enriched" "Detected in single" 54 "granulocytes: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034987, HPA057919" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "Vesicles, Cell Junctions" "HPA034987: AB_10669681, HPA057919: " "unprognostic (3.93e-2)" "unprognostic (8.30e-3)" "unprognostic (1.48e-1)" "unprognostic (7.68e-5)" "unprognostic (3.45e-2)" "unprognostic (8.98e-4)" "unprognostic (5.23e-3)" "unprognostic (7.65e-3)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (2.07e-2)" "unprognostic (3.24e-2)" "unprognostic (3.85e-3)" "unprognostic (3.22e-2)" "unprognostic (2.69e-1)" "unprognostic (4.10e-2)" "unprognostic (3.78e-2)" 8.5 7.6 9.6 2.9 13.7 2.8 5.2 5.1 11.9 6.8 5.9 5.5 3.7 2.1 3.3 5.0 2.9 4.5 4.4 10.1 8.8 4.3 7.2 7.9 4.3 2.5 8.7 4.7 14.3 7.2 1.8 12.1 4.4 7.7 4.8 3.4 4.3 8.4 9.9 3.6 3.2 3.6 5.6 9.1 8.7 4.5 4.4 10.5 0.0 3.1 3.0 1.6 4.1 6.3 0.0 0.0 5.4 0.0 0.0 0.0 0.0 5.7 2.1 17.3 0.0 0.0 0.0 6.4 2.2 1.5 1.6 3.0 0.0 2.1 0.0 6.2 2.4 0.8 5.7 2.4 1.3 0.0 4.3 0.0 4.0 4.1 1.4 0.0 0.0 0.8 2.1 3.1 8.5 3.7 0.0 0.0 4.7 1.4 0.0 0.0 7.3 2.7 0.0 5.8 0.0 4.0 1.9 2.7 2.3 0.0 1.6 1.5 1.8 0.0 0.3 7.2 6.5 0.0 4.6 1.0 0.0 0.0 2.1 0.0 3.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 13.7 5.1 11.9 8.8 4.3 8.7 4.7 7.7 10.5 FLRT3 ENSG00000125848 "Fibronectin leucine rich transmembrane protein 3" Q9NZU0 20 14322988-14337616 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.1" "Cell line enhanced" "Detected in some" "AF22: 15.3;hTCEpi: 28.9;RPTEC TERT1: 9.7;WM-115: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056033 Enhanced Supported "Plasma membrane,Cell Junctions,Cytosol" "Intracellular and membrane" 240000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA056033: " "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.98e-1)" "unprognostic (1.14e-3)" "unprognostic (2.30e-1)" "unprognostic (6.00e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (9.85e-5)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (1.54e-4)" "unprognostic (3.05e-1)" "prognostic favourable (1.49e-7)" "unprognostic (1.54e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-3)" "unprognostic (3.65e-1)" 7.3 4.3 3.4 2.2 7.4 0.1 2.7 27.5 18.9 3.8 5.0 0.7 3.2 12.4 2.6 5.5 2.5 2.7 5.6 1.6 9.3 4.1 43.1 28.9 26.2 0.2 2.3 5.3 11.9 2.3 4.6 2.1 2.0 2.9 12.7 1.0 1.9 1.5 16.4 2.1 6.9 6.0 3.9 2.3 0.8 9.7 1.7 0.7 4.8 8.5 1.8 0.4 12.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 15.3 0.0 0.0 0.0 0.0 1.5 0.4 0.1 0.0 8.4 3.1 0.0 0.5 0.3 4.3 0.0 4.5 0.1 0.0 0.9 0.0 0.2 0.1 1.3 0.0 0.0 2.7 28.9 0.0 5.4 0.0 0.0 0.1 2.9 0.2 1.9 0.0 5.0 0.0 0.0 0.1 0.0 9.7 1.8 0.3 3.1 0.0 0.0 4.8 0.2 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 7.4 27.5 18.9 9.3 4.1 2.3 5.3 2.9 0.7 FLT4 "PCL, VEGFR3" ENSG00000037280 "Fms related tyrosine kinase 4" P35916 5 180601506-180649624 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 56.3" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;BEWO: 10.2;HEK 293: 12.6;HL-60: 7.4;HUVEC TERT2: 8.1;T-47d: 12.0;TIME: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.7" "Lineage enriched" "Detected in single" 35 "T-cells: 7.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000099, HPA046519, HPA067906" Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Secreted to blood" 270000000 "Plasma membrane" "Nucleoplasm, Cell Junctions" "CAB000099: , HPA046519: , HPA067906: " "unprognostic (7.35e-2)" "unprognostic (1.63e-1)" "unprognostic (9.45e-3)" "unprognostic (3.81e-1)" "unprognostic (9.26e-2)" "unprognostic (3.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-1)" "unprognostic (1.88e-2)" "unprognostic (9.41e-3)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (1.32e-1)" 14.8 7.1 1.6 4.9 6.0 0.7 28.5 1.3 2.7 6.3 7.3 1.9 2.1 3.1 7.3 6.2 5.7 9.2 5.3 6.4 1.7 0.9 11.7 10.2 14.1 23.6 2.0 0.8 5.8 2.3 2.3 6.2 56.3 2.1 4.9 1.4 6.7 3.3 4.4 4.8 2.8 4.7 4.7 1.5 14.5 2.4 3.5 2.0 0.3 19.4 4.4 2.3 6.1 14.7 0.0 0.1 0.2 0.0 0.0 7.7 0.2 0.1 2.0 2.7 8.3 0.0 0.0 10.2 0.2 0.1 0.0 0.0 0.3 0.3 0.2 0.8 0.1 0.3 2.8 0.1 0.2 0.1 12.6 1.0 0.4 0.4 0.1 7.4 0.2 0.2 0.0 0.1 0.3 8.1 0.3 0.3 1.7 4.5 0.1 0.4 5.8 0.5 6.5 0.0 0.1 0.1 0.2 0.2 0.9 0.1 0.2 0.0 12.0 0.2 12.7 0.1 5.9 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.9 0.0 7.7 0.0 0.4 1.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 1.6 6.0 1.3 2.7 1.7 0.9 2.0 0.8 2.1 2.0 FLVCR1 "AXPC1, FLVCR, MFSD7B, PCA" ENSG00000162769 "Feline leukemia virus subgroup C cellular receptor 1" Q9Y5Y0 1 212858255-212899363 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Erythrocyte maturation, Transport" Receptor "Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 40.6" "Cell line enhanced" "Detected in all" "NTERA-2: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046646 Approved Approved "Cell Junctions" "Cell Junctions" "HPA046646: " "unprognostic (2.09e-1)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (1.01e-1)" "unprognostic (2.83e-2)" "unprognostic (2.48e-1)" "prognostic unfavourable (2.52e-5)" "unprognostic (1.03e-1)" "unprognostic (1.21e-1)" "unprognostic (3.88e-2)" "prognostic favourable (3.50e-4)" "unprognostic (1.89e-1)" "prognostic unfavourable (1.06e-5)" "unprognostic (7.15e-2)" "unprognostic (2.25e-1)" "unprognostic (3.91e-2)" "unprognostic (7.29e-3)" 3.2 3.8 4.6 4.5 7.2 7.8 4.8 11.3 5.9 4.4 12.9 4.7 3.3 13.5 4.0 7.5 3.2 3.6 3.6 2.5 5.0 7.5 3.5 3.1 3.7 4.1 5.3 5.9 4.0 5.1 7.0 16.8 3.5 7.2 5.3 4.4 4.0 2.9 4.3 1.6 4.3 40.6 3.8 4.8 4.2 7.1 4.0 5.5 5.4 3.6 2.1 3.3 4.0 5.0 1.2 1.6 4.7 0.8 0.7 1.4 0.2 4.7 6.3 9.9 3.0 1.7 2.0 18.5 1.4 1.0 2.8 1.7 9.2 8.8 5.2 2.6 1.0 7.2 10.6 3.1 2.8 3.0 4.6 3.1 6.2 8.4 1.9 8.1 5.0 1.6 2.1 3.0 3.9 2.2 8.1 4.4 1.9 1.8 2.3 4.0 32.4 4.5 5.1 9.0 6.0 3.5 4.6 10.7 7.5 6.5 6.5 5.9 10.6 3.8 1.3 1.4 3.4 4.5 6.3 2.7 5.4 6.2 2.0 4.7 1.7 1.6 0.8 4.7 0.8 0.6 0.9 0.9 1.2 1.0 0.5 1.2 1.2 1.1 2.6 0.7 0.8 1.6 1.4 0.2 4.6 7.2 11.3 5.9 5.0 7.5 5.3 5.9 7.2 5.5 FOXA2 HNF3B ENSG00000125798 "Forkhead box A2" Q9Y261 20 22581005-22585455 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 44.4;pancreas: 47.9;stomach 1: 20.7" "Cell line enhanced" "Detected in some" "A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;PC-3: 15.1;SCLC-21H: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.1" "Region enriched" "Detected in single" 7 "midbrain: 4.9" "CAB001388, HPA066846" Enhanced Supported "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "CAB001388: AB_2262810, HPA066846: " "unprognostic (1.19e-1)" "unprognostic (1.99e-1)" "prognostic favourable (7.57e-6)" "unprognostic (6.82e-2)" "unprognostic (1.50e-6)" "unprognostic (1.38e-1)" "unprognostic (8.17e-2)" "prognostic favourable (6.28e-4)" "prognostic favourable (2.34e-4)" "unprognostic (3.18e-1)" "unprognostic (2.55e-15)" "unprognostic (2.50e-2)" "unprognostic (1.68e-1)" "unprognostic (7.12e-2)" "unprognostic (3.93e-3)" 0.2 0.0 0.2 1.3 0.2 0.0 0.2 0.2 0.3 9.7 4.5 0.2 0.2 2.2 1.8 0.2 0.2 3.8 13.1 0.2 0.2 0.1 0.2 44.4 15.9 0.2 1.4 0.2 3.4 47.9 0.0 0.4 0.3 0.4 0.5 6.0 0.2 0.2 0.2 0.2 0.0 1.8 0.2 0.2 0.2 20.7 0.3 0.2 0.2 2.2 0.2 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.1 0.0 0.0 0.0 11.7 0.0 0.0 0.7 0.0 0.0 16.2 0.0 0.0 0.0 0.0 6.3 0.0 7.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.5 0.0 26.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.1 1.4 0.2 0.4 0.2 FZD2 ENSG00000180340 "Frizzled class receptor 2" Q14332 17 44557459-44559570 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 25.7;BJ hTERT+ SV40 Large T+: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 3.5;myeloid DC: 5.6;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 6 "dendritic cells: 5.6;monocytes: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057667 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" "Nucleoplasm, Nuclear bodies" "Cell Junctions" "HPA057667: " "unprognostic (6.94e-2)" "unprognostic (1.12e-2)" "unprognostic (3.04e-2)" "unprognostic (8.83e-3)" "unprognostic (2.04e-1)" "unprognostic (5.29e-3)" "unprognostic (1.44e-2)" "unprognostic (2.29e-1)" "unprognostic (9.45e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-2)" "unprognostic (1.86e-1)" "unprognostic (5.10e-3)" "unprognostic (1.19e-2)" "unprognostic (6.35e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 2.3 2.8 2.3 3.9 5.8 0.9 3.2 0.7 3.1 16.1 2.9 2.1 3.0 2.9 10.8 7.6 2.4 6.6 7.7 5.8 3.2 1.5 5.0 0.5 6.9 3.1 2.1 2.9 12.1 2.7 1.6 1.9 8.4 4.9 4.2 0.8 14.3 2.9 7.9 1.8 1.1 3.6 3.3 2.0 3.7 2.1 6.5 1.8 1.1 5.3 2.4 3.1 3.8 4.3 0.2 5.6 0.0 3.5 0.0 0.8 0.6 7.5 25.7 14.7 8.4 3.3 2.9 0.3 21.3 13.0 25.5 18.4 19.8 4.4 0.0 6.7 5.3 3.5 1.7 1.8 6.1 1.9 5.0 0.8 4.2 0.1 4.3 0.1 4.4 5.5 1.4 6.2 4.2 1.0 1.6 0.2 6.4 4.0 3.4 1.9 16.1 4.8 9.8 4.4 1.3 3.3 0.3 1.9 6.4 2.7 0.7 1.6 8.2 3.6 0.4 13.8 12.2 2.6 12.5 0.6 0.4 1.8 2.5 1.4 6.3 0.0 3.5 0.0 0.1 0.2 0.0 0.0 0.0 0.8 5.6 0.2 0.0 0.2 0.0 0.0 0.2 2.6 0.0 0.6 2.3 5.8 0.7 2.1 3.2 1.5 2.1 2.9 4.9 1.8 GAS2L1 GAR22 ENSG00000185340 "Growth arrest specific 2 like 1" Q99501 22 29306582-29312785 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 40.5" "Cell line enhanced" "Detected in many" "U-138 MG: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.0;eosinophil: 3.1" "Group enriched" "Detected in many" 10 "dendritic cells: 1.1;granulocytes: 3.1;monocytes: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019858 Approved Approved "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "HPA019858: AB_1849486" "unprognostic (3.66e-1)" "unprognostic (5.22e-2)" "unprognostic (1.38e-1)" "unprognostic (4.95e-3)" "unprognostic (1.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-3)" "unprognostic (8.99e-2)" "unprognostic (1.28e-1)" "unprognostic (6.05e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "prognostic favourable (8.44e-4)" "unprognostic (4.23e-2)" "unprognostic (9.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-2)" 15.1 10.7 15.2 5.3 13.4 5.4 7.6 10.5 19.8 4.5 5.6 6.8 40.5 17.9 5.1 8.4 8.6 4.6 4.3 7.0 12.9 8.1 6.0 6.6 7.5 2.2 11.3 10.2 2.9 10.0 4.6 6.8 4.3 9.5 7.1 2.2 3.2 12.7 22.9 4.9 22.4 13.0 4.5 10.0 11.5 8.3 16.6 8.8 0.0 4.5 9.2 3.5 3.9 4.7 0.0 1.1 3.1 2.0 0.0 0.2 1.2 8.2 9.6 1.5 6.1 2.4 2.3 9.6 12.3 3.8 5.2 2.7 4.3 5.9 0.0 5.6 6.5 25.1 2.5 7.0 0.9 11.2 1.2 10.8 7.6 3.0 3.0 0.1 7.6 2.4 4.8 5.0 2.0 6.9 5.1 1.7 3.7 7.0 0.2 6.0 2.2 21.7 0.2 4.3 0.7 3.1 5.3 0.5 8.1 9.5 12.8 6.8 12.7 1.7 14.7 33.1 22.8 14.7 12.3 0.1 0.1 0.1 14.6 0.4 8.1 0.0 2.0 3.1 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.0 0.5 0.0 1.4 0.0 0.0 1.2 15.2 13.4 10.5 19.8 12.9 8.1 11.3 10.2 9.5 8.8 GIPC1 "C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2" ENSG00000123159 "GIPC PDZ domain containing family member 1" O14908 19 14477760-14496149 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043958, HPA061786" Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA043958: AB_10963436, HPA061786: AB_2756319" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (8.21e-2)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (4.82e-2)" "unprognostic (3.53e-2)" "unprognostic (7.72e-2)" "unprognostic (1.04e-2)" "unprognostic (7.17e-3)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" 16.4 15.1 17.4 12.0 21.0 2.0 11.2 12.1 28.8 19.4 51.0 29.7 15.3 14.2 11.9 14.9 71.2 14.4 21.2 17.9 16.9 14.8 18.7 16.9 20.5 7.9 18.3 23.0 10.2 15.1 6.5 12.4 24.0 23.0 14.0 23.9 15.2 22.1 19.6 26.8 40.4 13.3 15.8 21.8 10.8 35.7 6.5 16.6 11.1 18.2 26.0 24.7 17.1 26.3 2.0 4.0 2.4 1.2 1.5 12.1 1.9 65.4 30.4 9.3 14.6 8.6 8.7 7.4 24.6 12.4 20.3 18.4 16.3 24.8 0.9 46.3 17.3 37.6 8.0 20.6 6.9 6.8 14.2 12.8 20.8 15.8 26.5 1.3 15.8 10.0 20.6 12.3 10.8 13.6 5.9 11.3 10.2 48.8 4.2 2.6 10.1 30.5 4.3 7.8 8.7 25.0 57.4 8.7 9.7 13.7 33.9 31.5 21.3 7.1 23.5 28.7 15.8 40.0 26.2 10.6 13.4 3.3 24.0 10.4 30.1 2.4 0.8 0.1 5.8 1.2 5.4 2.0 5.9 5.9 1.2 1.0 4.9 3.9 0.3 1.5 0.5 4.0 12.1 1.9 17.4 21.0 12.1 28.8 16.9 14.8 18.3 23.0 23.0 16.6 HCAR3 "GPR109B, HCA3, HM74" ENSG00000255398 "Hydroxycarboxylic acid receptor 3" P49019 12 122714756-122716892 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.7" "Group enriched" "Detected in some" 5 "HaCaT: 7.1;RT4: 27.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "midbrain: 3.5" "Group enriched" "Detected in some" 6 "basophil: 12.1;neutrophil: 47.7;non-classical monocyte: 21.3" "Group enriched" "Detected in many" 49 "granulocytes: 47.7;monocytes: 21.3" HPA028660 Approved Approved "Cell Junctions" "Cell Junctions" "HPA028660: AB_10602139" "unprognostic (2.32e-1)" "unprognostic (5.82e-2)" "unprognostic (8.23e-2)" "unprognostic (2.27e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" "unprognostic (1.64e-3)" "unprognostic (1.60e-1)" "unprognostic (6.29e-2)" "unprognostic (9.87e-2)" "unprognostic (1.50e-2)" "unprognostic (2.80e-1)" "unprognostic (1.23e-1)" "unprognostic (2.30e-2)" "unprognostic (2.83e-1)" "unprognostic (1.16e-1)" "unprognostic (9.28e-2)" 4.8 0.2 0.6 7.9 0.3 20.8 4.0 0.4 0.5 2.3 0.9 0.2 2.2 0.1 0.4 0.4 18.2 0.5 0.5 1.0 0.3 0.3 0.9 2.5 10.2 3.5 3.5 0.0 1.6 0.2 6.6 1.1 3.0 0.7 4.2 0.0 0.3 2.9 4.3 0.6 13.9 0.3 0.4 1.2 21.6 0.5 1.6 0.4 0.3 0.5 12.0 14.9 5.7 7.2 0.0 0.7 47.7 21.3 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 7.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 12.1 0.5 0.2 0.0 4.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 47.7 0.0 21.3 0.0 0.0 0.6 0.6 0.3 0.4 0.5 0.3 0.3 3.5 0.0 0.7 0.4 HOXC5 "HOX3, HOX3D" ENSG00000172789 "Homeobox C5" Q00444 12 54032853-54035358 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.8;ovary: 13.4" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;ASC TERT1: 6.1;HSkMC: 5.7;SH-SY5Y: 9.1" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Region enriched" "Detected in single" 14 "pons and medulla: 8.8" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;naive CD8 T-cell: 1.9" "Lineage enriched" "Detected in single" 59 "T-cells: 5.9" "Region enriched" "Detected in single" 40 "pons and medulla: 4.8" "Region enriched" "Detected in single" 7 "pons and medulla: 1.0" HPA026794 Uncertain Supported "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA026794: AB_10612118" "unprognostic (1.57e-1)" "unprognostic (7.73e-3)" "unprognostic (1.70e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-3)" "unprognostic (2.87e-3)" "unprognostic (6.89e-2)" "unprognostic (9.53e-3)" "unprognostic (1.86e-2)" "unprognostic (2.69e-2)" "unprognostic (2.01e-3)" "unprognostic (1.17e-2)" "unprognostic (7.53e-3)" "unprognostic (2.19e-3)" "unprognostic (1.08e-2)" 1.8 1.6 0.2 1.0 0.2 0.0 1.8 0.2 0.6 0.2 1.6 0.2 0.2 0.3 0.5 5.3 1.7 8.0 1.5 0.2 0.2 0.0 1.5 0.2 0.2 0.3 0.4 0.2 13.4 0.2 0.0 0.2 1.4 8.8 0.2 0.0 0.8 0.2 0.2 4.2 2.1 4.6 2.5 2.6 0.2 3.9 2.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.9 2.1 0.0 8.3 5.0 6.1 0.0 0.5 0.4 0.9 0.7 3.5 0.4 0.0 0.6 2.5 1.3 0.1 0.0 0.3 2.6 2.9 0.0 1.0 0.1 0.2 0.0 0.1 5.7 0.6 4.1 0.4 0.0 0.0 0.0 1.8 1.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 9.1 0.6 0.2 4.3 1.7 0.1 0.0 1.4 0.9 3.1 0.3 0.0 0.0 0.0 0.2 0.1 3.2 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.6 0.2 0.0 0.4 0.2 8.8 0.2 HOXD4 "HOX4, HOX4B" ENSG00000170166 "Homeobox D4" P09016 2 176151222-176153226 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 21.0;seminal vesicle: 26.2" "Cell line enhanced" "Detected in some" "EFO-21: 9.1;HEK 293: 21.6;RPTEC TERT1: 16.0;SK-MEL-30: 6.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.3" "Region enriched" "Detected in some" 7 "pons and medulla: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 31 "pons and medulla: 8.2" "HPA054383, HPA070349" Approved Supported "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA054383: , HPA070349: " "unprognostic (9.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.03e-3)" "unprognostic (1.10e-3)" "unprognostic (9.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.19e-2)" "unprognostic (6.69e-3)" "unprognostic (1.66e-1)" "unprognostic (3.47e-1)" "unprognostic (1.49e-1)" "unprognostic (2.50e-1)" "unprognostic (7.78e-2)" "unprognostic (1.12e-2)" "unprognostic (9.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.61e-1)" 3.4 4.9 0.5 0.5 0.5 0.0 4.0 0.5 0.7 2.8 3.4 0.5 13.8 0.2 15.6 21.0 0.5 7.9 0.5 0.5 0.5 0.0 10.2 0.5 0.5 0.6 1.1 0.5 9.7 0.5 0.0 0.5 0.5 7.6 1.5 0.8 0.5 0.5 26.2 1.3 1.0 3.5 5.3 3.7 4.4 0.4 1.5 0.5 0.5 0.8 0.5 0.5 2.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.1 1.7 0.0 0.1 0.4 0.0 0.6 0.5 0.0 0.0 9.1 1.6 0.1 1.5 0.0 0.2 0.0 21.6 0.2 0.0 0.0 0.3 0.0 0.0 4.9 1.4 0.0 0.2 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 16.0 2.5 1.3 2.1 0.3 0.0 6.0 0.0 0.0 2.7 0.2 0.1 1.4 1.1 0.0 0.0 0.0 1.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.7 0.5 0.0 1.1 0.5 7.6 0.5 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;ovary: 21.1;testis: 39.9" "Cell line enhanced" "Detected in some" "A549: 5.9;HEL: 4.3;SK-MEL-30: 25.6;U-266/70: 8.9;U-266/84: 10.4" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 1.1 10.5 12.5 1.4 14.6 0.9 1.2 3.4 23.9 1.3 2.6 27.8 0.0 1.1 1.6 2.3 2.0 1.6 1.9 2.2 12.3 6.0 10.6 0.9 1.0 1.0 25.2 8.9 21.1 5.1 3.8 1.4 1.1 15.3 1.3 1.8 7.0 1.4 2.0 2.9 2.6 1.6 1.5 20.5 1.0 1.4 39.9 20.7 0.0 5.0 0.0 1.1 1.1 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 5.9 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 2.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 25.6 0.5 0.1 0.0 0.0 1.0 0.0 0.0 8.9 10.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.5 14.6 3.4 13.6 12.3 6.0 25.2 8.9 15.3 20.7 IGSF23 ENSG00000216588 "Immunoglobulin superfamily member 23" A1L1A6 19 44613630-44636781 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 6.0;intestine: 19.9;liver: 20.6" "Cell line enhanced" "Detected in some" "CACO-2: 13.7;Hep G2: 8.1;SiHa: 6.3" "Cancer enriched" "Detected in some" 10 "liver cancer: 12.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.0" "HPA051811, HPA054591" Uncertain Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA051811: , HPA054591: " "unprognostic (1.54e-1)" "unprognostic (1.84e-3)" "unprognostic (5.74e-2)" "unprognostic (1.53e-3)" "unprognostic (4.58e-2)" "unprognostic (1.11e-1)" "prognostic favourable (7.20e-6)" "unprognostic (7.35e-3)" "unprognostic (2.71e-1)" "unprognostic (3.27e-2)" "unprognostic (2.93e-3)" "unprognostic (1.52e-1)" "unprognostic (1.19e-8)" "unprognostic (1.26e-1)" "unprognostic (6.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.85e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 10.8 0.1 0.1 12.2 0.1 0.5 0.1 0.1 0.1 0.6 0.1 0.1 0.4 20.6 0.1 0.1 0.1 0.1 0.1 3.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.1 0.1 0.0 19.9 0.1 0.6 0.1 0.0 1.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 6.0 1.2 0.0 0.0 0.2 0.4 0.8 0.0 0.5 0.0 0.0 0.7 0.5 0.6 0.0 0.6 13.7 0.4 0.0 1.0 0.4 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.3 8.1 0.0 0.0 0.1 0.4 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 6.3 2.2 0.0 0.3 0.0 2.5 0.4 0.5 0.6 0.0 1.2 0.0 0.0 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 IL13RA2 "CD213a2, CT19, IL-13R, IL13BP" ENSG00000123496 "Interleukin 13 receptor subunit alpha 2" Q14627 X 115003975-115019977 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 16.1;testis: 31.5" "Group enriched" "Detected in some" 9 "PC-3: 26.4;U-2197: 84.9;U-251 MG: 57.0;U-87 MG: 33.8" "Cancer enhanced" "Detected in many" "glioma: 17.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "olfactory region: 8.7" "Low region specificity" "Detected in many" "HPA045831, HPA067363" Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "Nucleoplasm, Vesicles" "HPA045831: , HPA067363: " "unprognostic (1.97e-1)" "unprognostic (2.83e-1)" "unprognostic (6.62e-4)" "unprognostic (7.39e-2)" "unprognostic (8.45e-2)" "unprognostic (1.80e-1)" "prognostic favourable (3.55e-4)" "unprognostic (3.54e-1)" "unprognostic (2.85e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-3)" "unprognostic (2.19e-2)" "unprognostic (1.53e-5)" "unprognostic (1.58e-1)" "unprognostic (1.63e-1)" "unprognostic (9.70e-3)" "unprognostic (1.20e-1)" 0.5 4.8 3.7 3.9 11.3 0.0 0.8 0.3 3.1 1.2 0.4 2.1 5.7 0.3 0.9 4.4 0.5 0.1 0.8 0.6 5.1 11.2 3.5 9.6 1.0 0.1 1.2 2.6 0.1 0.1 0.5 16.1 2.1 3.9 4.3 0.7 1.6 0.8 3.7 0.0 0.1 0.3 0.4 0.6 0.2 0.1 31.5 1.4 0.0 1.3 0.2 0.2 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.7 0.0 5.8 5.5 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.9 5.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.4 0.0 0.1 0.0 0.0 0.0 3.0 0.0 84.9 57.0 0.0 0.0 0.0 33.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 11.3 0.3 3.1 5.1 11.2 1.2 2.6 3.9 1.4 IP6K2 IHPK2 ENSG00000068745 "Inositol hexakisphosphate kinase 2" Q9UHH9 3 48688003-48740353 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007532, HPA070811" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA007532: AB_1851542, HPA070811: " "prognostic favourable (1.25e-4)" "unprognostic (2.55e-2)" "unprognostic (8.86e-2)" "unprognostic (6.69e-3)" "unprognostic (1.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.76e-3)" "prognostic favourable (2.95e-4)" "unprognostic (6.57e-3)" "unprognostic (1.56e-1)" "unprognostic (1.92e-3)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.64e-1)" "unprognostic (3.50e-2)" "prognostic favourable (1.83e-4)" 18.3 31.1 40.4 20.0 55.9 51.7 28.2 74.1 37.3 29.5 32.5 23.7 34.0 36.9 34.6 56.1 30.0 28.1 24.0 19.0 30.7 19.2 32.4 24.3 18.4 22.5 35.4 27.6 33.9 28.1 23.5 42.3 20.7 29.4 34.9 41.9 22.2 28.3 32.1 19.1 50.0 31.6 21.1 28.3 25.5 27.6 26.0 37.4 31.7 35.7 21.6 19.5 24.1 34.0 27.3 22.8 50.7 25.7 27.9 35.1 19.0 8.7 17.2 35.7 25.1 20.1 25.2 25.8 16.8 18.9 19.3 22.4 14.2 23.6 15.6 13.8 15.6 23.0 17.8 25.1 18.0 18.3 15.7 17.8 53.2 30.4 16.3 16.8 17.4 23.9 36.6 26.1 21.6 26.6 13.3 19.6 22.3 19.5 36.0 23.1 27.4 31.9 15.1 11.8 17.0 26.2 42.2 22.3 33.7 36.3 24.7 17.8 23.9 28.5 18.9 21.0 20.9 13.1 16.5 18.1 21.4 21.9 19.1 19.7 18.3 50.7 22.5 38.5 29.7 21.6 26.5 27.3 25.8 27.7 21.7 25.7 24.2 24.9 35.3 27.9 25.7 22.8 35.1 19.0 40.4 55.9 74.1 37.3 30.7 19.2 35.4 27.6 29.4 37.4 IREB2 IRP2 ENSG00000136381 "Iron responsive element binding protein 2" P48200 15 78437431-78501456 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032885, HPA040371, HPA068982" Uncertain Approved "Cell Junctions,Cytosol" "Cell Junctions" Cytosol "CAB032885: AB_2126703, HPA040371: , HPA068982: " "unprognostic (1.00e-2)" "unprognostic (1.30e-1)" "unprognostic (6.54e-2)" "unprognostic (3.44e-2)" "unprognostic (3.39e-2)" "unprognostic (2.29e-1)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (7.30e-2)" "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (6.51e-2)" "unprognostic (3.85e-3)" "unprognostic (4.09e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-2)" "unprognostic (9.40e-2)" 18.9 42.4 12.0 16.2 22.0 22.6 18.3 22.3 24.9 19.0 16.2 14.8 14.3 16.6 20.4 17.9 19.7 17.6 14.4 13.6 10.7 11.8 18.2 21.1 22.4 31.1 10.3 16.7 23.1 17.0 20.3 23.6 23.2 21.7 16.5 19.7 19.2 17.1 15.8 27.3 18.6 25.3 15.5 13.7 25.5 15.7 18.0 12.3 39.6 27.8 14.0 20.3 17.8 18.4 7.1 9.5 7.1 7.8 7.2 8.8 3.4 7.4 13.2 20.6 12.9 18.2 12.0 13.9 12.7 9.9 11.6 10.6 13.0 13.0 27.6 8.7 10.6 14.5 47.9 12.9 10.3 8.7 16.6 23.9 13.9 9.1 9.5 25.7 25.8 12.6 8.8 8.9 10.9 13.6 25.0 9.9 9.9 11.2 15.7 13.1 26.9 4.8 18.5 20.6 7.8 12.7 20.6 12.4 18.6 17.3 12.2 13.3 11.4 22.6 11.0 12.0 8.2 6.5 11.0 12.3 27.0 15.8 8.6 23.9 8.5 7.1 5.8 4.4 6.0 7.8 7.7 6.5 6.6 5.9 8.0 7.1 6.5 8.8 6.8 7.2 6.0 9.5 5.3 3.4 12.0 22.0 22.3 24.9 10.7 11.8 10.3 16.7 21.7 12.3 ITGA9 "ALPHA-RLC, ITGA4L, RLC" ENSG00000144668 "Integrin subunit alpha 9" Q13797 3 37452115-37823514 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 4.6;CACO-2: 10.6;HEL: 8.5;HMC-1: 5.0;SH-SY5Y: 12.7;WM-115: 6.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.1" "Lineage enhanced" "Detected in single" "granulocytes: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030609 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Intracellular and membrane" 250000 Vesicles "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA030609: AB_10600815" "unprognostic (2.35e-2)" "unprognostic (3.36e-2)" "unprognostic (5.58e-2)" "unprognostic (3.94e-2)" "unprognostic (4.48e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (8.87e-3)" "unprognostic (3.23e-1)" "unprognostic (2.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-2)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-2)" "unprognostic (3.16e-2)" 8.5 15.5 3.1 5.3 3.7 5.8 9.6 1.6 5.7 17.9 11.1 2.9 5.8 4.6 17.3 7.5 12.3 6.9 17.8 25.0 4.5 2.0 4.6 13.6 8.3 16.8 3.4 2.7 7.5 2.1 2.4 3.0 7.3 2.6 10.0 5.3 8.4 4.7 8.7 3.7 3.5 8.7 16.2 4.0 30.5 10.9 10.2 2.7 1.0 35.4 7.2 3.6 7.4 8.4 0.0 0.7 2.1 0.2 0.0 0.0 0.4 0.2 0.0 4.6 0.3 0.0 0.3 0.1 0.1 0.0 0.0 0.0 10.6 0.0 3.4 1.5 0.0 0.2 4.1 0.0 0.0 0.1 0.6 8.5 0.2 0.2 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.3 0.0 0.2 0.6 12.7 0.1 0.6 0.7 0.0 3.3 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.2 6.6 2.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 3.1 3.7 1.6 5.7 4.5 2.0 3.4 2.7 2.6 2.7 KCNK13 "K2p13.1, THIK-1, THIK1" ENSG00000152315 "Potassium two pore domain channel subfamily K member 13" Q9HB14 14 90061765-90185857 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.3;parathyroid gland: 14.3;testis: 13.2" "Cell line enhanced" "Detected in some" "MCF7: 2.3;RT4: 5.1;SCLC-21H: 2.2;SK-BR-3: 2.2;U-2 OS: 2.5;U-266/84: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8" "Group enriched" "Detected in many" 7 "dendritic cells: 3.8;monocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003514 Approved Approved "Nuclear speckles,Cell Junctions" "Nuclear speckles, Cell Junctions" "HPA003514: " "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (6.17e-2)" "unprognostic (6.31e-2)" "unprognostic (2.56e-1)" "unprognostic (5.55e-2)" "unprognostic (3.56e-2)" "unprognostic (3.98e-2)" "unprognostic (2.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-2)" "unprognostic (1.97e-1)" "unprognostic (2.04e-2)" "unprognostic (6.32e-2)" "unprognostic (1.46e-1)" "unprognostic (5.65e-2)" 0.8 1.1 2.9 2.2 3.5 0.1 0.4 0.2 4.2 0.4 0.6 4.0 0.0 0.6 0.3 1.5 0.3 0.4 0.5 2.7 2.9 2.4 4.8 0.7 0.7 1.6 6.3 1.4 0.4 2.7 14.3 0.6 1.2 3.6 0.4 0.7 0.1 1.1 0.7 0.1 0.1 0.7 0.4 8.3 1.1 0.5 13.2 5.4 0.7 2.7 0.0 0.6 0.8 0.1 0.0 3.8 0.0 1.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.9 1.2 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.9 1.2 0.0 0.0 0.0 0.5 5.1 2.2 0.7 0.0 2.2 1.4 0.0 1.9 0.0 0.0 2.5 0.0 0.8 0.7 2.2 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 2.9 3.5 0.2 4.2 2.9 2.4 6.3 1.4 3.6 5.4 KIAA0895 ENSG00000164542 KIAA0895 Q8NCT3 7 36324221-36390125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021036, HPA061066" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" Nucleoplasm "Plasma membrane, Cell Junctions, Cytosol" "HPA021036: , HPA061066: " "unprognostic (4.94e-2)" "unprognostic (9.59e-2)" "unprognostic (2.93e-1)" "unprognostic (1.39e-1)" "unprognostic (8.85e-2)" "unprognostic (1.15e-3)" "unprognostic (3.79e-3)" "unprognostic (3.43e-1)" "unprognostic (3.74e-1)" "unprognostic (4.71e-3)" "unprognostic (1.46e-1)" "unprognostic (3.49e-1)" "unprognostic (4.51e-2)" "unprognostic (6.68e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-2)" "unprognostic (5.24e-2)" 1.5 9.9 8.1 1.3 11.0 2.8 5.2 28.9 13.5 3.7 3.0 5.8 6.0 3.0 4.6 9.1 3.6 8.6 4.6 2.6 6.2 8.1 13.1 10.4 4.2 0.7 4.2 8.2 12.7 12.4 18.6 14.7 2.0 8.0 4.6 2.1 6.6 4.1 4.7 2.1 7.8 1.7 4.4 4.7 1.2 14.3 27.1 4.9 2.1 5.5 1.5 0.9 2.3 2.7 0.6 0.5 1.3 0.1 0.5 1.5 0.4 7.2 4.4 9.1 8.9 0.2 0.2 2.0 1.9 2.2 4.3 5.3 1.9 3.7 0.0 2.0 0.4 4.2 11.8 3.8 3.8 0.6 7.5 0.1 6.9 1.7 1.6 1.1 0.2 1.0 7.0 3.9 4.9 0.1 2.9 0.1 0.4 2.3 3.6 2.5 0.4 1.0 1.4 0.3 0.0 9.9 0.8 27.9 9.7 3.6 8.5 2.5 8.5 1.2 0.0 0.6 2.2 1.3 2.8 4.1 9.2 0.0 1.7 0.3 2.1 0.8 0.1 0.3 0.1 0.1 1.3 0.3 0.9 0.2 0.1 0.6 1.4 0.6 1.3 0.5 0.1 0.5 1.5 0.4 8.1 11.0 28.9 13.5 6.2 8.1 4.2 8.2 8.0 4.9 LDLRAD3 LRAD3 ENSG00000179241 "Low density lipoprotein receptor class A domain containing 3" Q86YD5 11 35943981-36232136 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.5" "Cell line enhanced" "Detected in many" "hTCEpi: 28.1;RH-30: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.1;non-classical monocyte: 7.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038251 Approved Approved "Cell Junctions" "Cell Junctions" "HPA038251: AB_10675790" "unprognostic (1.59e-3)" "prognostic unfavourable (2.24e-4)" "unprognostic (3.25e-2)" "unprognostic (4.08e-3)" "unprognostic (1.81e-1)" "unprognostic (1.93e-1)" "unprognostic (2.29e-2)" "prognostic unfavourable (9.34e-6)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (1.68e-2)" "unprognostic (6.93e-2)" "prognostic unfavourable (5.05e-8)" "unprognostic (3.32e-2)" "unprognostic (9.21e-3)" "unprognostic (9.33e-2)" "prognostic unfavourable (2.14e-5)" 12.0 5.0 9.5 6.0 13.7 2.0 23.4 32.5 17.9 9.3 2.8 20.7 1.7 2.9 8.2 4.7 8.8 5.0 6.5 3.6 10.8 7.2 3.0 2.6 3.3 4.4 18.0 4.0 15.0 5.1 1.5 9.2 3.4 18.1 14.8 3.2 5.3 23.9 6.0 5.5 17.0 3.3 7.2 24.4 2.9 3.4 4.8 13.5 0.1 3.0 2.6 4.8 5.3 6.5 0.0 4.1 1.9 7.7 0.0 0.0 2.0 4.8 4.6 14.2 8.6 11.3 12.5 10.8 2.8 2.5 6.3 5.6 3.4 3.0 0.0 2.1 3.0 2.4 4.3 6.2 8.8 0.4 9.2 15.5 3.0 1.0 15.0 3.3 1.9 14.9 28.1 2.8 24.9 10.5 4.0 0.5 11.6 2.7 0.0 0.7 5.8 8.0 0.0 26.5 1.5 1.1 0.7 4.8 11.0 4.8 5.3 15.6 7.3 4.5 10.6 7.6 6.8 0.6 9.2 0.3 0.0 0.0 3.8 4.1 13.5 1.9 6.1 0.6 0.0 6.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 0.0 7.7 0.3 0.0 2.0 9.5 13.7 32.5 9.1 10.8 7.2 18.0 4.0 18.1 13.5 LMCD1 ENSG00000071282 "LIM and cysteine rich domains 1" Q9NZU5 3 8501707-8574673 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 189.9" "Cell line enhanced" "Detected in many" "HHSteC: 29.8;HSkMC: 41.7;hTEC/SVTERT24-B: 30.6;U-2197: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "T-reg: 17.0" "Lineage enriched" "Detected in many" 6 "T-cells: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024059 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane, Cell Junctions" "HPA024059: AB_1852950" "unprognostic (2.46e-1)" "unprognostic (1.79e-1)" "unprognostic (5.13e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (8.21e-3)" "unprognostic (4.29e-1)" "unprognostic (2.54e-2)" "prognostic unfavourable (8.66e-5)" "unprognostic (3.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.01e-3)" "unprognostic (3.68e-3)" 38.6 3.3 1.6 10.1 1.8 0.0 36.4 3.9 1.9 11.7 4.4 3.8 5.2 1.9 22.3 20.8 8.3 11.9 15.4 15.9 2.3 1.7 5.5 2.2 25.9 3.8 2.4 1.7 17.9 8.5 5.8 2.0 14.1 4.5 16.1 1.6 4.6 19.2 7.0 189.9 5.7 3.3 72.9 3.7 14.3 10.6 9.3 1.3 0.8 4.6 34.3 7.1 29.4 15.7 1.8 2.7 0.0 0.3 0.0 17.0 0.2 2.9 16.6 2.8 2.1 20.7 11.7 2.9 12.1 6.2 6.7 16.5 12.2 3.7 0.0 1.4 14.0 0.2 1.6 3.1 2.7 5.0 1.1 3.6 1.1 2.4 29.8 0.0 0.3 41.7 0.0 30.6 0.2 3.2 0.0 0.0 8.6 2.1 0.0 0.0 5.4 0.7 0.0 9.2 0.0 6.1 1.1 0.1 6.9 2.0 10.1 6.3 13.2 0.0 1.5 6.7 13.5 27.0 8.1 1.6 1.9 0.8 1.3 0.9 8.7 0.0 0.0 0.0 0.0 0.3 0.1 1.8 2.6 0.5 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.9 17.0 0.2 1.6 1.8 3.9 1.9 2.3 1.7 2.4 1.7 4.5 1.3 LMTK3 "KIAA1883, LMR3, PPP1R101, TYKLM3" ENSG00000142235 "Lemur tyrosine kinase 3" Q96Q04 19 48485271-48513189 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.1" "Cell line enhanced" "Detected in many" "HMC-1: 8.4;SK-BR-3: 10.0;U-266/70: 9.3;U-266/84: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040203, HPA077070" Enhanced Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA040203: AB_10671690, HPA077070: " "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (5.37e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-1)" "unprognostic (1.71e-2)" "unprognostic (5.67e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-3)" "unprognostic (5.71e-2)" "unprognostic (1.47e-1)" "prognostic favourable (3.18e-8)" "unprognostic (1.38e-1)" "unprognostic (3.22e-2)" "unprognostic (3.24e-1)" "unprognostic (6.11e-2)" 1.3 4.4 19.8 2.3 28.6 2.0 2.0 20.0 38.1 2.0 1.5 6.0 0.2 6.2 1.4 1.5 2.3 1.6 1.9 1.7 17.2 11.1 2.5 1.3 3.2 2.2 6.5 23.8 1.3 2.1 8.5 6.1 2.1 12.5 3.5 1.2 1.6 5.2 3.1 1.2 2.4 4.0 1.2 6.6 1.8 2.9 1.5 10.3 0.0 2.3 0.0 2.2 1.6 1.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 4.5 3.0 0.3 0.0 0.0 0.0 4.4 0.0 0.2 0.0 0.1 2.2 3.6 1.6 1.2 0.0 2.1 0.3 1.6 0.0 0.0 1.2 0.2 0.3 0.7 0.0 0.0 8.4 0.2 0.9 0.0 0.0 0.1 1.4 2.8 0.0 3.0 0.6 0.8 1.1 0.9 3.8 0.0 1.3 1.1 0.7 0.7 2.8 0.1 10.0 0.0 3.8 0.2 0.1 0.0 0.8 0.1 0.0 9.3 7.5 0.4 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 19.8 28.6 20.0 38.1 17.2 11.1 6.5 23.8 12.5 10.3 LRRC34 MGC27085 ENSG00000171757 "Leucine rich repeat containing 34" Q8IZ02 3 169793428-169812986 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 13.7;testis: 23.8" "Cell line enhanced" "Detected in many" "HEK 293: 7.5;HEL: 9.4;HL-60: 9.9;NTERA-2: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.2;myeloid DC: 1.4;naive B-cell: 1.5;plasmacytoid DC: 4.6" "Group enriched" "Detected in many" 7 "B-cells: 2.2;dendritic cells: 4.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA035747 Approved Approved "Cell Junctions,Microtubules" "Cell Junctions, Microtubules" "HPA035747: AB_10670120" "unprognostic (1.04e-2)" "unprognostic (5.71e-2)" "unprognostic (5.67e-2)" "unprognostic (5.64e-2)" "unprognostic (9.74e-3)" "unprognostic (5.46e-2)" "unprognostic (9.74e-2)" "unprognostic (8.24e-2)" "unprognostic (6.39e-3)" "unprognostic (2.57e-1)" "unprognostic (6.05e-2)" "unprognostic (1.23e-1)" "unprognostic (8.39e-2)" "unprognostic (1.16e-2)" "unprognostic (3.48e-1)" "unprognostic (3.37e-1)" "unprognostic (2.79e-1)" 2.8 1.1 4.8 1.2 9.6 2.7 2.3 1.1 4.0 2.3 0.9 4.2 1.4 1.0 1.9 3.9 1.0 13.7 1.1 2.0 4.1 3.8 2.1 0.9 3.4 1.9 3.5 5.6 2.2 0.5 1.0 7.9 0.9 11.8 2.0 0.7 2.6 1.3 2.4 0.9 1.0 1.1 2.0 3.6 1.8 1.1 23.8 4.8 1.7 2.7 0.5 1.2 1.0 0.9 2.2 4.6 0.1 0.3 0.0 0.5 0.4 2.7 0.4 0.8 0.0 1.1 4.1 0.0 1.2 2.4 2.8 2.7 0.1 0.0 1.6 0.0 0.7 0.0 2.5 0.0 1.0 0.4 7.5 9.4 0.1 0.0 0.7 9.9 2.5 1.4 0.5 1.1 0.0 1.8 0.2 0.0 1.1 0.0 0.9 2.0 10.0 3.1 4.9 0.0 0.5 2.3 0.2 4.9 3.8 0.8 0.1 0.0 0.0 4.8 0.4 0.6 0.0 0.3 0.0 0.0 0.0 2.3 4.5 0.1 2.7 0.0 0.2 0.0 0.0 0.3 0.2 2.2 0.0 0.0 1.4 1.5 0.0 0.0 0.1 0.0 0.0 4.6 0.5 0.4 4.8 9.6 1.1 4.0 4.1 3.8 3.5 5.6 11.8 4.8 MAP2K4 "JNKK1, MEK4, MKK4, PRKMK4, SERK1" ENSG00000065559 "Mitogen-activated protein kinase kinase 4" P45985 17 12020824-12143830 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007751, HPA060074" Enhanced Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "CAB007751: , HPA060074: " "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (4.47e-2)" "unprognostic (1.02e-2)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "unprognostic (2.89e-1)" "unprognostic (2.16e-1)" "unprognostic (1.93e-3)" "unprognostic (2.53e-1)" "unprognostic (2.76e-3)" "unprognostic (4.82e-2)" "unprognostic (5.32e-3)" "unprognostic (3.13e-1)" "unprognostic (2.30e-1)" "unprognostic (7.00e-2)" "unprognostic (1.79e-1)" 10.7 13.2 23.7 9.4 21.0 3.1 14.4 25.0 42.7 12.5 11.5 7.9 8.5 9.6 12.1 17.8 18.5 11.5 10.7 14.9 31.7 29.3 15.8 20.6 11.4 14.6 24.5 27.1 13.0 11.1 19.6 16.7 15.1 23.4 14.5 13.1 6.5 9.8 13.2 20.6 14.4 9.9 13.5 16.3 10.7 10.7 10.3 9.8 10.3 16.5 11.6 13.4 11.1 11.2 2.8 1.8 13.2 4.3 3.5 3.3 2.3 17.9 15.5 20.4 10.5 11.3 14.7 13.0 12.3 16.2 14.0 13.4 9.2 6.2 7.5 10.0 19.1 12.1 17.7 17.1 21.1 13.2 20.8 8.3 9.1 17.3 13.3 7.9 12.6 12.1 17.0 16.4 17.2 12.7 8.8 4.4 17.6 6.7 9.6 7.4 11.9 7.6 11.8 22.9 5.1 19.2 11.6 4.1 12.1 14.2 7.6 11.8 9.6 5.8 11.6 6.9 10.7 9.5 14.5 8.7 9.7 5.9 13.0 6.3 10.0 0.6 2.7 2.0 3.0 1.5 2.7 2.8 2.4 2.4 1.8 2.7 2.0 3.3 13.2 3.5 4.3 1.8 2.6 2.3 23.7 21.0 25.0 42.7 31.7 29.3 24.5 27.1 23.4 9.8 MAP3K12 "DLK, MEKK12, MUK, ZPK, ZPKP1" ENSG00000139625 "Mitogen-activated protein kinase kinase kinase 12" Q12852 12 53479669-53500063 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.3" "Cell line enhanced" "Detected in many" "ASC diff: 28.4;HHSteC: 27.1;HSkMC: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039936, HPA071996" Enhanced Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA039936: AB_10795239, HPA071996: " "unprognostic (4.01e-1)" "unprognostic (3.30e-1)" "unprognostic (8.89e-3)" "unprognostic (6.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-1)" "unprognostic (6.97e-2)" "unprognostic (3.61e-2)" "unprognostic (2.39e-1)" "unprognostic (2.70e-1)" "prognostic favourable (1.51e-4)" "unprognostic (8.50e-3)" "prognostic unfavourable (5.43e-10)" "unprognostic (1.65e-2)" "unprognostic (2.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.18e-1)" 8.0 8.7 12.3 5.8 16.0 3.0 5.1 40.3 20.6 14.1 6.1 7.0 7.8 3.6 15.1 5.8 4.6 11.5 16.1 4.2 9.4 7.7 4.5 1.4 8.8 4.5 6.4 14.7 13.7 1.8 3.0 12.7 7.3 10.8 5.9 4.6 9.5 2.4 13.5 1.2 4.5 4.1 16.9 5.3 5.3 3.9 6.5 7.4 2.7 4.3 1.4 3.2 11.3 6.4 0.3 0.6 3.4 1.7 0.6 2.8 0.5 0.2 7.5 4.7 7.3 28.4 15.2 0.6 5.1 9.6 5.6 5.6 0.1 0.9 1.7 2.9 5.4 0.0 2.1 3.4 2.2 2.5 2.6 1.8 3.8 0.0 27.1 0.0 1.9 27.0 2.4 7.6 4.0 8.7 0.0 8.1 5.3 3.3 1.8 0.4 1.6 2.8 2.6 3.2 0.4 2.8 0.0 4.7 6.4 2.7 3.5 7.2 2.4 4.7 6.4 5.4 5.8 2.4 1.3 3.3 3.7 0.0 8.7 3.3 5.2 0.0 1.7 0.0 1.5 1.3 2.8 0.3 2.1 2.3 0.6 0.0 0.9 1.2 3.4 0.6 0.4 0.3 0.4 0.5 12.3 16.0 40.3 20.6 9.4 7.7 6.4 14.7 10.8 7.4 MAPK15 "ERK7, ERK8" ENSG00000181085 "Mitogen-activated protein kinase 15" Q8TD08 8 143716259-143722458 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;epididymis: 27.6;fallopian tube: 29.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.1;HeLa: 14.0;MCF7: 13.6;T-47d: 12.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002704 Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA002704: AB_1079307" "unprognostic (9.11e-2)" "unprognostic (1.38e-1)" "unprognostic (8.04e-3)" "unprognostic (2.94e-1)" "unprognostic (2.54e-2)" "unprognostic (1.14e-2)" "unprognostic (1.22e-1)" "unprognostic (6.09e-2)" "unprognostic (2.59e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-1)" "unprognostic (9.51e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (5.78e-1)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" 0.6 0.1 3.6 0.3 8.1 0.1 1.1 0.2 2.1 4.5 0.4 8.7 5.2 0.5 2.2 27.6 1.3 29.5 0.4 1.1 5.4 4.6 3.9 0.2 7.4 0.5 0.2 1.5 4.7 2.0 9.1 4.2 0.6 26.9 0.9 0.4 1.6 3.0 2.4 0.2 4.9 0.7 0.5 0.4 0.5 0.9 7.3 2.4 0.1 8.4 0.5 0.4 0.5 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.7 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.2 7.1 0.0 1.3 0.0 5.3 0.0 0.2 0.0 1.1 1.6 0.0 14.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 13.6 0.0 0.0 2.0 1.1 0.0 2.9 0.3 0.9 1.3 3.9 3.9 0.0 2.8 0.0 12.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.1 0.2 2.1 5.4 4.6 0.2 1.5 26.9 2.4 MCMBP "C10orf119, FLJ13081, MCM-BP" ENSG00000197771 "Minichromosome maintenance complex binding protein" Q9BTE3 10 119829404-119892556 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013792, HPA038481" Uncertain Enhanced "Nucleoplasm,Cell Junctions,Cytosol" Nucleoplasm "Cell Junctions, Cytosol" "CAB013792: , HPA038481: AB_10794620" "unprognostic (1.26e-1)" "unprognostic (7.92e-2)" "unprognostic (4.62e-2)" "unprognostic (2.31e-2)" "unprognostic (1.72e-2)" "unprognostic (4.64e-2)" "unprognostic (1.31e-3)" "unprognostic (5.61e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (2.20e-4)" "unprognostic (7.32e-2)" "prognostic unfavourable (6.18e-4)" "unprognostic (2.23e-2)" "unprognostic (8.24e-2)" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" 33.6 15.3 11.7 23.2 13.8 14.6 35.5 17.2 13.8 27.0 26.3 16.9 11.4 15.5 28.0 14.9 26.4 23.0 18.7 26.3 12.0 10.2 18.7 23.7 28.5 38.6 17.4 8.5 29.2 18.2 23.2 17.6 35.4 14.2 22.5 21.4 15.7 21.0 17.4 30.1 23.8 20.7 26.0 16.8 26.0 20.7 15.4 15.5 38.0 24.5 28.2 24.7 32.5 28.6 4.5 6.9 12.1 9.7 4.1 5.1 2.4 30.4 21.6 30.4 21.0 15.4 18.9 17.8 28.2 31.0 36.0 37.3 28.2 24.9 35.5 13.0 22.5 28.4 36.2 28.4 42.2 26.0 26.8 18.2 17.2 21.6 23.9 33.6 44.1 15.5 16.1 32.6 42.9 24.6 16.8 26.8 23.5 22.6 42.2 20.3 15.3 15.7 26.6 58.8 18.1 15.4 20.9 13.1 16.9 20.6 17.2 23.6 11.6 24.0 19.0 17.7 17.4 18.0 33.6 19.3 21.5 39.3 21.1 22.6 10.8 12.1 5.3 3.6 4.2 9.7 5.1 4.5 3.9 4.4 6.9 1.8 4.2 3.8 6.4 4.1 6.1 3.5 3.9 2.4 11.7 13.8 17.2 13.8 12.0 10.2 17.4 8.5 14.2 15.5 MEF2B RSRFR2 ENSG00000213999 "Myocyte enhancer factor 2B" Q02080 19 19145568-19170289 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "lymphoid tissue: 81.2" "Group enriched" "Detected in some" 12 "Daudi: 49.8;U-266/70: 50.0;U-698: 65.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004734 Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (7.31e-3)" "unprognostic (4.06e-2)" "unprognostic (9.44e-5)" "unprognostic (5.07e-2)" "unprognostic (2.01e-1)" "unprognostic (7.19e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-1)" "unprognostic (2.76e-1)" "unprognostic (1.98e-2)" "unprognostic (8.66e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-11)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (3.68e-1)" "unprognostic (8.98e-3)" 2.0 1.0 0.8 81.2 1.2 1.4 1.9 0.6 1.4 2.7 3.0 0.9 0.6 1.5 2.2 1.1 1.5 2.3 2.2 1.9 1.0 0.6 1.8 2.9 2.0 32.3 1.1 0.9 3.7 0.8 0.8 2.1 0.8 1.0 3.7 1.0 1.8 3.5 1.1 1.4 2.3 3.1 1.1 1.2 6.7 1.7 1.7 0.8 1.6 3.0 3.5 58.7 1.9 2.9 0.1 0.2 1.1 0.9 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 49.8 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.5 0.0 0.2 0.3 0.3 0.0 0.9 0.4 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.5 0.1 0.0 0.4 0.5 0.1 50.0 4.6 65.8 0.1 0.3 0.0 0.0 0.9 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.6 1.4 1.0 0.6 1.1 0.9 1.0 0.8 MEPCE "BCDIN3, FLJ20257, MePCE" ENSG00000146834 "Methylphosphate capping enzyme" Q7L2J0 7 100428790-100434126 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026384, HPA051587" Supported Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "CAB026384: , HPA051587: " "unprognostic (8.59e-2)" "unprognostic (1.23e-2)" "unprognostic (3.77e-2)" "prognostic unfavourable (6.01e-6)" "unprognostic (1.09e-1)" "unprognostic (1.53e-2)" "unprognostic (3.83e-2)" "unprognostic (2.19e-1)" "unprognostic (1.69e-2)" "unprognostic (2.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.09e-1)" "prognostic favourable (1.01e-10)" "unprognostic (9.66e-2)" "unprognostic (9.31e-2)" "unprognostic (4.57e-1)" "unprognostic (9.50e-3)" 17.5 24.1 17.7 13.9 22.8 18.5 15.0 24.1 24.1 15.7 14.0 16.7 26.9 14.1 18.8 22.5 16.1 18.6 22.9 12.4 20.1 13.7 18.7 20.8 13.5 19.7 19.7 16.4 29.2 18.3 32.5 15.0 19.0 19.3 15.8 10.2 17.2 18.5 24.2 21.4 26.1 15.8 15.7 17.7 34.9 14.4 63.1 20.4 21.7 25.7 17.1 17.9 16.3 20.4 8.4 8.7 9.3 3.6 7.3 9.1 10.6 13.5 17.5 13.0 13.9 12.6 12.7 9.6 15.1 22.2 16.4 12.7 14.3 19.9 27.9 25.3 9.5 12.5 14.2 11.5 10.9 12.5 16.1 14.4 13.5 10.7 10.7 18.3 17.8 13.1 13.8 18.7 23.8 13.6 28.3 20.7 15.7 50.3 20.9 41.8 24.0 19.6 16.9 10.5 25.3 11.0 8.4 19.6 16.9 23.7 46.5 15.8 11.8 16.8 11.7 27.7 21.5 18.6 19.9 13.8 13.0 31.1 15.5 23.0 24.2 2.5 3.6 4.8 5.6 3.2 6.5 8.0 6.4 6.0 4.4 8.4 9.1 8.0 9.3 7.3 2.6 8.7 5.7 10.6 17.7 22.8 24.1 24.1 20.1 13.7 19.7 16.4 19.3 20.4 METTL9 DREV1 ENSG00000197006 "Methyltransferase like 9" Q9H1A3 16 21597218-21657473 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053588, HPA056347" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" "Nucleoplasm, Cell Junctions" Cytosol "HPA053588: , HPA056347: " "unprognostic (1.55e-1)" "unprognostic (2.18e-2)" "unprognostic (1.98e-3)" "unprognostic (5.43e-2)" "unprognostic (5.81e-2)" "unprognostic (3.13e-1)" "prognostic unfavourable (8.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.11e-2)" "unprognostic (7.57e-3)" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.49e-3)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (5.17e-2)" "unprognostic (1.65e-1)" 24.0 45.5 29.6 18.8 34.9 50.0 45.1 12.2 31.9 34.2 19.1 18.7 15.5 14.9 23.4 35.6 30.2 23.8 19.4 32.0 22.2 20.0 61.0 8.7 24.0 38.8 26.8 8.4 22.8 28.8 37.2 25.0 25.4 17.7 23.8 20.3 32.5 22.1 19.3 30.6 21.5 20.6 21.1 25.0 29.6 18.8 10.8 18.1 39.8 37.8 20.0 25.9 24.9 24.6 4.9 14.1 30.5 24.5 5.6 7.3 7.6 13.4 10.3 26.0 22.5 26.9 48.8 9.3 21.6 31.0 17.1 20.7 7.4 24.6 23.7 18.5 37.8 8.4 17.2 19.3 23.4 18.0 14.1 10.2 10.4 27.5 19.3 8.0 21.3 28.7 20.6 17.6 23.1 32.6 15.1 19.5 33.8 14.9 20.8 13.4 23.3 10.7 30.4 20.3 21.5 28.2 13.2 15.1 27.3 18.3 12.7 46.0 12.9 4.2 18.4 28.5 12.4 17.3 13.3 16.6 26.6 19.0 27.9 19.9 20.0 30.5 24.5 10.7 4.0 4.5 4.8 4.6 6.8 7.3 14.1 4.9 7.3 5.4 12.5 5.6 3.9 4.4 5.4 7.6 29.6 34.9 12.2 31.9 22.2 20.0 26.8 8.4 17.7 18.1 MIGA2 "C9orf54, FAM73B, FLJ00199, FLJ14596" ENSG00000148343 "Mitoguardin 2" Q7L4E1 9 129036621-129072082 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041363 Approved Approved "Cell Junctions,Cytosol" Cytosol "Cell Junctions" "HPA041363: AB_10794664" "unprognostic (2.10e-1)" "unprognostic (4.82e-3)" "unprognostic (1.07e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-2)" "unprognostic (1.01e-1)" "unprognostic (3.93e-2)" "unprognostic (3.07e-3)" "unprognostic (2.90e-2)" "prognostic favourable (3.04e-6)" "unprognostic (1.12e-2)" "unprognostic (1.44e-3)" "unprognostic (8.57e-3)" "unprognostic (1.25e-1)" "unprognostic (4.63e-2)" "unprognostic (4.15e-3)" 10.1 14.3 7.7 11.5 10.2 17.3 6.8 17.6 16.0 5.6 17.2 8.9 14.6 23.7 7.6 8.7 11.5 7.1 13.3 24.4 7.9 11.6 7.6 7.4 5.2 7.5 9.0 10.9 8.4 6.8 7.5 8.5 3.1 9.4 9.3 5.5 8.7 11.1 12.3 13.0 9.8 21.6 9.0 7.6 7.1 9.9 7.0 7.2 8.0 9.6 5.3 10.8 10.0 9.8 2.8 3.9 8.5 3.1 1.2 6.5 2.2 4.0 8.3 2.6 13.0 7.1 3.7 5.7 7.2 5.5 8.4 5.3 7.1 8.4 6.1 3.3 5.6 19.2 3.5 5.4 1.3 5.6 5.1 4.4 16.1 5.2 7.9 4.9 10.1 5.2 4.3 7.5 3.9 5.7 6.4 2.6 4.5 10.6 4.9 10.3 5.9 12.0 10.2 7.6 10.0 4.4 7.8 8.2 5.8 8.0 12.9 4.5 9.2 5.4 5.7 5.4 6.2 9.1 5.5 3.5 5.0 5.6 7.7 4.0 6.4 8.5 2.6 2.4 3.0 3.1 6.5 2.3 2.2 3.9 2.9 2.8 2.2 1.3 4.8 1.2 1.7 3.9 1.9 2.2 7.7 10.2 17.6 16.0 7.9 11.6 9.0 10.9 9.4 7.2 MLST8 "GbetaL, GBL, Lst8, Pop3" ENSG00000167965 "MTOR associated protein, LST8 homolog" Q9BVC4 16 2204248-2209416 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019935, HPA041841" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" Nucleoplasm "Golgi apparatus, Cell Junctions" "CAB019935: AB_561447, HPA041841: " "unprognostic (2.19e-1)" "unprognostic (7.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (3.35e-3)" "unprognostic (1.74e-1)" "unprognostic (8.17e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" "unprognostic (5.70e-3)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "prognostic favourable (7.60e-4)" "unprognostic (8.74e-2)" "unprognostic (1.20e-1)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" 12.4 18.6 24.0 11.9 22.8 15.7 10.4 23.1 39.1 11.6 14.4 15.7 12.5 16.6 9.9 14.0 15.9 17.4 12.6 18.4 23.9 18.5 15.5 17.9 9.1 13.3 20.7 20.0 16.0 32.3 11.1 12.6 15.5 16.1 14.4 6.8 17.3 25.5 13.0 36.6 13.5 13.9 8.7 14.1 10.5 15.6 25.5 13.3 13.4 20.8 13.9 11.8 13.2 9.0 8.5 14.8 2.5 18.6 7.4 9.6 11.5 7.2 20.9 8.7 22.1 11.4 8.0 14.3 6.0 8.2 10.5 9.7 28.3 10.2 18.7 15.1 7.1 8.9 8.8 18.1 1.2 14.2 40.0 12.7 20.7 18.1 16.6 19.5 18.0 11.5 13.1 12.2 15.8 11.2 18.3 13.0 5.5 30.6 18.4 26.1 16.7 19.5 19.4 8.7 32.9 7.9 4.3 27.4 14.0 9.9 22.4 15.9 13.2 19.1 7.9 12.3 13.9 9.8 8.1 14.9 9.0 20.5 6.1 17.2 10.3 0.0 15.2 2.5 8.5 18.6 6.6 8.5 7.5 9.6 14.8 7.2 9.0 9.0 1.7 7.4 16.9 8.2 7.2 11.5 24.0 22.8 23.1 39.1 23.9 18.5 20.7 20.0 16.1 13.3 MOAP1 "MAP-1, PNMA4" ENSG00000165943 "Modulator of apoptosis 1" Q96BY2 14 93182196-93184928 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000939 Enhanced Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA000939: AB_1079402" "unprognostic (9.40e-3)" "unprognostic (1.26e-1)" "unprognostic (1.57e-1)" "unprognostic (7.52e-2)" "unprognostic (1.21e-1)" "unprognostic (8.75e-2)" "unprognostic (1.01e-1)" "prognostic favourable (7.37e-9)" "unprognostic (1.98e-1)" "unprognostic (6.52e-2)" "unprognostic (1.05e-3)" "unprognostic (1.58e-2)" "prognostic favourable (3.15e-6)" "unprognostic (6.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (9.27e-2)" 6.9 14.5 21.9 5.7 30.0 15.9 8.6 30.5 69.5 12.8 10.1 7.1 7.7 7.1 9.3 12.0 8.0 11.1 8.2 23.9 24.2 35.9 14.2 9.0 9.7 7.9 22.9 27.8 8.6 9.0 25.0 12.0 7.1 27.8 15.0 7.4 10.1 8.2 14.9 13.9 5.2 7.0 10.1 11.2 7.8 8.3 4.4 7.8 5.9 10.6 3.6 7.5 8.4 3.8 6.3 4.2 16.4 4.4 8.8 14.3 7.5 3.8 3.0 7.3 9.8 6.3 2.4 4.9 4.5 5.2 4.7 5.3 3.2 3.8 11.6 8.3 5.2 6.0 5.2 4.5 5.2 5.3 6.6 6.5 6.1 4.3 8.2 5.8 11.8 4.3 6.8 2.8 5.7 5.7 2.3 7.1 5.3 15.9 9.1 5.5 3.3 3.9 5.6 9.9 7.0 11.9 10.9 16.8 14.6 4.6 6.5 18.4 10.0 4.3 6.2 1.8 2.9 4.2 2.2 13.4 13.7 7.0 4.8 3.7 3.2 16.4 4.0 10.3 11.3 4.4 12.6 6.0 10.5 11.5 4.2 6.3 14.3 12.2 3.7 8.8 4.4 4.0 9.8 7.5 21.9 30.0 30.5 69.5 24.2 35.9 22.9 27.8 27.8 7.8 MPZL2 "EVA, EVA1" ENSG00000149573 "Myelin protein zero like 2" O60487 11 118253403-118264536 "Predicted membrane proteins" "Cell adhesion" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 24.8;EFO-21: 27.3;HaCaT: 34.1;RT4: 64.9;TIME: 71.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 9.3;intermediate monocyte: 7.2;myeloid DC: 13.4;neutrophil: 10.9" "Group enriched" "Detected in many" 10 "dendritic cells: 13.4;granulocytes: 10.9;monocytes: 9.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA060740 Approved Approved "Cell Junctions" "Cell Junctions" "HPA060740: " "unprognostic (1.74e-1)" "unprognostic (6.02e-2)" "unprognostic (8.23e-2)" "unprognostic (3.28e-3)" "unprognostic (9.95e-3)" "unprognostic (1.56e-1)" "unprognostic (2.11e-3)" "unprognostic (3.58e-1)" "unprognostic (7.39e-2)" "unprognostic (5.45e-2)" "prognostic unfavourable (1.14e-4)" "unprognostic (1.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.07e-2)" "unprognostic (1.80e-1)" "prognostic favourable (1.62e-4)" "unprognostic (2.08e-2)" 11.7 1.7 1.5 2.8 1.5 0.0 17.1 1.5 1.6 31.0 8.5 1.0 26.3 4.4 6.8 17.8 103.8 13.4 12.3 4.7 2.4 1.5 11.7 7.9 21.7 1.8 2.4 0.6 7.4 4.6 10.2 9.2 1.5 4.0 17.8 8.7 6.2 21.6 32.8 7.8 11.4 4.4 5.6 4.3 1.3 10.0 3.7 1.3 5.7 21.7 52.3 41.1 29.4 37.4 0.0 13.4 10.9 9.3 0.3 1.0 2.8 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 24.8 0.0 27.3 0.0 34.1 0.0 7.9 0.0 0.0 1.9 0.0 0.3 7.1 0.0 0.0 0.0 0.0 18.8 0.0 0.6 17.8 0.0 0.0 0.0 10.2 0.0 0.0 0.3 0.0 0.0 0.0 1.2 3.1 64.9 0.0 0.0 1.1 12.7 0.0 5.4 0.1 71.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 9.3 2.3 0.1 7.2 1.0 0.0 0.5 0.4 13.4 0.0 0.6 0.7 10.9 0.3 1.0 0.2 0.2 2.8 1.5 1.5 1.5 1.6 2.4 1.5 2.4 0.6 4.0 1.3 MRPS18B "C6orf14, HSPC183, MRPS18-2, PTD017" ENSG00000204568 "Mitochondrial ribosomal protein S18B" Q9Y676 6 30617709-30626395 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043485, HPA050334" Supported Supported "Cell Junctions,Mitochondria" Mitochondria "Cell Junctions" "HPA043485: , HPA050334: " "unprognostic (8.18e-3)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (2.51e-2)" "unprognostic (4.20e-2)" "unprognostic (7.40e-2)" "unprognostic (9.45e-2)" "unprognostic (1.32e-1)" "unprognostic (1.89e-1)" "unprognostic (2.98e-2)" "unprognostic (1.76e-1)" "unprognostic (1.40e-2)" "prognostic favourable (3.99e-5)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.39e-2)" 17.1 18.9 9.9 10.3 10.7 5.4 16.0 8.5 13.1 11.6 13.4 12.8 11.9 12.8 9.3 15.5 15.5 16.5 12.3 26.6 9.0 8.0 22.4 49.1 10.5 17.3 13.1 9.3 16.4 21.8 17.4 10.2 11.8 9.1 10.9 16.4 10.1 17.1 18.0 55.4 13.7 14.0 10.4 12.4 14.4 13.5 10.2 11.2 13.5 21.5 31.1 15.6 11.2 9.3 15.7 8.9 6.3 10.2 12.4 15.2 11.2 9.5 5.8 4.6 6.6 7.0 9.5 8.5 3.6 8.2 11.2 7.0 9.0 4.6 9.8 8.3 5.5 7.7 10.7 10.0 11.0 5.9 11.4 9.5 4.5 10.5 6.2 8.9 4.2 8.2 12.6 9.3 25.5 6.3 14.4 9.5 10.2 7.3 5.9 5.5 3.3 7.4 7.8 6.3 18.8 10.4 4.0 10.1 3.3 3.2 13.4 13.5 17.2 4.7 3.6 7.4 7.1 4.2 6.1 8.0 9.6 8.3 3.5 13.6 10.8 6.3 8.0 4.0 9.1 10.1 12.3 15.7 12.1 9.8 8.9 14.7 15.2 12.2 0.6 12.4 10.2 8.1 11.4 11.2 9.9 10.7 8.5 13.1 9.0 8.0 13.1 9.3 9.1 11.2 MTFR1L FAM54B ENSG00000117640 "Mitochondrial fission regulator 1 like" Q9H019 1 25818640-25832942 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027124, HPA027130" Approved Approved "Cell Junctions,Mitochondria" Mitochondria "Cell Junctions" "HPA027124: AB_10600211, HPA027130: AB_10611251" "unprognostic (9.90e-2)" "unprognostic (6.86e-3)" "unprognostic (9.29e-2)" "prognostic favourable (6.81e-4)" "unprognostic (1.16e-1)" "unprognostic (1.58e-2)" "unprognostic (1.43e-1)" "unprognostic (4.52e-3)" "unprognostic (2.12e-1)" "unprognostic (2.24e-1)" "unprognostic (9.89e-3)" "unprognostic (5.33e-2)" "prognostic favourable (5.89e-12)" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (2.69e-1)" "unprognostic (1.33e-1)" 13.2 43.5 17.8 8.1 23.9 6.2 14.0 19.4 26.5 13.8 20.2 17.1 21.6 18.2 16.7 23.3 19.2 17.1 13.4 58.7 16.8 17.6 27.7 25.1 10.7 9.0 17.7 20.7 26.8 14.5 38.7 16.4 15.6 19.2 19.9 14.8 24.2 16.3 28.8 76.9 11.4 15.3 28.0 13.0 13.4 16.4 46.4 15.0 5.8 16.5 23.1 9.9 21.1 16.6 10.1 21.1 41.1 20.3 10.3 10.6 18.1 7.6 10.5 21.3 21.6 27.7 26.2 9.0 17.8 25.3 18.2 20.1 3.4 15.9 2.6 15.8 31.4 7.0 17.4 15.2 18.0 17.2 15.7 21.8 17.6 13.8 26.6 17.8 21.9 26.9 14.4 19.4 14.6 14.9 13.2 11.7 26.0 8.0 10.1 12.7 11.7 15.5 10.2 19.2 7.6 18.8 7.0 21.8 19.9 13.3 12.9 26.5 10.8 16.6 15.4 15.1 12.0 35.2 11.1 12.3 7.4 9.2 26.4 24.3 16.7 20.4 19.4 41.1 10.4 18.8 6.2 10.1 9.9 9.3 21.1 10.0 10.6 9.7 5.2 10.3 20.3 8.5 10.3 18.1 17.8 23.9 19.4 26.5 16.8 17.6 17.7 20.7 19.2 15.0 MTHFR ENSG00000177000 "Methylenetetrahydrofolate reductase" P42898 1 11785723-11806920 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063389, HPA076180, HPA077255" Enhanced Approved "Cell Junctions" "Cell Junctions" "HPA063389: , HPA076180: , HPA077255: " "unprognostic (3.25e-2)" "unprognostic (8.19e-2)" "unprognostic (4.48e-2)" "unprognostic (2.11e-2)" "unprognostic (1.34e-1)" "prognostic favourable (3.97e-5)" "prognostic unfavourable (1.19e-4)" "unprognostic (1.75e-2)" "unprognostic (2.85e-1)" "unprognostic (8.69e-2)" "prognostic favourable (4.81e-5)" "unprognostic (3.10e-1)" "prognostic favourable (2.12e-4)" "unprognostic (2.35e-3)" "unprognostic (2.94e-1)" "unprognostic (4.14e-2)" "unprognostic (1.80e-2)" 11.7 11.0 8.9 10.3 12.4 24.5 9.7 15.3 15.8 9.0 10.4 13.5 8.3 10.7 10.4 54.5 11.3 12.7 10.9 23.4 9.2 8.6 12.0 12.4 16.2 13.3 9.9 10.7 28.8 11.2 6.7 17.5 6.6 10.7 10.2 9.1 14.1 7.3 7.2 15.3 13.2 13.6 10.9 7.4 18.3 13.6 10.6 10.9 10.2 15.8 9.8 11.7 10.4 17.9 4.9 3.2 4.7 7.4 3.4 4.7 2.3 1.3 5.8 6.7 7.7 6.7 10.3 1.1 4.1 8.7 3.9 3.4 5.3 8.5 11.2 2.3 4.2 2.6 4.8 3.9 1.7 5.3 4.3 8.2 7.3 1.5 9.0 4.5 10.7 9.0 4.0 3.0 3.2 6.1 26.9 7.4 4.0 1.8 4.9 2.1 2.2 2.1 5.1 3.7 12.4 6.3 7.0 6.6 11.4 5.1 5.0 8.0 7.9 7.1 5.4 3.9 3.3 4.6 1.0 4.1 5.6 20.9 4.8 10.4 3.6 1.1 3.8 1.9 4.7 7.4 1.8 3.0 1.6 2.5 3.2 4.9 2.4 2.7 4.7 3.4 6.9 1.5 1.0 2.3 8.9 12.4 15.3 15.8 9.2 8.6 9.9 10.7 10.7 10.9 MVD MPD ENSG00000167508 "Mevalonate diphosphate decarboxylase" P53602 16 88651935-88663161 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041404, HPA048250" Uncertain Approved "Cell Junctions,Cytosol" 30000 Cytosol "Cell Junctions" "HPA041404: , HPA048250: " "unprognostic (1.67e-1)" "unprognostic (3.05e-1)" "unprognostic (2.42e-1)" "prognostic favourable (2.17e-4)" "unprognostic (1.89e-1)" "unprognostic (9.56e-2)" "unprognostic (9.26e-3)" "unprognostic (8.33e-2)" "unprognostic (6.68e-2)" "unprognostic (5.47e-2)" "unprognostic (2.51e-1)" "unprognostic (6.22e-2)" "unprognostic (1.19e-3)" "unprognostic (4.12e-2)" "unprognostic (1.69e-1)" "unprognostic (2.11e-1)" "unprognostic (5.00e-2)" 11.9 18.5 15.8 16.9 19.7 7.6 12.5 21.7 27.9 10.8 19.4 17.1 10.8 39.6 8.4 7.3 30.0 7.4 8.7 11.9 17.2 18.2 9.2 25.9 14.6 12.6 14.6 17.3 11.1 19.0 11.0 7.8 7.6 24.5 13.7 5.1 10.8 16.1 8.7 27.8 18.3 20.7 6.6 23.8 11.1 21.2 23.0 14.6 4.3 9.2 18.6 12.2 7.3 13.8 15.0 17.6 2.5 8.9 18.1 18.1 9.4 14.6 9.4 15.7 10.2 5.3 11.8 8.9 7.3 7.6 5.0 4.2 24.8 37.1 7.1 11.7 4.3 21.8 7.0 38.6 1.4 4.4 11.9 5.2 5.2 37.7 10.8 3.3 3.7 9.3 7.4 13.2 4.2 5.3 14.4 3.9 2.7 34.2 11.1 16.8 18.9 9.2 11.7 4.5 18.3 14.6 9.2 15.9 5.3 18.1 4.1 5.3 20.6 14.8 11.3 4.6 9.4 8.2 4.1 10.8 4.8 24.2 5.6 16.2 7.6 2.5 8.2 1.5 18.1 8.6 13.5 10.3 12.1 11.9 9.5 15.0 9.4 11.5 1.1 18.1 8.9 17.6 12.6 9.4 15.8 19.7 21.7 27.9 17.2 18.2 14.6 17.3 24.5 14.6 NAMPT "PBEF, PBEF1" ENSG00000105835 "Nicotinamide phosphoribosyltransferase" P43490 7 106248285-106286326 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Biological rhythms, Pyridine nucleotide biosynthesis" "Cytokine, Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-87 MG: 108.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 18 "neutrophil: 143.5" "Lineage enriched" "Detected in many" 20 "granulocytes: 143.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034349, HPA047776, HPA057722" Approved Approved "Nuclear speckles,Cell Junctions" "Secreted to blood" 2140000 410000 "Nuclear speckles" "Cell Junctions" "CAB034349: AB_2251220, HPA047776: , HPA057722: " "unprognostic (2.87e-1)" "prognostic unfavourable (4.78e-4)" "unprognostic (5.90e-3)" "unprognostic (1.63e-2)" "unprognostic (1.50e-2)" "prognostic unfavourable (8.81e-4)" "unprognostic (2.15e-1)" "unprognostic (2.74e-2)" "unprognostic (2.74e-1)" "unprognostic (3.30e-1)" "prognostic unfavourable (1.51e-4)" "unprognostic (3.02e-1)" "prognostic unfavourable (2.49e-6)" "unprognostic (6.83e-2)" "unprognostic (6.96e-2)" "unprognostic (7.76e-2)" "unprognostic (6.44e-3)" 67.3 22.2 8.1 113.6 18.1 110.4 52.6 7.8 12.9 11.6 18.2 2.9 9.5 9.3 9.9 13.5 53.4 27.8 28.1 84.4 13.4 6.3 13.5 92.9 48.9 117.5 10.3 5.2 27.3 18.3 5.5 10.0 23.9 29.2 17.4 10.5 8.2 32.9 14.3 41.0 12.9 14.1 44.9 59.1 41.1 26.4 11.9 7.1 6.2 13.5 40.7 13.2 48.8 26.4 0.8 2.0 143.5 7.3 1.0 1.5 1.3 18.9 12.6 4.6 7.6 19.4 22.6 7.5 6.0 34.0 12.2 21.6 7.4 11.5 15.9 14.4 6.7 15.0 8.4 18.1 26.8 9.4 9.1 6.4 5.4 5.8 72.5 12.4 11.9 21.6 20.7 21.8 25.5 38.8 13.4 60.9 14.5 9.9 12.3 5.2 8.8 10.2 5.9 6.5 34.9 11.6 17.8 9.3 5.1 8.4 18.5 21.4 5.9 3.6 33.0 18.2 14.1 26.1 11.0 42.0 23.8 22.8 108.1 14.1 26.9 8.1 2.3 3.5 0.4 5.6 0.7 0.8 0.5 0.6 2.0 0.7 0.8 0.4 143.5 1.0 7.3 0.8 1.5 1.3 8.1 18.1 7.8 12.9 13.4 6.3 10.3 5.2 29.2 7.1 NECTIN2 "CD112, HVEB, PRR2, PVRL2, PVRR2" ENSG00000130202 "Nectin cell adhesion molecule 2" Q92692 19 44846175-44889228 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 11.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012759, CAB026138, HPA073459" Enhanced Approved "Nucleoli fibrillar center,Cell Junctions" 3400000 "Nucleoli fibrillar center, Cell Junctions" "CAB026138: , HPA012759: AB_1846227, HPA073459: " "unprognostic (3.30e-2)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "unprognostic (5.61e-3)" "unprognostic (7.45e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-2)" "unprognostic (6.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.97e-1)" "unprognostic (6.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (2.15e-1)" "unprognostic (1.61e-1)" "unprognostic (8.19e-2)" "unprognostic (2.05e-1)" 29.5 28.2 7.9 15.6 7.7 5.6 38.0 4.5 9.0 24.2 34.0 9.3 22.3 24.2 23.2 27.4 33.6 16.7 54.1 21.9 10.5 8.1 29.0 53.7 39.6 23.0 8.2 6.8 25.5 20.6 22.5 15.9 45.8 11.2 25.8 14.8 22.9 24.4 28.9 14.6 18.3 42.9 13.8 8.4 31.4 26.2 38.7 5.8 3.8 32.2 19.2 24.1 21.6 31.4 0.0 3.3 11.5 2.6 0.0 0.3 0.7 17.8 21.4 27.7 32.7 14.0 8.5 32.2 15.3 18.9 27.1 31.3 44.1 39.3 0.1 20.7 17.7 24.5 24.5 12.6 21.6 0.7 12.8 10.8 7.4 28.5 33.7 0.1 29.0 14.9 5.1 12.9 10.5 35.0 17.6 0.1 13.5 32.5 0.1 1.2 23.0 6.4 1.0 9.4 0.7 32.1 22.1 1.3 3.7 19.0 28.9 6.5 22.5 10.6 34.9 7.4 26.3 5.5 11.2 2.2 6.4 0.1 13.6 2.3 19.3 1.5 2.6 11.5 0.0 0.9 0.3 0.0 0.1 0.0 3.3 0.0 0.0 0.0 2.4 0.0 0.5 0.3 0.0 0.7 7.9 7.7 4.5 9.0 10.5 8.1 8.2 6.8 11.2 5.8 NHSL2 ENSG00000204131 "NHS like 2" Q5HYW2 X 71910818-72161750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1" "Group enriched" "Detected in some" 4 "AF22: 16.5;EFO-21: 19.5;HUVEC TERT2: 18.0;TIME: 10.4;U-937: 13.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;granulocytes: 13.5;monocytes: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049771 Uncertain Approved "Plasma membrane,Cell Junctions" "Cell Junctions" "Plasma membrane" "HPA049771: " "unprognostic (9.71e-3)" "unprognostic (1.96e-1)" "unprognostic (1.92e-1)" "unprognostic (4.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.50e-2)" "unprognostic (2.88e-2)" "unprognostic (5.72e-4)" "unprognostic (5.46e-2)" "unprognostic (3.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.91e-1)" "unprognostic (1.61e-2)" "unprognostic (4.27e-3)" "unprognostic (9.99e-2)" "unprognostic (7.76e-2)" "unprognostic (4.37e-4)" 7.8 2.3 11.0 4.8 22.5 3.4 5.2 27.1 9.4 6.6 5.5 1.5 0.9 1.3 8.7 2.7 5.5 3.8 7.4 3.6 4.9 3.2 2.0 1.6 5.5 1.3 2.2 4.9 3.1 1.6 3.1 6.1 3.7 4.3 6.4 3.3 6.2 2.6 8.7 2.8 2.3 2.6 11.7 2.4 4.5 3.4 9.6 2.7 0.3 5.3 4.6 1.6 6.3 4.4 0.0 3.5 13.5 5.7 0.9 1.8 1.7 0.2 0.4 16.5 0.0 0.2 0.7 0.1 0.5 3.0 0.1 0.2 0.1 0.0 0.1 19.5 1.6 0.0 1.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.9 0.3 0.0 0.6 0.0 18.0 0.0 2.7 0.1 0.1 0.1 1.3 3.1 0.0 0.0 0.9 0.0 0.1 1.8 0.4 3.8 0.0 0.0 0.0 0.0 1.1 10.4 0.0 1.0 1.3 0.0 0.0 0.0 0.1 0.7 13.1 0.0 4.1 5.7 11.8 1.8 3.9 1.7 0.0 1.0 1.6 3.5 0.0 0.1 0.2 13.5 0.9 3.0 0.0 0.1 1.7 11.0 22.5 27.1 9.4 4.9 3.2 2.2 4.9 4.3 2.7 NLRX1 "CLR11.3, NOD9" ENSG00000160703 "NLR family member X1" Q86UT6 11 119166568-119184016 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061516 Supported Supported "Plasma membrane,Cell Junctions,Mitochondria" 35000 Mitochondria "Plasma membrane, Cell Junctions" "HPA061516: " "unprognostic (7.58e-2)" "unprognostic (3.71e-1)" "unprognostic (6.36e-2)" "prognostic favourable (2.47e-5)" "unprognostic (5.60e-3)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (8.80e-2)" "unprognostic (1.17e-1)" "unprognostic (3.49e-1)" "unprognostic (3.29e-1)" "prognostic favourable (2.59e-6)" "unprognostic (3.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (4.22e-2)" 4.8 6.1 1.9 3.3 3.7 3.6 3.6 2.5 4.9 8.9 5.1 2.9 8.0 2.9 5.6 5.3 34.9 6.7 4.9 8.7 2.9 1.6 4.3 4.4 3.4 3.4 1.8 2.7 2.9 6.2 5.6 2.5 3.3 3.0 4.4 2.0 5.4 5.6 4.8 14.3 11.6 3.2 4.6 2.4 4.5 4.0 3.2 1.3 3.8 4.3 38.9 37.5 5.3 8.5 0.6 2.0 14.3 3.3 1.3 1.3 1.9 4.0 12.0 1.3 9.6 4.1 4.8 1.9 5.4 6.3 2.7 4.7 0.6 10.1 7.3 16.7 6.9 10.2 3.7 3.1 0.9 9.4 3.9 9.6 4.1 6.5 6.3 3.3 5.6 5.3 13.0 3.5 6.9 5.5 0.1 4.9 2.8 10.8 5.6 8.1 5.9 6.8 11.1 1.6 2.4 6.5 5.2 1.8 6.3 8.0 4.3 3.5 13.9 9.9 6.4 5.4 4.9 4.8 2.8 1.7 1.9 2.4 0.8 10.3 3.8 2.8 3.3 14.3 0.9 1.5 1.0 0.6 0.8 1.3 2.0 0.4 1.0 1.1 8.1 1.3 1.3 0.9 1.3 1.9 1.9 3.7 2.5 4.9 2.9 1.6 1.8 2.7 3.0 1.3 NPNT "EGFL6L, POEM" ENSG00000168743 Nephronectin Q6UXI9 4 105894775-106004027 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 125.3" "Cell line enhanced" "Detected in some" "BEWO: 14.9;HeLa: 16.8;Hep G2: 13.5;MCF7: 12.0;RPTEC TERT1: 19.6;T-47d: 26.3" "Cancer enhanced" "Detected in all" "thyroid cancer: 104.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003711, HPA050203" Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to extracellular matrix" "Nucleoplasm, Cell Junctions, Cytosol" "HPA003711: AB_1854591, HPA050203: " "unprognostic (1.24e-1)" "unprognostic (7.93e-2)" "unprognostic (1.59e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-1)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (7.85e-3)" "unprognostic (4.78e-4)" "unprognostic (1.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "prognostic favourable (8.28e-8)" "unprognostic (4.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (2.31e-2)" 5.4 1.6 3.4 2.4 4.4 0.0 8.3 0.7 2.5 13.3 11.0 1.9 4.2 16.4 8.7 11.4 5.7 5.9 19.0 2.5 2.5 2.7 22.7 1.3 34.9 0.9 7.5 2.4 4.1 11.6 0.0 14.6 3.0 2.2 26.3 7.6 16.9 2.8 5.7 2.6 2.1 37.7 4.0 0.9 4.4 4.0 3.0 2.8 3.4 125.3 3.7 2.3 3.7 6.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 14.9 0.1 0.0 0.0 0.0 7.4 9.7 0.1 0.4 0.1 0.9 3.7 0.0 0.0 0.0 3.8 0.3 16.8 13.5 0.0 0.0 0.1 1.6 1.3 0.0 0.0 0.0 0.0 0.2 0.0 12.0 0.2 0.7 0.1 6.0 0.0 0.0 0.1 19.6 0.8 0.8 0.3 0.9 7.2 0.0 26.3 0.6 0.0 0.3 0.2 0.2 0.5 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.4 0.7 2.5 2.5 2.7 7.5 2.4 2.2 2.8 NR2C1 "TR2, TR2-11" ENSG00000120798 "Nuclear receptor subfamily 2 group C member 1" P13056 12 95020229-95073703 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035040, HPA035041, HPA067767" Supported Supported "Nucleoplasm,Cell Junctions,Cytosol" Nucleoplasm "Cell Junctions, Cytosol" "HPA035040: , HPA035041: , HPA067767: " "unprognostic (2.44e-1)" "unprognostic (8.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.51e-1)" "unprognostic (3.56e-3)" "unprognostic (3.01e-2)" "prognostic unfavourable (5.18e-5)" "unprognostic (1.30e-2)" "unprognostic (1.29e-2)" "unprognostic (1.86e-1)" "unprognostic (3.83e-2)" "unprognostic (4.56e-2)" "prognostic unfavourable (1.03e-6)" "unprognostic (2.31e-1)" "unprognostic (1.42e-1)" "unprognostic (2.16e-1)" "prognostic favourable (5.62e-5)" 11.6 15.8 15.9 11.8 14.7 15.5 12.4 38.3 23.9 12.5 11.2 12.5 12.9 11.2 17.6 20.2 8.3 15.5 11.1 14.8 14.6 9.3 10.3 14.0 14.2 9.9 11.7 15.2 16.3 12.5 16.4 15.4 11.2 13.7 10.7 12.7 14.6 8.0 17.4 19.6 11.0 11.2 15.7 14.2 14.3 10.5 22.2 14.9 12.3 18.0 9.0 10.2 12.3 10.7 4.5 6.2 3.5 4.2 3.5 9.0 3.9 8.0 10.0 15.9 7.4 3.7 6.6 22.6 7.9 5.7 7.9 7.4 8.8 4.5 9.7 2.8 5.2 8.6 7.8 6.1 6.0 4.2 16.6 11.8 8.0 10.5 8.4 7.9 5.2 7.6 5.0 5.4 6.7 8.4 9.0 3.8 9.2 5.3 8.5 18.3 10.7 17.5 8.2 11.1 5.8 8.8 9.3 8.2 6.5 12.6 5.4 5.8 9.5 5.0 7.9 6.4 6.3 7.8 4.4 5.6 9.1 9.4 1.6 9.2 3.0 0.5 4.1 3.5 7.1 4.2 9.0 3.7 5.7 6.0 6.2 4.5 7.2 5.0 2.6 3.5 3.7 6.2 3.7 3.9 15.9 14.7 38.3 23.9 14.6 9.3 11.7 15.2 13.7 14.9 NUDT9 MGC3037 ENSG00000170502 "Nudix hydrolase 9" Q9BW91 4 87422582-87459454 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036917, HPA044866, HPA078535" Approved Approved "Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria" "Intracellular and membrane" 9000 "Nuclear bodies, Mitochondria" "Nuclear membrane, Cell Junctions" "HPA036917: AB_10696790, HPA044866: , HPA078535: " "unprognostic (7.22e-2)" "unprognostic (2.59e-2)" "unprognostic (1.45e-2)" "prognostic favourable (7.43e-5)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (3.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.09e-2)" "unprognostic (4.23e-1)" "prognostic favourable (8.00e-11)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-3)" 14.2 25.6 19.5 10.0 22.7 4.0 31.1 22.5 22.3 17.9 19.6 11.8 18.0 27.0 17.3 24.5 12.8 16.2 11.4 18.0 21.8 19.4 28.1 30.9 15.8 12.2 22.9 16.5 18.4 64.1 35.4 33.1 17.5 20.0 22.5 18.3 11.3 20.2 18.7 23.8 10.2 30.0 16.0 17.0 9.9 14.1 14.1 22.6 7.6 22.7 16.0 9.7 13.6 35.9 13.9 13.8 3.7 13.9 9.3 18.3 10.6 10.6 11.5 12.8 6.4 25.4 16.0 10.4 20.5 13.3 7.9 7.9 8.1 18.4 15.6 21.0 16.6 7.3 11.8 14.4 12.7 11.7 9.1 5.1 13.4 14.1 16.0 9.3 8.4 15.4 19.2 9.4 8.9 15.8 14.3 10.5 14.9 14.0 13.0 10.1 10.3 4.7 15.3 11.4 9.1 59.7 9.8 15.5 10.6 13.2 23.4 10.4 13.4 13.5 16.2 12.8 12.4 9.3 10.0 8.1 6.3 12.7 18.4 8.8 16.1 0.9 11.7 3.7 13.4 13.8 12.4 13.9 13.4 13.2 13.8 12.0 15.9 18.3 1.3 9.3 13.9 13.0 12.3 10.6 19.5 22.7 22.5 22.3 21.8 19.4 22.9 16.5 20.0 22.6 PCDHA11 "CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11" ENSG00000249158 "Protocadherin alpha 11" Q9Y5I1 5 140868183-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.3;parathyroid gland: 4.7" "Cell line enhanced" "Detected in some" "AN3-CA: 16.5;EFO-21: 8.6;MCF7: 4.4;T-47d: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077160 Approved "Vesicles,Cell Junctions,Cytoplasmic bodies" "Vesicles, Cell Junctions" "Cytoplasmic bodies" "HPA077160: " "unprognostic (1.54e-2)" "unprognostic (1.83e-3)" "unprognostic (2.75e-1)" "unprognostic (2.59e-1)" "unprognostic (6.98e-3)" "unprognostic (1.36e-1)" "unprognostic (9.28e-3)" "unprognostic (2.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (3.13e-4)" "unprognostic (9.91e-5)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (3.26e-2)" 0.1 0.6 1.0 0.1 1.6 0.0 0.2 7.0 9.3 1.3 0.0 0.0 0.6 0.1 0.0 0.2 1.0 0.0 0.8 1.0 1.2 0.0 0.8 0.0 0.3 0.0 3.3 4.7 1.6 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.9 16.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 8.6 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.1 0.0 4.4 0.0 0.0 3.6 3.1 0.0 0.0 0.0 0.4 1.9 0.8 2.2 0.0 1.8 0.4 5.8 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDGFRA "CD140a, GAS9, PDGFR2" ENSG00000134853 "Platelet derived growth factor receptor alpha" P16234 4 54229097-54298247 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 81.5" "Cell line enhanced" "Detected in some" "ASC diff: 81.0;ASC TERT1: 37.9;BJ hTERT+: 47.0;fHDF/TERT166: 32.7;HHSteC: 27.4;HSkMC: 68.9" "Cancer enhanced" "Detected in all" "glioma: 30.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004947, CAB018143" Supported Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" 150000 "Nucleoplasm, Plasma membrane, Cell Junctions" "CAB018143: AB_2162351, HPA004947: " "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "unprognostic (4.59e-3)" "unprognostic (1.60e-1)" "unprognostic (8.92e-2)" "prognostic favourable (9.33e-4)" "unprognostic (1.24e-1)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (2.18e-2)" "unprognostic (2.18e-1)" "unprognostic (7.01e-2)" "prognostic unfavourable (9.79e-6)" "unprognostic (9.58e-3)" "unprognostic (9.87e-2)" "unprognostic (2.16e-2)" "unprognostic (1.72e-3)" 35.0 12.4 12.6 16.1 7.6 0.9 17.2 2.4 20.1 33.2 19.1 9.2 6.4 9.6 27.6 14.6 21.9 22.5 16.2 15.3 8.9 7.4 22.8 8.4 24.1 26.9 9.2 4.0 81.5 6.8 1.6 2.1 25.1 7.2 18.6 15.2 19.2 8.5 8.3 11.9 7.0 17.4 19.7 8.8 51.6 13.6 19.0 9.3 0.5 11.3 12.8 4.3 35.9 24.6 0.9 0.4 2.5 0.4 0.3 0.8 0.3 0.0 0.0 0.2 0.1 81.0 37.9 0.1 4.2 47.0 0.0 0.1 11.2 0.0 0.1 0.1 32.7 0.1 3.2 0.0 0.0 0.4 0.1 0.1 0.1 0.2 27.4 0.0 0.0 68.9 0.0 5.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.3 0.1 6.6 0.0 0.1 0.0 0.1 0.0 0.1 14.8 0.5 16.2 0.0 0.0 0.0 0.1 0.4 0.0 0.3 2.5 0.4 0.2 0.5 0.2 0.2 0.6 0.8 0.4 0.0 0.9 0.7 0.4 2.3 0.3 0.3 0.4 0.2 0.3 12.6 7.6 2.4 7.3 8.9 7.4 9.2 4.0 7.2 9.3 PDLIM1 "CLIM1, CLP-36, CLP36, hCLIM1" ENSG00000107438 "PDZ and LIM domain 1" O00151 10 95237572-95291024 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 95.1;HHSteC: 92.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 39.1;memory B-cell: 49.1;naive B-cell: 44.9" "Group enriched" "Detected in many" 6 "B-cells: 49.1;granulocytes: 39.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA017010, CAB072838, CAB072840" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" 210000000 "Actin filaments" "Plasma membrane, Cell Junctions" "CAB072838: , CAB072840: , HPA017010: AB_1855147" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.58e-2)" "prognostic favourable (1.14e-5)" "unprognostic (3.18e-2)" "unprognostic (7.54e-2)" "unprognostic (2.07e-1)" "unprognostic (8.99e-2)" "unprognostic (2.26e-1)" "unprognostic (2.82e-3)" "unprognostic (5.77e-2)" "unprognostic (6.56e-2)" "unprognostic (1.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.97e-1)" "unprognostic (4.21e-3)" "unprognostic (1.11e-1)" 60.9 6.4 2.9 32.3 3.7 2.7 69.9 3.6 3.7 30.6 78.8 3.0 24.3 27.8 30.0 35.6 48.3 28.0 38.4 107.5 3.0 2.4 19.8 49.0 78.8 91.6 6.3 2.2 23.3 20.5 11.7 6.7 53.0 16.5 34.7 34.7 12.8 34.5 27.4 150.1 26.4 96.3 27.2 8.6 52.9 28.3 14.3 3.6 23.4 76.9 54.9 41.9 65.0 38.9 49.1 6.8 39.1 0.5 1.7 3.2 9.2 33.9 21.9 1.5 0.0 8.1 5.5 35.3 10.4 32.4 27.1 44.5 46.2 52.7 0.0 2.9 28.1 95.1 11.1 60.2 27.5 0.0 17.2 33.8 6.5 74.9 92.7 0.0 1.7 15.8 31.7 13.8 50.0 48.4 7.3 8.6 6.4 6.0 0.1 0.5 3.1 17.7 28.5 1.2 11.9 13.9 32.3 6.1 2.5 11.2 10.3 0.1 8.4 14.9 42.6 10.6 2.5 0.0 0.0 4.1 0.0 11.1 11.6 0.0 5.0 0.0 0.5 39.1 2.8 0.1 0.0 49.1 0.5 3.2 6.8 44.9 0.1 2.0 1.7 1.7 0.3 0.7 0.4 9.2 2.9 3.7 3.6 3.7 3.0 2.4 6.3 2.2 16.5 3.6 PGLYRP2 "PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like" ENSG00000161031 "Peptidoglycan recognition protein 2" Q96PD5 19 15468645-15498956 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 95.8" "Group enriched" "Detected in some" 6 "MCF7: 10.6;T-47d: 10.7" "Cancer enriched" "Detected in some" 16 "liver cancer: 42.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033468, HPA046311, HPA075237" Supported Approved "Cell Junctions" "Secreted to blood" 160000000000 "Cell Junctions" "CAB033468: AB_1127187, HPA046311: , HPA075237: " "unprognostic (7.39e-3)" "unprognostic (1.52e-2)" "unprognostic (5.22e-2)" "unprognostic (8.79e-2)" "unprognostic (3.97e-1)" "unprognostic (4.88e-4)" "unprognostic (5.93e-3)" "unprognostic (6.48e-2)" "unprognostic (1.99e-1)" "unprognostic (1.18e-2)" "unprognostic (3.15e-2)" "unprognostic (2.40e-1)" "unprognostic (6.66e-16)" "unprognostic (6.35e-3)" "unprognostic (2.80e-1)" "unprognostic (2.45e-2)" "unprognostic (2.81e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 3.6 7.1 0.6 3.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.6 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 3.6 0.7 0.3 2.6 2.4 2.5 0.3 1.6 1.3 0.2 0.0 3.6 3.7 2.5 0.6 7.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PGS1 DKFZP762M186 ENSG00000087157 "Phosphatidylglycerophosphate synthase 1" Q32NB8 17 78378640-78425114 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022526 Approved Approved "Vesicles,Cell Junctions,Intermediate filaments" "Vesicles, Cell Junctions, Intermediate filaments" "HPA022526: AB_1855271" "unprognostic (1.19e-2)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (1.86e-3)" "unprognostic (1.35e-2)" "unprognostic (1.71e-2)" "prognostic unfavourable (1.37e-4)" "unprognostic (5.76e-3)" "unprognostic (3.17e-2)" "unprognostic (8.46e-3)" "prognostic favourable (7.33e-5)" "prognostic unfavourable (9.94e-4)" "prognostic unfavourable (1.16e-5)" "unprognostic (9.94e-2)" "unprognostic (5.60e-2)" "unprognostic (1.33e-1)" "unprognostic (2.72e-2)" 16.4 11.6 14.5 20.8 20.3 41.4 28.2 17.6 17.4 14.4 13.1 18.4 13.2 13.7 17.3 13.2 14.5 16.9 17.2 14.0 15.7 16.1 14.3 8.0 25.5 19.1 21.6 17.0 18.3 14.0 16.0 13.3 24.0 15.3 13.9 10.2 12.9 13.1 16.8 13.8 11.9 15.1 13.4 18.0 22.6 12.6 13.9 18.8 17.7 18.6 7.8 14.3 16.9 32.3 8.0 14.0 26.0 12.6 6.7 11.3 8.4 13.1 11.6 11.3 8.5 10.0 16.0 13.4 12.4 11.9 13.3 14.7 10.8 10.4 13.6 7.5 7.0 10.2 13.4 8.4 10.5 20.4 15.2 14.9 13.8 10.8 9.8 11.2 12.1 16.3 11.1 9.6 8.7 25.4 17.3 9.5 9.0 7.2 25.3 10.1 11.8 11.2 13.3 20.3 11.6 13.0 12.1 15.0 22.8 10.6 11.7 11.3 12.3 13.6 15.9 17.3 12.0 9.2 10.4 10.5 6.2 10.3 13.1 12.6 12.8 1.5 12.6 13.2 8.4 10.4 9.8 7.8 8.8 8.8 14.0 8.0 11.3 8.1 26.0 6.7 4.6 6.6 10.4 8.4 14.5 20.3 17.6 17.4 15.7 16.1 21.6 17.0 15.3 18.8 PLEKHA6 "KIAA0969, PEPP3" ENSG00000143850 "Pleckstrin homology domain containing A6" Q9Y2H5 1 204218851-204377665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.1" "Cell line enhanced" "Detected in many" "A-431: 20.6;BEWO: 33.5;CAPAN-2: 28.0;RT4: 23.2;SK-BR-3: 20.7;T-47d: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028152 Enhanced Approved "Vesicles,Cell Junctions" "Cell Junctions" Vesicles "HPA028152: AB_10601048" "unprognostic (9.81e-3)" "unprognostic (3.05e-1)" "unprognostic (1.59e-2)" "unprognostic (3.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (1.38e-2)" "unprognostic (9.01e-2)" "unprognostic (3.32e-1)" "unprognostic (9.60e-3)" "unprognostic (1.53e-1)" "unprognostic (5.02e-3)" "unprognostic (1.23e-1)" "unprognostic (8.22e-2)" "unprognostic (5.17e-2)" "prognostic favourable (3.57e-4)" 2.4 4.6 18.2 4.1 27.8 0.4 10.6 60.1 34.5 3.4 23.2 13.4 1.4 18.2 2.6 10.0 13.0 7.4 9.8 11.8 14.2 11.4 20.9 13.9 2.4 0.6 11.5 23.3 2.8 7.6 3.7 17.6 6.3 18.9 9.4 21.9 21.7 5.2 11.2 2.6 2.0 20.8 4.8 19.0 1.9 29.1 2.7 14.2 0.0 2.2 1.3 1.9 7.3 6.1 0.9 1.4 0.1 0.2 0.0 0.4 0.0 20.6 13.0 8.2 0.0 0.1 0.2 33.5 0.7 2.3 0.0 0.1 6.2 28.0 0.1 6.2 0.4 2.3 0.1 2.2 0.1 0.0 1.3 0.0 5.1 8.8 1.2 0.0 0.0 0.3 6.9 0.0 1.8 3.7 0.0 0.0 8.5 9.2 0.0 0.0 2.6 15.9 0.0 0.0 0.0 8.3 23.2 1.7 17.2 9.4 20.7 0.1 19.7 0.1 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 18.2 27.8 60.1 34.5 14.2 11.4 11.5 23.3 18.9 14.2 PLEKHG4 "ARHGEF44, DKFZP434I216, SCA4" ENSG00000196155 "Pleckstrin homology and RhoGEF domain containing G4" Q58EX7 16 67277510-67289499 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 28.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 4.0" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 3.7" "Not detected" "Not detected" HPA055696 Approved "Cell Junctions" "Cell Junctions" "HPA055696: " "unprognostic (2.63e-1)" "unprognostic (1.98e-3)" "unprognostic (1.16e-1)" "unprognostic (9.90e-2)" "unprognostic (3.40e-1)" "unprognostic (6.34e-2)" "unprognostic (1.50e-1)" "unprognostic (7.88e-2)" "unprognostic (6.88e-2)" "unprognostic (4.06e-3)" "unprognostic (4.48e-2)" "unprognostic (7.92e-2)" "prognostic unfavourable (6.72e-9)" "unprognostic (1.85e-1)" "unprognostic (6.78e-2)" "unprognostic (9.35e-3)" "unprognostic (5.01e-2)" 5.6 3.5 1.1 3.8 3.9 1.1 7.4 1.0 3.2 4.8 4.5 8.0 3.3 3.6 4.7 5.0 6.1 3.3 6.1 2.2 1.2 1.5 2.2 0.3 4.8 6.8 5.4 2.4 15.2 7.3 0.5 2.6 4.7 3.9 2.2 2.7 9.5 5.7 2.1 1.3 8.2 3.7 2.7 4.7 6.5 2.0 28.2 1.3 5.9 3.4 3.4 5.5 1.6 4.3 0.6 4.0 0.2 0.7 0.4 2.0 1.0 2.5 4.8 0.3 2.9 2.5 24.1 3.7 5.9 8.0 6.0 10.0 13.8 2.3 7.1 17.3 5.5 0.1 3.6 0.3 4.3 1.2 1.9 14.2 11.4 3.3 7.8 8.4 11.4 18.0 2.9 20.2 0.2 11.8 11.3 0.1 0.1 1.9 10.6 2.8 2.2 5.1 0.0 0.0 7.3 2.8 0.5 1.5 8.9 20.0 1.5 8.2 1.1 6.0 17.8 2.9 10.6 21.1 0.1 17.2 16.9 6.6 12.2 0.2 3.6 0.0 0.2 0.2 0.8 0.7 1.5 0.6 1.0 1.1 0.3 0.1 2.0 1.2 0.0 0.4 0.3 4.0 1.4 1.0 1.1 3.9 1.0 3.2 1.2 1.5 5.4 2.4 3.9 1.3 PROM2 ENSG00000155066 "Prominin 2" Q8N271 2 95274453-95291308 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 23.2;CAPAN-2: 41.1;HaCaT: 22.2;hTCEpi: 24.1;MCF7: 18.2;RT4: 25.0;SK-BR-3: 35.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB046005, HPA063728" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB046005: AB_2284371, HPA063728: " "prognostic unfavourable (2.16e-4)" "unprognostic (1.60e-1)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (2.90e-4)" "unprognostic (1.26e-1)" "prognostic unfavourable (1.55e-6)" "unprognostic (1.46e-2)" "unprognostic (4.59e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-2)" 0.3 0.2 0.5 2.9 0.6 0.0 9.3 1.1 0.5 11.4 5.2 0.3 22.2 4.4 1.4 22.5 42.6 2.2 37.2 0.5 0.6 0.5 18.8 0.4 1.3 0.3 0.6 0.3 1.5 8.6 8.1 1.5 12.5 0.3 11.6 4.2 0.3 35.6 20.0 1.3 26.7 2.6 2.7 0.7 0.4 11.5 1.8 0.3 1.7 5.7 21.6 22.2 20.0 14.8 0.0 0.2 0.6 0.0 0.0 0.3 0.0 23.2 0.0 0.0 0.2 0.1 0.0 11.8 0.0 0.0 0.1 0.1 0.2 41.1 0.0 0.0 0.0 22.2 0.0 12.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 24.1 0.0 0.1 0.0 0.0 0.0 0.0 18.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 25.0 0.2 0.0 0.0 35.9 0.0 11.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.2 0.0 0.5 0.6 1.1 0.5 0.6 0.5 0.6 0.3 0.3 0.3 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: " "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavourable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favourable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 16.3 15.3 21.0 13.4 34.9 19.2 15.7 15.5 24.7 16.5 26.2 66.1 9.5 26.6 14.2 15.4 19.0 12.6 17.1 9.9 28.6 18.2 19.7 16.9 16.9 10.8 42.1 20.7 13.5 15.0 21.8 9.2 22.7 31.8 13.6 25.6 15.0 16.8 13.4 13.0 24.7 27.9 14.6 61.9 14.6 16.3 16.8 39.7 15.4 19.7 8.7 15.9 17.2 13.5 9.0 24.4 38.1 34.0 11.7 10.5 17.1 14.2 21.9 20.5 8.1 28.7 20.5 18.7 21.0 24.1 21.5 27.2 27.2 35.7 9.3 13.9 19.9 38.0 17.2 15.9 23.6 21.2 10.7 10.6 14.9 13.2 26.5 10.7 20.8 21.0 28.9 17.8 22.0 17.2 11.8 19.0 20.1 28.3 8.1 13.9 8.9 16.3 10.3 17.4 11.8 30.0 30.3 11.4 15.2 22.9 21.5 18.7 26.6 23.9 18.2 21.9 18.1 17.9 9.9 12.4 18.2 9.4 18.4 13.0 13.3 29.2 27.1 27.1 7.2 30.8 7.0 7.2 7.0 5.9 24.4 9.0 6.6 6.4 38.1 11.7 34.0 12.8 10.5 17.1 21.0 34.9 15.5 24.7 28.6 18.2 42.1 20.7 31.8 39.7 PTPRB PTPB ENSG00000127329 "Protein tyrosine phosphatase, receptor type B" P23467 12 70515866-70637440 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 11.1;HUVEC TERT2: 27.5;TIME: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "memory B-cell: 3.5" "Lineage enriched" "Detected in single" 7 "B-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004782, HPA067868" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" 6700000 "Plasma membrane" "Vesicles, Cell Junctions" "CAB004782: , HPA067868: " "unprognostic (3.18e-1)" "unprognostic (2.99e-6)" "unprognostic (1.56e-1)" "unprognostic (1.80e-1)" "unprognostic (3.55e-2)" "unprognostic (1.77e-2)" "prognostic favourable (6.05e-4)" "unprognostic (4.59e-1)" "unprognostic (2.22e-2)" "unprognostic (1.85e-1)" "unprognostic (2.28e-2)" "unprognostic (1.40e-1)" "prognostic favourable (1.02e-4)" "unprognostic (2.91e-2)" "unprognostic (7.18e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" 23.5 7.0 4.5 5.5 7.0 0.1 22.9 3.6 6.1 11.3 8.0 4.3 7.1 5.3 17.1 8.5 5.8 8.2 11.4 17.6 6.2 5.1 18.7 12.0 39.9 3.3 6.9 4.6 5.5 4.4 4.9 5.7 23.3 7.8 6.1 8.2 16.0 3.6 7.1 11.8 4.7 7.4 13.3 7.3 22.9 5.2 3.7 4.3 0.7 14.0 12.2 2.6 6.5 14.7 3.5 0.1 0.2 0.0 0.4 0.3 0.2 1.9 0.1 0.8 0.1 0.0 0.0 0.4 0.4 1.9 1.0 2.4 0.0 1.5 0.7 11.1 0.3 6.8 0.1 0.3 3.5 0.5 0.3 0.1 0.7 0.4 0.1 0.3 0.0 0.0 0.3 2.7 0.0 27.5 1.5 0.4 0.6 0.0 0.0 0.0 1.0 0.4 0.0 0.7 0.3 5.1 0.7 0.0 0.4 0.7 0.0 1.6 0.0 0.6 40.2 0.4 0.4 0.1 2.3 0.5 0.3 0.3 0.2 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.3 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 4.5 7.0 3.6 6.1 6.2 5.1 6.9 4.6 7.8 4.3 PVALB D22S749 ENSG00000100362 Parvalbumin P20472 22 36800684-36819479 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 125.0;parathyroid gland: 137.5" "Cell line enriched" "Detected in single" 198 "RPMI-8226: 130.9" "Group enriched" "Detected in many" 10 "breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3" "Region enhanced" "Detected in all" "cerebellum: 125.0" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.4" "Region enriched" "Detected in many" 5 "cerebellum: 2377.5" "Low region specificity" "Detected in many" "CAB002515, HPA048536" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" Nucleoplasm "Nucleoli, Cell Junctions" "CAB002515: AB_563948, HPA048536: " "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "unprognostic (9.75e-2)" "unprognostic (1.79e-3)" "unprognostic (7.80e-2)" "unprognostic (2.49e-2)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (2.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-1)" "unprognostic (5.21e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-1)" "unprognostic (1.65e-2)" "unprognostic (8.99e-3)" 0.9 0.8 1.2 0.9 3.9 0.8 4.3 125.0 47.2 0.8 0.8 6.6 0.0 0.8 1.1 0.9 0.8 0.8 0.9 0.8 4.5 9.4 16.7 1.8 1.2 1.2 28.6 2.5 0.8 0.8 137.5 0.2 1.2 22.9 0.9 0.9 27.3 1.2 1.0 5.0 0.8 0.8 0.9 12.6 1.2 0.9 1.1 1.2 0.0 0.9 0.0 1.4 1.2 1.0 0.0 0.5 3.4 0.4 0.0 0.3 12.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 130.9 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.5 0.3 12.2 1.2 3.9 125.0 47.2 4.5 9.4 28.6 2.5 22.9 1.2 PYM1 "PYM, WIBG" ENSG00000170473 "PYM homolog 1, exon junction complex associated factor" Q9BRP8 12 55901413-55932618 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012803, HPA039717, HPA046200" Supported Supported "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" "Nucleoplasm, Nucleoli, Cytosol" "Cell Junctions" "CAB012803: AB_2269494, HPA039717: , HPA046200: AB_10965556" "unprognostic (3.03e-2)" "unprognostic (1.00e-1)" "unprognostic (5.65e-2)" "unprognostic (8.82e-2)" "unprognostic (1.97e-1)" "unprognostic (2.28e-1)" "prognostic unfavourable (3.05e-4)" "unprognostic (3.29e-1)" "unprognostic (2.17e-3)" "unprognostic (2.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.29e-1)" "unprognostic (1.32e-2)" "unprognostic (1.59e-2)" "unprognostic (2.22e-1)" "unprognostic (1.29e-1)" "prognostic favourable (1.34e-4)" 17.5 21.4 16.2 21.2 14.8 13.2 20.3 16.3 17.1 15.2 21.2 14.2 27.1 21.8 16.1 30.8 46.7 16.3 21.5 13.6 14.0 14.7 19.4 31.3 14.4 28.6 14.7 14.0 13.3 24.8 15.3 19.8 21.5 12.8 20.7 21.5 18.3 22.9 24.5 18.2 27.2 29.9 16.3 13.2 25.5 15.8 21.1 14.1 26.3 22.5 31.2 39.1 16.5 19.9 29.5 35.9 21.6 27.2 14.4 53.6 24.1 17.4 13.9 20.4 11.3 12.4 16.2 33.5 12.8 15.5 12.2 10.3 20.3 20.8 21.9 19.6 12.4 13.7 15.7 27.5 9.8 16.9 11.7 17.8 11.9 25.0 15.2 20.6 16.3 14.5 17.8 13.7 20.6 12.9 15.2 24.4 14.2 26.2 13.2 36.8 35.6 7.3 11.9 8.1 25.1 24.9 24.8 13.8 15.9 16.4 22.1 11.5 26.9 43.7 10.0 7.4 10.4 11.4 9.3 12.9 19.5 33.8 12.6 14.3 11.4 3.9 24.5 21.6 18.7 27.2 22.9 29.5 34.0 26.1 35.9 25.2 22.6 22.6 5.8 14.4 18.5 19.6 53.6 24.1 16.2 14.8 16.3 17.1 14.0 14.7 14.7 14.0 12.8 14.1 RAB3B ENSG00000169213 "RAB3B, member RAS oncogene family" P20337 1 51907956-51990764 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;placenta: 37.6;prostate: 20.0" "Cell line enhanced" "Detected in many" "BJ: 43.7;BJ hTERT+: 16.9;fHDF/TERT166: 15.8;TIME: 33.9" "Group enriched" "Detected in many" 6 "prostate cancer: 19.4;testis cancer: 6.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003159, CAB023293" Enhanced Approved "Cell Junctions" "Cell Junctions" "CAB023293: , HPA003159: AB_1856005" "unprognostic (1.10e-1)" "unprognostic (2.20e-3)" "unprognostic (5.43e-3)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (1.38e-2)" "unprognostic (1.20e-2)" "unprognostic (8.77e-3)" "unprognostic (2.79e-1)" "unprognostic (2.81e-1)" "unprognostic (2.42e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-2)" "unprognostic (2.02e-3)" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.15e-2)" 0.4 5.8 16.6 1.4 8.5 0.8 1.8 2.0 13.8 0.4 3.1 0.9 0.0 1.6 0.5 0.8 0.5 0.7 2.7 0.4 9.9 15.8 1.4 1.3 0.5 0.5 4.5 9.3 3.2 2.1 0.4 13.7 37.6 18.2 20.0 4.4 0.1 0.8 0.6 1.0 3.7 1.9 0.9 1.4 0.5 2.7 0.8 1.3 0.0 0.5 0.0 0.6 0.6 0.4 1.1 0.8 2.1 0.5 0.5 0.4 0.0 0.6 2.9 0.4 0.4 0.1 0.8 0.0 43.7 16.9 8.8 4.3 3.5 1.3 0.2 0.7 15.8 0.0 5.4 4.5 15.0 0.0 0.4 0.0 0.2 1.1 0.7 0.0 0.0 0.4 0.1 14.6 3.3 2.7 0.1 0.1 9.7 0.1 0.0 0.0 7.0 0.4 0.1 0.0 0.0 1.4 0.2 1.5 0.4 0.0 0.1 0.0 0.0 0.1 33.9 8.6 3.2 0.1 14.2 0.0 0.2 0.1 7.8 0.0 0.3 1.1 0.5 0.3 0.4 0.3 0.3 0.6 0.3 0.4 0.1 1.1 0.4 0.4 2.1 0.5 0.5 0.8 0.2 0.0 16.6 8.5 2.0 13.8 9.9 15.8 4.5 9.3 18.2 1.3 RAD51C "FANCO, RAD51L2" ENSG00000108384 "RAD51 paralog C" O43502 17 58692573-58735611 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045198 Supported "Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol" "Nucleoplasm, Mitochondria, Cytosol" "Vesicles, Cell Junctions" "HPA045198: " "unprognostic (5.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (6.20e-2)" "unprognostic (1.83e-1)" "unprognostic (4.59e-2)" "prognostic unfavourable (8.68e-5)" "unprognostic (3.65e-2)" "unprognostic (2.91e-2)" "unprognostic (1.03e-2)" "prognostic favourable (5.33e-4)" "unprognostic (2.55e-1)" "unprognostic (2.62e-2)" "unprognostic (7.62e-2)" "unprognostic (2.41e-1)" "unprognostic (9.52e-2)" "unprognostic (2.42e-2)" 11.1 22.7 22.1 10.1 20.8 19.4 15.4 20.8 31.0 12.3 13.7 16.0 11.1 7.3 14.3 23.1 13.2 11.8 10.9 24.9 20.2 17.4 13.7 13.9 8.9 19.6 17.2 21.4 13.4 11.2 20.0 18.3 15.1 28.9 18.3 15.0 13.2 10.6 12.7 15.5 10.3 9.6 14.4 14.0 14.4 13.2 18.9 12.7 23.8 12.6 11.7 18.6 12.6 11.8 14.4 13.0 18.8 11.3 11.2 21.7 9.2 15.4 18.0 11.1 12.2 6.1 5.3 25.4 8.5 3.9 11.4 14.5 7.6 10.0 9.1 12.6 5.8 5.9 14.9 12.0 21.3 22.2 30.7 12.8 20.2 28.9 6.0 16.5 11.5 3.1 10.8 12.7 10.3 12.7 19.9 12.5 9.7 77.6 23.3 23.0 3.0 16.7 15.1 17.6 17.2 6.9 9.7 13.8 12.8 6.8 3.3 12.8 10.1 17.5 4.0 9.6 25.6 8.7 10.3 11.8 43.8 26.7 9.8 16.3 11.0 18.8 7.5 9.8 13.7 11.3 13.3 14.1 15.0 14.9 13.0 14.4 16.4 15.4 4.6 11.2 9.8 11.7 21.7 9.2 22.1 20.8 20.8 31.0 20.2 17.4 17.2 21.4 28.9 12.7 RASAL1 RASAL ENSG00000111344 "RAS protein activator like 1" O95294 12 113098819-113136239 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 64.0" "Cell line enhanced" "Detected in some" "Daudi: 8.3;EFO-21: 10.9;REH: 12.0;RPMI-8226: 26.8;RPTEC TERT1: 10.7;U-698: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 21.7;cerebral cortex: 20.9;hippocampal formation: 33.7" HPA041650 Approved Approved "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cytosol" "Cell Junctions" "HPA041650: " "unprognostic (9.95e-2)" "unprognostic (1.11e-2)" "unprognostic (5.44e-3)" "prognostic unfavourable (3.26e-5)" "unprognostic (1.27e-2)" "unprognostic (7.73e-3)" "unprognostic (1.57e-2)" "unprognostic (1.43e-2)" "unprognostic (2.65e-1)" "unprognostic (3.02e-3)" "unprognostic (3.16e-2)" "unprognostic (2.53e-1)" "unprognostic (1.74e-2)" "unprognostic (2.85e-3)" "unprognostic (1.15e-1)" "unprognostic (3.34e-2)" "unprognostic (2.64e-1)" 0.9 10.4 8.6 2.5 11.2 1.2 1.6 0.4 18.2 2.5 2.1 18.8 3.7 1.2 0.9 0.9 16.9 2.2 1.8 0.8 11.8 4.9 7.4 0.9 0.9 1.7 7.3 10.9 0.8 1.4 64.0 3.9 1.0 4.0 0.9 1.7 0.0 22.4 7.4 0.8 8.0 1.1 0.9 1.8 1.0 9.6 1.1 8.4 0.0 8.0 6.0 5.0 1.0 3.7 0.4 0.2 1.3 0.2 0.3 1.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.1 8.3 10.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.3 0.0 12.0 0.0 26.8 10.7 0.0 0.3 0.0 0.0 4.0 0.0 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 1.3 0.2 0.1 0.1 0.0 1.6 0.2 0.9 0.4 0.0 0.4 1.2 0.5 0.4 0.3 0.0 0.2 0.4 0.3 8.6 11.2 0.4 18.2 11.8 4.9 7.3 10.9 4.0 8.4 RASSF4 "AD037, MGC44914" ENSG00000107551 "Ras association domain family member 4" Q9H2L5 10 44959407-44995891 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 21.0;RH-30: 53.4;RPMI-8226: 17.4;U-937: 27.3;WM-115: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 28.3;intermediate monocyte: 21.7;myeloid DC: 28.5;non-classical monocyte: 11.5" "Group enriched" "Detected in many" 9 "dendritic cells: 28.5;monocytes: 28.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038834 Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA038834: AB_10795576" "unprognostic (1.83e-1)" "unprognostic (8.21e-3)" "unprognostic (1.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (5.14e-2)" "unprognostic (3.15e-2)" "unprognostic (2.18e-2)" "unprognostic (8.81e-2)" "unprognostic (4.83e-2)" "unprognostic (8.75e-3)" "unprognostic (4.20e-1)" "unprognostic (4.11e-3)" "unprognostic (4.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.42e-1)" "unprognostic (6.20e-2)" 23.4 5.9 16.7 17.0 25.5 6.0 8.4 12.5 36.5 3.6 8.2 26.7 12.1 11.2 2.6 14.9 4.3 3.3 9.0 29.1 16.6 15.1 37.2 10.5 9.7 14.1 34.5 9.7 3.0 11.5 2.2 8.4 10.4 19.4 4.5 5.3 8.4 14.0 9.9 7.6 2.9 10.8 7.0 21.8 12.6 4.3 5.7 31.5 1.2 23.0 2.9 7.4 8.3 3.9 0.0 28.5 0.9 28.3 2.2 3.0 13.8 0.4 0.1 1.9 3.8 6.0 0.3 1.3 0.2 0.3 0.6 1.1 1.5 0.1 0.0 0.7 0.2 0.0 0.8 0.9 0.9 11.9 0.0 0.0 0.0 12.4 6.3 0.8 0.0 4.4 0.0 0.6 0.0 0.9 0.0 21.0 0.9 0.0 0.9 13.6 0.3 0.4 2.5 53.4 17.4 0.1 0.3 0.3 0.2 0.0 0.1 0.6 0.3 10.4 0.2 0.1 1.2 1.0 2.0 0.2 0.2 0.0 6.3 27.3 17.7 0.0 28.3 0.0 3.0 21.7 0.0 0.0 0.2 1.3 28.5 0.0 0.2 1.0 0.9 2.2 11.5 0.7 0.1 13.8 16.7 25.5 12.5 18.2 16.6 15.1 34.5 9.7 19.4 31.5 RPUSD1 "C16orf40, MGC19600, RLUCL" ENSG00000007376 "RNA pseudouridylate synthase domain containing 1" Q9UJJ7 16 784974-788397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041144, HPA041938" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol" "Golgi apparatus" "Nucleoplasm, Cell Junctions, Cytosol" "HPA041144: AB_10794265, HPA041938: AB_10795601" "unprognostic (1.51e-2)" "unprognostic (1.26e-3)" "unprognostic (2.03e-1)" "unprognostic (4.01e-1)" "unprognostic (2.99e-1)" "unprognostic (9.05e-3)" "unprognostic (1.07e-3)" "unprognostic (3.45e-2)" "unprognostic (1.08e-1)" "unprognostic (3.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (6.25e-2)" "unprognostic (8.07e-3)" "unprognostic (5.44e-2)" "unprognostic (2.95e-1)" "unprognostic (1.41e-1)" 9.5 9.7 12.0 16.5 14.8 20.9 10.4 15.3 23.8 7.4 11.2 9.4 6.2 17.6 10.5 14.0 13.9 8.6 11.2 8.1 12.7 10.4 10.7 13.4 8.2 18.2 9.5 11.3 10.0 15.3 9.9 8.9 8.2 11.2 11.3 5.1 10.9 19.8 10.5 11.1 16.8 12.8 8.3 7.0 17.4 15.1 6.2 9.2 15.5 8.5 15.1 15.6 10.8 10.7 17.3 23.1 17.7 19.9 18.0 20.4 15.8 10.5 12.5 3.1 13.9 2.7 3.2 14.3 8.8 5.1 11.6 8.5 29.1 10.0 14.8 9.7 4.2 18.2 7.1 8.9 2.1 13.4 28.8 7.3 19.2 10.5 4.4 13.4 12.3 4.7 8.6 10.0 2.6 8.0 17.0 6.7 3.9 33.6 16.7 14.1 15.7 21.6 29.8 8.3 30.4 4.2 6.5 16.1 11.6 10.2 16.7 9.7 8.6 16.8 9.0 11.6 15.1 12.1 12.7 10.7 10.7 17.0 5.6 10.5 9.5 17.5 19.9 17.7 18.3 18.0 18.1 14.9 15.5 20.4 23.1 17.3 16.2 16.3 12.7 18.0 17.4 21.2 18.7 15.8 12.0 14.8 15.3 23.8 12.7 10.4 9.5 11.3 11.2 9.2 RRP7A "CGI-96, Rrp7" ENSG00000189306 "Ribosomal RNA processing 7 homolog A" Q9Y3A4 22 42509968-42519802 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001586, HPA046768" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA001586: AB_1078506, HPA046768: " "unprognostic (8.46e-2)" "unprognostic (3.30e-3)" "unprognostic (5.96e-2)" "unprognostic (3.21e-3)" "unprognostic (9.71e-3)" "unprognostic (2.92e-1)" "prognostic unfavourable (1.21e-5)" "unprognostic (6.73e-2)" "unprognostic (3.00e-1)" "unprognostic (2.28e-1)" "unprognostic (2.41e-1)" "unprognostic (3.22e-2)" "unprognostic (9.53e-3)" "unprognostic (8.02e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" 10.4 12.9 19.9 15.4 26.6 16.5 13.5 18.5 20.9 12.8 12.2 15.1 9.4 10.2 12.0 47.3 15.1 18.9 12.0 11.1 17.5 14.8 14.0 18.1 11.3 21.5 14.8 9.3 21.2 12.0 16.6 10.3 17.7 17.4 17.8 10.8 12.6 15.2 14.6 13.5 14.9 13.3 11.9 11.7 15.6 12.0 11.2 18.6 17.4 11.6 8.7 16.4 10.7 11.0 26.2 30.5 17.4 27.5 15.2 18.4 20.3 12.8 18.1 10.0 11.7 6.4 4.3 20.2 11.0 6.6 14.2 12.1 23.1 7.4 21.4 5.6 7.8 14.3 11.4 15.2 6.1 5.4 23.4 11.7 12.7 12.4 6.1 27.9 10.1 5.4 7.7 19.2 9.8 8.6 16.4 6.2 8.4 26.1 26.8 11.4 8.3 13.2 46.7 10.2 9.5 7.4 15.8 5.4 3.9 8.0 23.2 10.6 9.5 12.6 6.4 10.9 14.0 8.3 11.1 9.5 7.1 25.3 9.0 10.7 15.5 10.0 23.5 17.4 18.4 26.4 17.7 20.5 16.1 16.8 18.1 26.2 17.7 16.5 4.7 15.2 27.5 30.5 13.5 20.3 19.9 26.6 18.5 20.9 17.5 14.8 14.8 9.3 17.4 18.6 S100A14 "BCMP84, S100A15" ENSG00000189334 "S100 calcium binding protein A14" Q9HCY8 1 153614255-153616986 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 256.0;tongue: 189.3" "Group enriched" "Detected in some" 10 "A-431: 62.5;HaCaT: 86.8;HBEC3-KT: 123.0;hTCEpi: 183.4;SK-BR-3: 129.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA027613 Enhanced Approved "Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" 110000 "Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol" "HPA027613: AB_10602298" "unprognostic (1.73e-1)" "unprognostic (1.85e-1)" "unprognostic (1.48e-1)" "unprognostic (3.94e-2)" "unprognostic (1.75e-2)" "unprognostic (6.27e-2)" "unprognostic (2.30e-2)" "unprognostic (9.48e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (2.75e-3)" "unprognostic (2.89e-1)" "unprognostic (3.16e-3)" "unprognostic (8.41e-2)" "unprognostic (1.80e-1)" "unprognostic (4.81e-2)" "unprognostic (9.53e-2)" 0.6 0.0 0.6 4.3 0.6 0.0 6.4 0.6 0.6 38.0 19.2 0.6 3.9 21.4 5.7 2.6 256.0 1.2 7.9 0.6 0.6 0.0 2.4 1.2 7.5 0.6 0.6 0.6 0.7 4.6 6.6 0.8 1.4 0.7 1.9 19.6 0.7 41.8 3.1 0.6 41.4 23.8 1.0 0.6 0.6 9.4 0.9 0.6 8.9 9.6 189.3 71.0 2.2 79.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 62.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 7.8 11.4 0.0 0.1 0.0 86.8 0.0 123.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 183.4 0.0 1.7 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 4.1 0.0 0.0 0.1 129.6 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.7 0.6 SAMD4A "DKFZP434H0350, hSmaug1, KIAA1053, SAMD4, Smaug, SMG, SMGA" ENSG00000020577 "Sterile alpha motif domain containing 4A" Q9UPU9 14 54567097-54793315 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 48.7;testis: 44.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.9;non-classical monocyte: 3.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043061, HPA065309" Approved Approved "Cell Junctions,Cytosol" "Cell Junctions" Cytosol "HPA043061: , HPA065309: " "unprognostic (1.46e-1)" "unprognostic (8.10e-3)" "unprognostic (9.66e-3)" "unprognostic (1.18e-4)" "unprognostic (2.79e-1)" "unprognostic (6.37e-2)" "unprognostic (1.46e-1)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "unprognostic (1.09e-2)" "unprognostic (2.83e-2)" "unprognostic (8.27e-2)" "unprognostic (5.41e-2)" "unprognostic (1.51e-1)" 7.5 2.9 7.8 9.0 6.0 0.5 4.0 5.6 7.0 8.9 10.1 8.0 3.0 2.3 11.1 5.5 5.4 4.2 6.5 28.2 5.5 7.3 2.5 7.6 6.4 2.9 10.6 5.2 2.1 4.1 4.8 2.0 6.0 10.8 7.7 3.3 3.4 2.4 6.3 48.7 2.6 3.3 23.8 26.5 4.6 3.9 44.6 6.1 0.7 2.4 1.3 4.8 15.9 5.8 0.9 2.6 0.0 3.9 0.0 0.4 0.8 16.7 1.7 3.3 1.7 7.1 11.3 6.2 14.6 21.0 11.6 11.9 17.3 4.0 1.0 7.5 20.2 11.7 3.2 7.3 16.4 9.6 1.6 0.0 2.0 3.5 4.0 0.0 0.1 6.3 2.5 8.3 12.4 9.0 1.3 0.0 5.4 1.1 0.2 0.0 1.6 4.1 0.5 6.7 0.0 5.4 5.4 0.5 5.5 2.3 2.8 7.6 11.1 0.2 18.3 13.8 22.8 3.4 4.5 0.1 0.0 0.0 3.9 0.3 4.4 0.0 2.3 0.0 0.0 3.9 0.0 0.3 0.0 0.0 2.6 0.9 0.0 0.0 0.0 0.0 3.6 0.0 0.4 0.8 7.8 6.0 5.6 5.7 5.5 7.3 10.6 5.2 10.8 6.1 SAPCD1 "C6orf26, NG23" ENSG00000228727 "Suppressor APC domain containing 1" Q5SSQ6 6 31762799-31764851 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 8.8;skin 1: 14.7" "Cell line enhanced" "Detected in some" "HeLa: 7.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA071699 Approved "Vesicles,Cell Junctions" Vesicles "Cell Junctions" "HPA071699: " "unprognostic (9.25e-4)" "unprognostic (1.32e-1)" "unprognostic (3.41e-2)" "unprognostic (3.28e-1)" "unprognostic (9.34e-2)" "unprognostic (8.02e-4)" "unprognostic (1.63e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (8.16e-3)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "unprognostic (8.15e-10)" "unprognostic (2.65e-2)" "unprognostic (4.45e-1)" "unprognostic (3.57e-1)" "unprognostic (7.98e-5)" 0.8 0.3 0.7 1.6 1.0 4.8 1.8 0.7 1.3 2.0 1.0 1.3 0.7 0.2 1.2 0.8 0.7 1.8 2.5 0.7 0.7 0.8 3.2 0.9 1.4 2.5 1.9 0.7 1.6 0.7 0.2 2.9 3.3 3.9 2.6 1.1 8.8 0.7 1.6 0.7 14.7 1.5 0.7 3.1 2.1 0.8 1.2 0.7 0.7 0.7 0.7 0.7 0.8 0.7 0.0 0.5 0.2 0.1 0.0 0.7 0.0 0.5 0.0 0.0 0.5 0.4 0.8 0.8 0.5 0.2 0.2 0.0 2.9 1.0 0.8 0.1 0.2 1.7 0.0 0.8 0.1 0.0 3.2 3.9 7.7 1.1 0.2 0.4 0.1 0.2 0.0 1.2 1.4 0.5 0.5 1.2 0.0 3.9 2.9 2.4 0.0 0.9 0.4 0.9 0.0 0.6 0.7 1.2 0.6 0.3 0.7 0.5 0.3 0.0 0.3 0.1 3.1 0.0 0.3 2.2 2.1 2.0 0.2 2.8 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.7 1.0 0.7 1.3 0.7 0.8 1.9 0.7 3.9 0.7 SCAMP1 SCAMP37 ENSG00000085365 "Secretory carrier membrane protein 1" O15126 5 78360583-78479071 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044753, CAB079009" Supported Approved "Nucleoplasm,Vesicles,Cell Junctions" "Nucleoplasm, Vesicles, Cell Junctions" "CAB079009: , HPA044753: " "unprognostic (8.25e-2)" "unprognostic (3.65e-2)" "unprognostic (1.40e-3)" "unprognostic (5.34e-3)" "unprognostic (2.60e-1)" "unprognostic (2.57e-3)" "unprognostic (5.51e-2)" "unprognostic (3.43e-2)" "unprognostic (1.31e-1)" "unprognostic (8.23e-3)" "unprognostic (2.35e-2)" "unprognostic (2.56e-1)" "prognostic favourable (1.92e-4)" "unprognostic (8.44e-3)" "unprognostic (7.56e-2)" "unprognostic (3.12e-2)" "unprognostic (4.99e-2)" 7.5 8.3 9.2 4.0 19.3 2.4 10.0 12.8 19.5 8.4 6.4 5.4 9.9 5.3 8.7 9.3 8.6 10.7 6.4 8.0 15.8 10.4 6.2 5.9 3.9 6.5 15.8 8.8 8.8 17.5 14.6 7.6 14.6 12.2 7.3 7.6 10.6 11.0 4.7 5.8 5.3 9.1 9.0 3.9 9.6 4.5 7.1 4.1 14.2 3.8 3.7 8.8 6.3 7.9 14.9 15.3 15.8 10.0 9.9 7.4 12.7 10.1 10.1 31.3 14.0 18.1 15.9 11.8 17.3 9.8 22.3 3.8 24.0 18.9 13.4 17.3 10.4 14.3 22.2 17.5 6.7 13.6 8.7 8.0 7.7 9.0 5.5 6.7 11.9 20.6 11.1 17.7 15.0 3.3 13.6 18.6 15.0 9.5 11.8 8.2 10.4 11.7 16.7 21.6 17.8 15.3 28.8 17.5 10.9 15.5 11.2 21.6 10.1 15.2 10.9 8.0 11.9 9.9 9.5 11.4 11.8 21.2 20.7 9.0 15.3 11.4 12.8 8.2 12.6 9.9 7.9 9.4 9.8 14.9 6.6 7.8 6.8 7.0 10.0 15.8 4.6 9.1 7.4 SCHIP1 SCHIP-1 ENSG00000151967 "Schwannomin interacting protein 1" P0DPB3 3 159839861-159897360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5" "Cell line enhanced" "Detected in some" "AF22: 9.3;AN3-CA: 16.9;HUVEC TERT2: 20.0;NTERA-2: 10.3;SH-SY5Y: 58.2" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 9.7" "Group enriched" "Detected in many" 58 "dendritic cells: 9.7;granulocytes: 3.1" "HPA003243, HPA069824" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA003243: AB_1079877, HPA069824: " "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (1.37e-2)" "unprognostic (2.36e-5)" "prognostic favourable (2.80e-4)" "unprognostic (6.25e-2)" "unprognostic (4.56e-3)" "unprognostic (1.11e-1)" "unprognostic (7.81e-2)" "unprognostic (1.38e-1)" "unprognostic (6.45e-3)" "unprognostic (4.67e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-4)" "unprognostic (2.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.96e-1)" 6.1 3.9 30.1 1.5 22.0 2.0 1.9 23.9 55.0 3.7 3.6 21.1 0.0 2.2 4.7 2.0 4.2 3.4 3.0 65.9 29.6 17.9 3.5 1.9 3.1 1.7 22.8 24.1 1.8 1.6 1.4 6.0 10.3 15.6 6.2 2.3 0.7 2.9 2.6 54.5 1.4 1.9 5.9 28.9 5.1 2.0 2.7 24.3 0.0 2.0 7.6 1.6 1.9 0.6 0.0 9.7 3.1 0.0 0.1 0.0 0.1 0.0 0.0 9.3 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.3 0.1 3.9 20.0 0.0 0.0 1.2 0.0 0.0 0.0 10.3 0.0 0.0 1.9 0.0 0.4 0.0 0.0 58.2 0.0 0.0 0.0 0.0 1.0 3.7 0.2 0.5 0.1 0.8 0.7 0.0 0.0 0.2 0.7 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 9.7 0.0 0.1 30.1 22.0 23.9 28.9 29.6 17.9 22.8 24.1 15.6 24.3 SCN8A "CerIII, CIAT, MED, NaCh6, Nav1.6, PN4" ENSG00000196876 "Sodium voltage-gated channel alpha subunit 8" Q9UQD0 12 51590266-51812864 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 27.6;pituitary gland: 9.7" "Cell line enhanced" "Detected in many" "AF22: 11.8;ASC TERT1: 12.4;BJ hTERT+: 11.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022169, HPA043937, HPA073590" Approved "Vesicles,Plasma membrane,Cell Junctions" "Plasma membrane" "Vesicles, Cell Junctions" "CAB022169: , HPA043937: , HPA073590: " "unprognostic (2.96e-2)" "unprognostic (8.49e-2)" "unprognostic (6.93e-2)" "unprognostic (3.52e-6)" "unprognostic (8.13e-2)" "unprognostic (1.51e-2)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.16e-1)" "unprognostic (4.73e-4)" "unprognostic (1.69e-2)" "unprognostic (1.29e-5)" "unprognostic (4.38e-1)" "unprognostic (1.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.75e-2)" 1.1 3.0 9.1 1.5 18.1 1.9 1.9 16.7 27.6 1.0 2.0 1.6 0.0 1.1 1.5 2.0 0.9 1.1 2.5 0.9 12.6 4.5 1.9 4.3 1.0 1.3 3.2 13.7 1.8 3.2 1.5 9.7 0.9 14.8 1.8 2.5 0.9 1.7 1.2 1.0 1.1 1.2 1.0 2.2 1.7 2.7 3.8 1.6 0.0 1.7 0.0 1.2 1.0 0.6 0.4 0.2 0.0 0.0 0.0 1.0 0.0 1.3 1.0 11.8 0.1 1.6 12.4 0.2 6.7 11.0 7.7 7.2 1.9 1.3 0.3 1.5 8.7 0.0 1.9 0.0 9.1 1.2 0.6 0.1 0.1 0.2 0.1 0.2 0.9 1.7 0.0 5.1 1.1 8.2 0.1 0.1 4.8 0.8 1.9 0.1 4.0 3.8 0.0 0.6 0.0 0.0 0.4 4.7 1.9 3.4 1.7 0.2 0.3 0.1 2.2 7.5 5.0 2.7 4.2 0.1 0.1 0.0 1.5 1.6 10.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 1.0 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 9.1 18.1 16.7 25.0 12.6 4.5 3.2 13.7 14.8 1.6 SEMA4B "KIAA1745, MGC131831, SEMAC, SemC" ENSG00000185033 "Semaphorin 4B" 15 90160604-90229679 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 51.8;RPTEC TERT1: 32.1;RT4: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 14.7;naive B-cell: 11.8;neutrophil: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 14.7;granulocytes: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013372 Approved Approved "Nucleoplasm,Vesicles,Cell Junctions" "Cell Junctions" "Nucleoplasm, Vesicles" "HPA013372: AB_1856670" "unprognostic (3.33e-2)" "unprognostic (5.96e-2)" "unprognostic (2.23e-2)" "unprognostic (2.50e-2)" "unprognostic (7.78e-2)" "unprognostic (4.48e-2)" "unprognostic (6.34e-3)" "prognostic unfavourable (1.25e-4)" "unprognostic (2.04e-1)" "unprognostic (9.31e-2)" "unprognostic (1.58e-3)" "unprognostic (4.67e-2)" "prognostic unfavourable (3.33e-8)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (3.57e-2)" "unprognostic (7.09e-2)" 7.0 19.8 13.1 13.7 16.7 7.1 13.6 9.1 13.1 16.2 21.7 9.4 18.2 24.0 9.0 12.3 56.7 16.3 20.3 13.8 13.3 7.6 18.6 32.1 11.6 10.0 13.4 11.1 17.0 19.8 9.4 10.8 14.6 15.4 18.1 10.0 15.4 21.3 15.7 4.0 29.0 22.2 13.5 18.8 16.3 22.4 8.3 14.8 12.8 32.7 15.5 27.2 31.6 24.6 14.7 0.9 4.0 2.0 0.3 0.7 1.0 5.8 15.9 1.2 3.8 1.1 0.8 8.8 1.8 3.9 2.2 2.4 1.9 51.8 4.1 20.1 1.3 27.8 1.0 25.8 1.8 23.6 3.3 5.4 3.9 2.6 4.4 0.6 2.5 3.1 11.3 2.4 5.1 2.5 2.6 6.6 1.2 4.3 1.4 2.3 5.4 14.6 1.7 0.9 9.0 32.1 34.9 3.8 3.9 6.3 10.2 2.4 7.1 1.6 5.6 1.8 3.4 3.7 4.0 9.6 11.5 2.0 17.1 4.5 1.8 0.0 2.0 0.3 0.7 1.2 0.5 14.7 0.5 0.4 0.9 11.8 0.4 0.5 4.0 0.3 2.0 0.1 0.1 1.0 13.1 16.7 9.1 13.1 13.3 7.6 13.4 11.1 15.4 14.8 SHKBP1 "PP203, Sb1" ENSG00000160410 "SH3KBP1 binding protein 1" Q8TBC3 19 40576851-40591399 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041887 Uncertain Approved "Cell Junctions" "Cell Junctions" "HPA041887: AB_10794639" "unprognostic (1.26e-1)" "unprognostic (7.55e-2)" "unprognostic (1.38e-1)" "unprognostic (4.52e-2)" "unprognostic (8.24e-2)" "unprognostic (9.14e-2)" "unprognostic (1.66e-3)" "unprognostic (3.53e-2)" "unprognostic (6.98e-2)" "unprognostic (6.69e-3)" "unprognostic (1.42e-1)" "unprognostic (6.87e-2)" "unprognostic (5.29e-2)" "unprognostic (6.15e-2)" "unprognostic (2.67e-1)" "unprognostic (1.65e-1)" "unprognostic (8.64e-2)" 12.1 13.0 9.8 25.4 15.2 40.1 19.5 2.7 11.3 12.1 10.7 11.7 9.0 12.7 14.1 12.1 17.8 13.4 12.2 10.7 7.5 5.2 16.5 14.7 20.0 53.5 17.8 5.9 11.4 14.6 9.9 9.2 11.7 11.0 13.6 7.4 9.0 12.7 10.3 5.8 12.1 17.0 11.8 11.1 51.8 15.2 7.5 15.1 33.9 14.0 11.1 25.3 14.4 13.5 14.9 28.4 81.8 40.7 12.2 19.3 30.6 23.0 35.7 7.2 10.2 6.3 7.1 13.6 9.0 13.5 14.1 19.5 15.6 15.9 24.4 17.9 14.1 10.1 9.3 17.0 6.7 37.4 22.0 17.6 9.8 10.4 13.6 16.5 50.6 11.5 12.4 12.9 8.1 20.5 9.9 20.4 10.7 20.2 16.9 23.3 5.2 13.3 30.5 9.3 18.1 11.6 18.9 5.9 13.9 13.8 7.6 8.1 12.0 27.3 15.4 14.2 18.8 22.1 17.7 19.3 9.1 16.4 22.8 19.5 12.6 35.8 37.1 37.0 14.3 36.0 11.6 14.9 13.8 14.6 28.4 13.1 8.2 9.4 81.8 12.2 40.7 8.5 19.3 30.6 9.8 15.2 2.7 11.3 7.5 5.2 17.8 5.9 11.0 15.1 SHROOM2 APXL ENSG00000146950 "Shroom family member 2" Q13796 X 9786456-9949443 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 12.4;RT4: 12.9;WM-115: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA051646, HPA061435" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions" Cytosol "HPA051646: , HPA061435: " "unprognostic (8.65e-3)" "unprognostic (1.36e-3)" "unprognostic (4.68e-2)" "unprognostic (4.06e-2)" "unprognostic (6.99e-3)" "unprognostic (8.05e-2)" "unprognostic (9.96e-2)" "unprognostic (1.28e-1)" "unprognostic (2.51e-1)" "unprognostic (6.54e-2)" "unprognostic (2.82e-2)" "unprognostic (9.73e-2)" "prognostic favourable (1.35e-7)" "unprognostic (1.56e-1)" "unprognostic (3.34e-1)" "unprognostic (1.93e-1)" "unprognostic (7.67e-3)" 1.3 3.6 6.8 1.3 7.7 0.5 2.5 2.8 17.0 4.7 3.2 3.7 4.6 1.8 3.3 5.8 7.2 3.6 6.3 1.5 7.4 5.5 5.3 7.6 8.1 1.0 5.7 9.1 13.8 7.2 5.5 6.1 14.3 5.8 10.6 3.0 3.6 6.0 5.8 0.7 7.9 1.4 2.1 7.9 1.7 2.6 5.8 2.5 1.8 3.1 3.4 3.4 6.4 4.3 0.0 0.9 1.1 0.0 0.0 0.2 0.0 4.0 0.5 7.6 1.0 0.4 1.2 4.3 0.4 1.3 1.6 2.7 5.0 0.0 0.0 1.4 1.0 3.3 3.9 10.8 1.9 0.0 2.9 0.0 0.0 0.8 2.5 0.0 5.2 0.2 7.5 12.4 0.5 9.3 0.0 0.0 2.6 4.3 0.0 0.0 6.6 0.0 0.0 8.3 0.0 7.0 12.9 1.1 0.6 0.3 0.1 12.0 4.4 0.2 4.3 12.1 1.5 0.0 0.4 0.0 0.0 0.0 7.9 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.9 0.0 0.0 6.8 7.7 2.8 17.0 7.4 5.5 5.7 9.1 5.8 2.5 SLC16A9 "C10orf36, FLJ43803, MCT9" ENSG00000165449 "Solute carrier family 16 member 9" Q7RTY1 10 59650761-59736002 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 58.0;kidney: 70.9" "Cell line enhanced" "Detected in some" "HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.8;U-251 MG: 8.3;U-937: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049286 Approved Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA049286: " "unprognostic (3.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-3)" "unprognostic (1.76e-2)" "unprognostic (5.96e-2)" "unprognostic (3.50e-3)" "unprognostic (5.01e-2)" "unprognostic (2.11e-3)" "unprognostic (5.99e-2)" "unprognostic (4.60e-2)" "prognostic favourable (2.56e-6)" "unprognostic (7.57e-3)" "unprognostic (1.27e-2)" "unprognostic (3.72e-1)" "unprognostic (1.94e-1)" 0.7 58.0 5.7 2.0 4.6 0.7 0.9 9.9 4.4 8.2 4.6 9.6 1.6 0.3 12.6 2.2 5.3 8.6 3.3 1.4 10.0 2.6 70.9 1.1 0.6 0.8 6.7 5.5 13.4 1.3 11.8 6.4 0.2 8.2 3.2 6.4 5.2 1.6 4.2 9.2 0.5 0.8 3.0 6.0 14.3 2.4 3.4 6.5 0.0 11.2 4.4 3.1 0.9 4.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 4.2 5.5 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.6 0.0 0.7 8.7 0.0 0.0 0.0 1.4 0.1 0.2 0.0 0.1 1.8 0.0 0.4 0.1 0.0 2.3 0.3 6.1 0.1 0.4 3.3 2.3 0.0 16.4 7.5 2.7 0.2 5.7 0.0 0.2 2.8 7.8 0.1 0.3 0.0 2.7 3.6 2.6 0.4 0.9 0.1 8.3 0.0 0.0 0.0 0.0 14.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.7 4.6 9.9 4.3 10.0 2.6 6.7 5.5 8.2 6.5 SLC23A3 "FLJ31168, SVCT3, Yspl1" ENSG00000213901 "Solute carrier family 23 member 3" Q6PIS1 2 219161465-219170095 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "intestine: 36.5;kidney: 32.4" "Cell line enhanced" "Detected in many" "hTCEpi: 8.9;U-266/70: 6.5" "Cancer enriched" "Detected in some" 9 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 1.3" "Low region specificity" "Detected in single" HPA019059 Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA019059: AB_1857017" "unprognostic (2.49e-2)" "unprognostic (6.65e-2)" "unprognostic (2.05e-4)" "unprognostic (6.97e-2)" "unprognostic (8.41e-2)" "unprognostic (1.22e-2)" "unprognostic (9.07e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (4.35e-2)" "unprognostic (3.10e-1)" "unprognostic (6.12e-4)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (2.41e-2)" "unprognostic (3.34e-1)" "unprognostic (6.52e-5)" 0.4 0.0 0.3 2.3 0.3 0.0 0.5 0.3 0.5 0.8 14.9 0.3 0.3 5.3 1.1 0.3 0.9 0.5 0.3 0.3 0.3 0.0 32.4 3.1 0.7 0.3 0.3 0.3 1.0 0.4 0.5 0.3 0.5 0.3 1.4 0.8 0.3 0.4 0.3 0.3 1.1 36.5 0.3 0.3 0.4 0.5 0.3 0.3 0.3 1.3 0.3 0.4 0.6 1.3 0.8 0.0 0.0 0.8 0.0 0.5 0.0 0.9 0.4 0.2 1.1 3.9 2.2 0.8 2.2 0.6 0.4 1.3 2.3 1.6 0.5 0.8 1.5 3.2 0.7 0.3 0.6 1.8 1.8 2.0 1.9 0.1 0.7 0.2 0.9 0.7 8.9 0.9 2.9 1.2 0.3 0.9 0.6 0.3 0.1 1.0 0.0 0.2 0.5 0.5 0.8 3.1 3.7 0.5 1.0 0.2 0.0 2.3 0.9 1.1 2.6 2.1 1.4 2.2 0.7 6.5 0.3 2.9 0.6 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.3 0.3 0.3 0.5 0.3 0.0 0.3 0.3 0.3 0.3 SLC26A9 ENSG00000174502 "Solute carrier family 26 member 9" Q7LBE3 1 205913048-205943460 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "salivary gland: 108.4" "Group enriched" "Detected in some" 13 "CAPAN-2: 16.6;Hep G2: 6.2" "Cancer enhanced" "Detected in many" "pancreatic cancer: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051485 Enhanced Approved "Cell Junctions" "Cell Junctions" "HPA051485: " "unprognostic (1.55e-2)" "unprognostic (2.70e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-1)" "unprognostic (1.83e-2)" "prognostic favourable (8.55e-5)" "unprognostic (1.26e-1)" "unprognostic (1.68e-1)" "unprognostic (3.49e-1)" "unprognostic (8.07e-2)" "unprognostic (8.85e-2)" "unprognostic (3.41e-1)" "unprognostic (2.43e-1)" "unprognostic (2.19e-1)" "unprognostic (1.05e-1)" "unprognostic (7.45e-3)" "unprognostic (2.01e-1)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.3 0.1 6.4 0.1 0.1 0.0 0.1 0.1 5.5 0.1 0.1 0.1 0.1 0.5 0.0 0.3 0.1 0.1 0.1 0.0 0.1 108.4 0.1 0.1 1.9 0.1 0.1 0.1 0.1 17.8 0.1 0.1 0.2 0.4 1.1 2.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.6 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SLC38A6 NAT-1 ENSG00000139974 "Solute carrier family 38 member 6" Q8IZM9 14 60981114-61083733 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018508 Approved Approved "Plasma membrane,Cell Junctions,Microtubules" "Cell Junctions" "Plasma membrane, Microtubules" "HPA018508: AB_2190518" "unprognostic (7.08e-2)" "unprognostic (4.14e-2)" "unprognostic (1.75e-1)" "unprognostic (3.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.74e-2)" "prognostic unfavourable (9.47e-6)" "unprognostic (9.89e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-2)" "unprognostic (2.20e-1)" "unprognostic (5.13e-2)" "prognostic unfavourable (1.37e-5)" "unprognostic (1.73e-1)" "unprognostic (4.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-1)" 26.1 16.9 8.3 6.7 16.6 4.0 11.4 9.7 14.0 8.1 7.1 5.2 5.5 4.5 10.0 20.5 5.0 8.4 14.4 5.4 8.8 8.6 16.9 9.2 12.2 9.6 8.6 10.9 9.9 6.1 23.8 21.5 13.7 14.3 8.1 10.1 10.9 11.7 6.4 4.1 4.6 5.6 8.0 7.6 10.8 6.4 10.9 6.5 8.8 9.7 7.1 7.2 11.6 8.1 2.4 5.2 0.2 8.6 0.7 5.2 3.4 7.1 10.0 3.3 5.9 34.2 12.4 2.3 5.5 16.4 5.2 4.9 2.5 19.7 1.7 9.4 4.9 6.3 3.1 5.6 4.8 2.5 1.5 3.0 4.1 6.6 11.2 1.5 5.9 9.8 2.4 5.0 5.9 6.8 4.1 3.7 18.0 4.1 2.8 3.9 2.0 6.6 0.5 9.5 5.5 15.1 4.0 1.5 1.3 4.6 3.3 8.8 4.8 2.6 7.3 8.1 3.5 9.4 3.0 0.7 2.1 0.6 16.5 1.4 6.3 0.0 8.4 0.1 2.2 8.6 2.6 2.4 4.0 2.9 4.4 2.2 3.3 4.3 0.2 0.7 5.4 5.2 5.2 3.4 8.3 16.6 9.7 14.0 8.8 8.6 8.6 10.9 14.3 6.5 SLC44A2 CTL2 ENSG00000129353 "Solute carrier family 44 member 2" Q8IWA5 19 10602457-10644559 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 61.1;SK-BR-3: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003228, HPA070799" Approved Approved "Vesicles,Cell Junctions" 78000 "Vesicles, Cell Junctions" "HPA003228: AB_1080009, HPA070799: " "unprognostic (6.35e-3)" "unprognostic (5.75e-2)" "unprognostic (4.34e-1)" "unprognostic (3.06e-3)" "unprognostic (4.38e-2)" "unprognostic (8.41e-3)" "unprognostic (1.64e-1)" "unprognostic (2.52e-1)" "unprognostic (2.66e-2)" "unprognostic (4.32e-1)" "prognostic unfavourable (6.01e-4)" "unprognostic (8.63e-2)" "prognostic favourable (1.71e-5)" "unprognostic (1.28e-1)" "unprognostic (1.67e-1)" "unprognostic (8.21e-3)" "unprognostic (3.61e-2)" 29.3 14.2 25.1 21.4 28.3 23.4 31.6 24.2 33.9 24.7 23.0 40.7 21.7 10.5 21.0 17.3 31.8 24.8 24.9 29.1 21.2 17.9 29.4 9.1 39.4 46.7 26.1 18.4 14.2 16.5 21.6 8.6 114.9 31.8 19.9 20.3 36.6 22.1 28.8 51.6 29.0 19.1 19.3 37.5 49.4 44.0 51.6 21.2 30.4 26.9 26.4 39.2 29.0 26.3 19.0 17.8 86.0 45.9 13.1 21.8 22.8 61.1 1.5 13.7 8.2 20.8 12.8 39.2 13.3 32.8 22.0 26.0 13.7 29.3 12.4 17.9 36.8 47.3 2.0 10.2 14.2 0.3 1.7 7.9 7.7 0.5 23.0 0.1 6.6 13.9 13.6 8.3 7.2 16.8 3.7 2.1 33.3 45.0 6.5 5.9 4.8 5.5 13.9 19.5 0.5 7.1 32.5 1.3 8.2 10.5 58.9 1.5 22.9 0.6 15.3 9.9 3.6 11.7 3.3 0.7 1.3 12.2 2.4 5.5 11.0 22.9 7.2 39.3 21.8 19.6 17.2 17.7 15.1 16.5 3.7 19.0 16.5 16.8 86.0 13.1 45.9 17.8 16.5 22.8 25.1 28.3 24.2 33.9 21.2 17.9 26.1 18.4 31.8 21.2 SLC5A6 SMVT ENSG00000138074 "Solute carrier family 5 member 6" Q9Y289 2 27199587-27212958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.0;placenta: 51.7" "Cell line enhanced" "Detected in all" "BEWO: 68.0;SK-BR-3: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036958 Approved Approved "Cell Junctions" "Cell Junctions" "HPA036958: AB_10672343" "unprognostic (5.85e-2)" "unprognostic (8.32e-3)" "unprognostic (1.38e-1)" "unprognostic (2.61e-3)" "unprognostic (9.38e-2)" "unprognostic (7.14e-2)" "unprognostic (3.20e-3)" "unprognostic (7.92e-2)" "unprognostic (6.96e-2)" "unprognostic (9.80e-2)" "unprognostic (2.05e-2)" "unprognostic (7.46e-2)" "prognostic unfavourable (3.60e-7)" "unprognostic (2.40e-3)" "unprognostic (1.20e-2)" "unprognostic (4.56e-3)" "unprognostic (4.18e-2)" 20.9 4.6 5.0 7.6 8.5 8.5 15.9 7.9 8.1 4.0 6.4 5.6 6.4 10.9 7.4 36.7 5.5 5.9 6.3 3.5 5.3 5.7 5.9 64.0 6.0 6.4 7.0 8.1 5.6 6.0 4.5 4.2 51.7 7.1 4.8 6.6 5.6 6.7 10.6 7.9 4.6 7.6 4.9 4.4 4.8 4.8 17.5 6.1 5.8 5.1 4.3 13.0 4.6 10.1 6.8 10.0 2.0 9.0 6.3 10.4 5.8 16.4 17.0 10.9 14.3 10.1 3.7 68.0 6.0 4.1 9.1 6.3 25.1 5.9 11.4 9.1 3.2 9.2 23.3 6.9 6.4 8.8 13.7 20.2 7.3 38.4 12.0 25.9 10.6 12.7 5.9 11.2 8.7 8.2 29.5 4.7 5.8 33.8 8.8 12.6 31.4 6.2 14.8 12.8 16.5 5.2 15.8 9.2 13.6 6.5 73.1 8.6 16.2 5.6 3.7 10.1 13.8 6.1 16.0 7.9 18.0 18.1 5.5 18.2 14.1 0.1 6.5 2.0 8.5 7.3 10.4 6.8 8.3 8.2 9.7 6.7 8.5 10.1 0.3 6.3 9.0 10.0 8.2 5.8 5.0 8.5 7.9 8.1 5.3 5.7 7.0 8.1 7.1 6.1 SLC5A7 "CHT1, hCHT" ENSG00000115665 "Solute carrier family 5 member 7" Q9GZV3 2 107986523-108013994 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport" "Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 45.1" "Group enriched" "Detected in some" 22 "RT4: 8.7;SCLC-21H: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Group enriched" "Detected in some" 13 "basal ganglia: 13.8;pons and medulla: 45.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1" "Group enriched" "Detected in some" 15 "basal ganglia: 20.7;hippocampal formation: 7.2;pons and medulla: 26.3" HPA046105 Approved "Nuclear bodies,Cell Junctions,Intermediate filaments" "Cell Junctions, Intermediate filaments" "Nuclear bodies" "HPA046105: " "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-3)" "unprognostic (7.10e-2)" "unprognostic (1.66e-1)" "unprognostic (3.39e-4)" "unprognostic (1.05e-2)" "unprognostic (9.78e-3)" "unprognostic (6.42e-2)" "unprognostic (1.61e-2)" 0.3 2.4 0.1 1.6 13.8 0.0 0.3 0.1 0.4 3.3 5.2 0.1 0.3 2.3 1.6 0.7 1.0 0.2 0.5 1.2 0.2 2.2 0.9 0.2 0.9 0.0 0.3 0.5 0.8 0.5 0.0 0.1 0.0 45.1 0.8 2.5 1.0 0.9 4.2 0.1 0.1 2.5 3.1 10.0 0.1 1.7 0.3 0.8 0.0 4.0 0.3 0.1 4.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 0.1 0.4 0.2 2.2 0.3 0.5 45.1 0.8 SLC6A6 TAUT ENSG00000131389 "Solute carrier family 6 member 6" P31641 3 14402576-14489349 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 76.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 33.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015028, HPA016488" Enhanced Approved "Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "HPA015028: AB_1857200, HPA016488: AB_1857202" "unprognostic (8.25e-2)" "unprognostic (7.29e-3)" "unprognostic (2.63e-2)" "prognostic favourable (5.22e-5)" "prognostic unfavourable (5.75e-8)" "unprognostic (4.14e-2)" "prognostic unfavourable (8.78e-4)" "unprognostic (2.58e-1)" "unprognostic (2.56e-1)" "unprognostic (3.81e-1)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-2)" "unprognostic (9.65e-2)" "unprognostic (1.90e-1)" 10.2 25.9 5.7 18.0 16.5 46.4 8.1 11.1 12.2 11.3 9.5 8.7 3.6 8.5 14.5 4.4 7.0 7.0 14.5 23.2 5.6 4.6 16.6 2.3 18.6 12.9 18.0 7.6 31.3 2.8 3.8 9.6 18.0 13.3 5.0 4.1 76.4 15.7 7.7 26.6 16.8 22.2 8.2 11.1 20.3 14.0 4.0 12.6 6.2 10.4 11.3 11.2 8.8 6.1 1.6 1.9 33.2 6.9 0.7 3.9 2.3 4.6 17.1 6.2 4.7 8.0 2.5 12.7 6.9 27.5 8.2 6.1 6.2 7.9 13.4 6.4 10.9 3.7 4.2 5.7 7.4 1.5 5.2 12.7 22.5 9.3 0.2 3.4 27.5 1.3 1.7 7.5 1.9 8.9 7.1 2.7 7.2 4.9 9.7 6.7 9.5 5.0 6.9 7.3 20.9 45.1 9.6 11.4 4.1 5.2 2.8 1.5 10.6 1.9 22.5 10.5 5.6 2.6 5.0 3.0 3.4 4.9 24.5 6.8 32.1 2.5 5.1 5.0 1.3 4.2 0.7 1.6 1.4 1.7 1.9 0.9 0.2 0.3 33.2 0.7 6.9 0.7 3.9 2.3 5.7 16.5 11.1 12.2 5.6 4.6 18.0 7.6 13.3 12.6 SMPD2 "ISC1, nSMase" ENSG00000135587 "Sphingomyelin phosphodiesterase 2" O60906 6 109440763-109443919 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA018110, HPA018125" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" "Vesicles, Plasma membrane" "Cell Junctions" "HPA018110: AB_1857292, HPA018125: AB_1857293" "unprognostic (1.61e-1)" "unprognostic (8.01e-2)" "unprognostic (1.97e-1)" "unprognostic (8.79e-3)" "unprognostic (3.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavourable (1.17e-4)" "unprognostic (7.08e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" "prognostic favourable (1.00e-3)" "unprognostic (3.60e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" "unprognostic (1.45e-2)" "prognostic favourable (1.70e-4)" 6.0 6.8 4.2 20.2 4.9 8.5 8.5 5.4 6.4 9.0 12.6 9.8 16.4 10.5 6.1 16.0 17.2 17.4 12.6 5.1 4.9 3.7 10.2 7.8 8.4 9.4 4.7 4.2 6.7 15.5 17.9 8.8 19.5 4.8 10.1 10.2 8.4 16.6 11.9 3.3 16.9 15.4 7.8 4.3 10.1 11.1 35.1 4.7 18.3 10.5 13.5 23.0 6.3 10.1 18.3 13.4 9.3 7.8 6.2 8.0 5.3 8.9 10.4 5.5 8.6 9.6 5.3 18.3 3.0 11.1 7.5 7.2 9.7 7.3 4.9 6.4 6.4 11.5 5.5 13.2 4.5 6.2 14.2 5.7 10.7 6.0 8.1 6.2 6.7 5.6 15.3 6.7 13.3 6.9 10.9 8.7 3.7 12.9 10.0 13.5 1.5 5.0 7.0 2.6 5.3 13.7 15.3 7.2 6.0 5.7 17.8 13.4 5.7 11.9 4.4 3.4 4.9 2.7 11.2 5.9 1.5 3.1 6.6 5.9 6.0 5.7 7.8 9.3 6.6 7.5 7.3 12.8 7.4 8.0 10.2 18.3 5.6 5.7 2.3 6.2 6.6 13.4 7.2 5.3 4.2 4.9 5.4 6.4 4.9 3.7 4.7 4.2 4.8 4.7 SNRK "FLJ20224, HSNFRK, KIAA0096" ENSG00000163788 "SNF related kinase" Q9NRH2 3 43286512-43424764 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 50.8;TIME: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042163 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Vesicles, Plasma membrane, Cell Junctions" Nucleoplasm "HPA042163: AB_10794645" "prognostic favourable (9.28e-4)" "unprognostic (8.46e-2)" "unprognostic (2.79e-3)" "unprognostic (6.41e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-3)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (2.63e-3)" "unprognostic (4.25e-1)" "unprognostic (2.32e-1)" "unprognostic (4.68e-2)" "prognostic favourable (9.41e-5)" "unprognostic (9.21e-3)" "unprognostic (2.04e-1)" "unprognostic (7.06e-3)" "unprognostic (7.38e-2)" 31.5 8.8 9.8 13.1 14.4 41.0 22.6 34.5 21.1 17.6 14.4 7.9 5.9 12.8 20.9 10.5 16.2 11.5 16.4 13.9 11.0 11.0 16.8 20.3 24.7 19.8 11.4 10.6 15.1 18.0 18.4 16.2 26.2 22.5 12.1 9.9 14.7 10.7 9.4 12.5 24.5 17.0 18.7 9.8 25.4 11.2 13.9 7.2 48.4 24.8 13.5 14.4 15.8 19.3 3.2 3.0 20.9 5.5 8.1 10.7 6.5 3.2 2.0 3.7 3.5 11.1 4.0 3.5 3.5 5.9 3.8 3.8 2.7 4.7 5.1 2.8 4.4 2.1 4.3 7.5 4.0 5.9 3.5 5.9 3.7 3.1 5.8 6.6 6.6 4.4 5.2 4.3 7.4 50.8 2.6 6.0 3.5 1.7 6.6 5.8 4.1 9.1 4.6 2.7 5.4 9.9 5.6 2.6 5.5 3.0 3.3 4.2 2.2 8.4 29.5 3.4 3.4 3.9 4.1 9.7 6.9 4.4 2.4 7.9 4.8 4.8 2.8 5.4 7.6 5.5 10.7 2.8 6.7 7.6 3.0 3.2 10.1 10.1 20.9 8.1 5.0 0.9 7.1 6.5 9.8 14.4 34.5 21.1 11.0 11.0 11.4 10.6 22.5 7.2 SPERT "CBY2, NURIT" ENSG00000174015 "Spermatid associated" Q8NA61 13 45702311-45714559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 66.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.7;HDLM-2: 3.4;hTCEpi: 1.2;MCF7: 1.3;SCLC-21H: 1.2;SK-BR-3: 2.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 32 "T-cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039359, HPA040046" Enhanced Approved "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA039359: AB_10794088, HPA040046: AB_10796117" "unprognostic (2.86e-1)" "unprognostic (3.38e-1)" "unprognostic (1.64e-2)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (4.19e-4)" "unprognostic (8.52e-2)" "unprognostic (8.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.38e-1)" "unprognostic (2.38e-2)" "unprognostic (1.21e-1)" "unprognostic (1.56e-2)" "unprognostic (1.97e-2)" "unprognostic (4.15e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.7 0.8 0.0 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRCIN1 "KIAA1684, p140Cap, SNIP" ENSG00000277363 "SRC kinase signaling inhibitor 1" Q9C0H9 17 38530016-38605930 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 21.2;salivary gland: 11.7;skin 1: 6.1" "Cell line enhanced" "Detected in some" "Karpas-707: 5.1;SCLC-21H: 16.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009701, HPA063795" Enhanced Approved "Cell Junctions" "Cell Junctions" "HPA009701: AB_1857324, HPA063795: " "unprognostic (4.53e-1)" "unprognostic (4.05e-1)" "unprognostic (2.45e-2)" "unprognostic (3.24e-4)" "unprognostic (4.10e-2)" "unprognostic (3.72e-3)" "unprognostic (1.53e-1)" "unprognostic (2.84e-2)" "unprognostic (9.95e-2)" "unprognostic (1.80e-1)" "unprognostic (1.16e-4)" "unprognostic (1.00e-1)" "unprognostic (5.07e-3)" "unprognostic (9.51e-2)" "unprognostic (6.50e-2)" "unprognostic (2.67e-2)" "prognostic favourable (1.76e-4)" 1.3 2.6 7.9 0.5 9.5 0.6 1.7 16.3 21.2 1.3 0.8 18.4 0.0 1.2 1.0 1.3 0.5 2.1 0.4 0.6 7.0 0.5 1.8 0.8 0.6 9.0 10.5 0.4 1.6 2.2 0.0 0.6 10.2 0.8 0.7 0.5 11.7 1.7 0.9 6.1 0.9 0.5 5.5 0.6 0.9 0.8 10.7 0.0 0.8 0.0 0.4 0.9 0.0 0.3 0.3 1.3 0.2 0.2 0.2 0.0 0.5 0.5 1.2 3.4 0.2 0.0 0.1 0.0 0.1 0.2 0.1 0.6 0.6 1.0 1.1 0.0 1.2 1.5 0.2 0.1 1.2 1.4 0.0 0.5 1.4 0.2 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.1 5.1 0.0 3.1 0.0 0.0 1.6 0.1 0.1 0.0 0.1 0.5 2.5 16.1 2.3 0.0 1.4 0.9 2.5 0.5 0.0 0.0 1.6 0.0 0.0 1.1 0.2 0.1 0.1 0.7 0.7 1.3 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.2 0.2 0.6 0.2 0.0 0.3 0.0 0.0 SSX2IP hMsd1 ENSG00000117155 "SSX family member 2 interacting protein" Q9Y2D8 1 84643707-84690803 "Predicted intracellular proteins" "Cell adhesion, Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 51.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027306, HPA075946" Approved Approved "Cell Junctions" "Cell Junctions" "HPA027306: AB_1857515, HPA075946: " "unprognostic (5.18e-3)" "unprognostic (2.13e-1)" "prognostic favourable (1.45e-4)" "unprognostic (2.83e-2)" "unprognostic (2.75e-1)" "unprognostic (3.29e-2)" "unprognostic (1.28e-3)" "unprognostic (7.73e-2)" "unprognostic (2.38e-1)" "unprognostic (3.37e-2)" "unprognostic (9.49e-2)" "unprognostic (1.39e-1)" "unprognostic (1.96e-2)" "unprognostic (7.23e-3)" "unprognostic (2.08e-2)" "unprognostic (2.45e-2)" "unprognostic (3.46e-2)" 1.8 2.0 10.6 2.8 25.2 6.5 2.7 17.7 25.7 3.9 7.9 1.6 3.0 22.2 5.1 12.4 3.8 3.8 4.6 4.9 9.8 5.0 9.0 7.5 2.2 3.1 3.8 12.4 1.6 3.7 5.6 10.2 3.2 6.9 7.0 4.2 5.2 3.8 6.6 3.1 3.3 13.3 5.6 3.1 2.7 3.7 51.4 5.1 4.8 4.4 1.7 3.2 3.1 3.0 1.5 5.8 4.8 3.2 5.4 11.0 5.0 16.0 8.0 6.4 11.8 2.2 6.9 7.9 27.6 14.2 12.2 9.9 5.7 3.6 15.9 4.9 23.3 9.0 11.4 8.9 17.2 3.1 9.6 15.0 9.7 4.9 4.5 13.0 1.2 2.9 14.7 13.7 8.7 4.1 31.0 6.0 7.7 6.1 9.1 5.2 9.5 12.5 6.2 28.3 7.0 12.8 9.3 12.6 15.8 7.7 12.6 13.8 7.3 6.8 1.2 11.6 17.1 15.8 27.2 6.3 7.5 17.4 9.7 11.7 7.1 1.1 1.1 4.8 11.0 2.4 6.2 1.4 3.7 4.5 4.4 1.5 4.6 6.9 1.5 5.4 3.2 5.8 2.0 5.0 10.6 25.2 17.7 25.7 9.8 5.0 3.8 12.4 6.9 5.1 SYNPO2L FLJ12921 ENSG00000166317 "Synaptopodin 2 like" Q9H987 10 73644881-73663803 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3" "Cell line enhanced" "Detected in some" "CACO-2: 7.5;HSkMC: 6.0;RH-30: 5.8;SK-BR-3: 6.1" "Group enriched" "Detected in some" 6 "breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA055192, HPA057142" Enhanced Supported "Nuclear speckles,Cell Junctions,Cytosol" "Nuclear speckles" "Cell Junctions, Cytosol" "HPA055192: , HPA057142: " "unprognostic (2.75e-1)" "unprognostic (1.58e-1)" "unprognostic (1.20e-3)" "unprognostic (3.65e-3)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (4.54e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-2)" "unprognostic (4.50e-2)" "unprognostic (2.32e-1)" "unprognostic (7.44e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-1)" 3.8 0.1 0.0 0.0 0.1 0.1 1.1 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 3.2 3.3 0.0 0.0 69.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.8 0.0 0.0 1.6 0.0 72.8 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.3 29.3 3.4 0.0 0.3 0.7 1.0 3.0 0.7 0.7 0.7 0.1 0.5 0.1 0.8 0.2 0.1 0.0 1.1 0.9 1.2 0.2 0.0 7.5 0.7 0.3 0.5 0.9 0.1 0.1 0.0 0.4 0.1 0.2 0.3 0.6 0.4 0.6 0.2 0.2 6.0 0.1 1.2 0.1 0.0 0.3 0.3 0.3 0.3 0.2 1.8 0.2 0.7 0.2 5.8 0.2 0.0 0.6 0.3 0.4 0.1 6.1 0.1 0.4 0.7 0.0 0.6 1.0 0.2 0.3 1.0 0.3 0.3 0.2 0.6 0.0 2.9 0.7 0.7 0.7 0.4 0.3 0.5 0.3 0.3 0.2 0.7 0.4 0.4 3.0 0.7 0.4 1.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 TEDC2 "C16orf59, FLJ13909" ENSG00000162062 "Tubulin epsilon and delta complex 2" Q7L2K0 16 2460080-2464963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.3;testis: 12.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051394, HPA055389" Approved Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA051394: , HPA055389: " "unprognostic (3.23e-1)" "unprognostic (1.03e-2)" "unprognostic (2.14e-2)" "unprognostic (7.46e-3)" "unprognostic (1.27e-1)" "unprognostic (1.38e-3)" "prognostic unfavourable (2.43e-5)" "prognostic unfavourable (7.58e-4)" "unprognostic (4.04e-3)" "unprognostic (8.85e-2)" "unprognostic (3.74e-2)" "unprognostic (3.72e-2)" "unprognostic (1.16e-4)" "unprognostic (1.28e-3)" "unprognostic (1.56e-1)" "unprognostic (1.24e-2)" "unprognostic (1.03e-1)" 0.8 1.8 2.3 6.2 4.1 9.3 1.1 2.8 4.6 1.2 2.6 0.8 0.0 4.3 1.2 1.4 4.5 1.2 1.4 1.3 2.3 2.7 2.2 1.7 1.0 5.6 2.1 1.9 1.0 1.9 0.3 2.4 3.8 2.0 1.3 2.2 1.0 1.3 0.8 1.0 2.6 3.8 1.1 1.4 2.5 2.2 12.5 0.8 15.3 0.9 4.2 3.9 0.6 2.2 1.2 1.4 0.0 1.0 0.0 2.1 0.7 5.2 16.6 9.5 11.1 0.1 0.6 9.6 4.2 2.5 6.8 6.6 11.4 4.3 7.3 6.9 1.7 8.1 6.9 4.2 1.6 8.1 9.2 6.5 11.7 11.7 0.2 6.3 8.9 0.6 0.5 6.0 1.6 3.1 11.2 2.8 2.3 10.0 11.1 11.8 21.1 6.0 27.1 8.2 16.4 1.4 2.2 9.0 14.8 4.8 5.1 3.6 7.6 7.4 1.1 7.2 10.5 6.9 9.4 6.2 10.1 14.6 3.7 6.4 9.8 0.0 0.0 0.0 0.1 0.1 0.0 0.6 2.1 0.0 0.3 1.2 0.7 1.3 0.0 0.0 1.0 1.4 1.9 0.7 2.3 4.1 2.8 4.6 2.3 2.7 2.1 1.9 2.0 0.8 TES "DKFZP586B2022, TESS-2, TESTIN" ENSG00000135269 "Testin LIM domain protein" Q9UGI8 7 116210493-116258783 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 50.9;hTCEpi: 57.6;SK-BR-3: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA015269, HPA018123" Approved Supported "Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol" "Focal adhesion sites, Cytosol" "Plasma membrane, Cell Junctions" "HPA015269: AB_1857899, HPA018123: AB_1857900" "unprognostic (9.81e-2)" "unprognostic (5.53e-3)" "unprognostic (4.79e-2)" "unprognostic (1.31e-1)" "unprognostic (4.01e-1)" "unprognostic (6.08e-3)" "unprognostic (1.84e-3)" "unprognostic (4.81e-3)" "unprognostic (8.81e-3)" "unprognostic (6.19e-3)" "prognostic unfavourable (1.20e-5)" "unprognostic (1.60e-2)" "prognostic favourable (8.71e-5)" "unprognostic (1.50e-1)" "unprognostic (5.47e-2)" "unprognostic (2.36e-2)" "unprognostic (3.86e-1)" 12.1 2.9 1.2 36.4 1.5 8.6 22.1 0.8 1.2 42.4 53.1 1.5 43.9 9.3 47.6 21.2 22.6 19.5 15.3 7.9 1.6 1.4 14.3 4.6 16.8 20.3 1.9 0.7 17.1 12.3 3.1 4.2 21.2 3.3 26.1 16.8 5.0 19.0 50.9 5.2 9.1 27.4 84.5 3.0 19.1 25.2 18.4 0.7 17.1 26.3 11.2 18.4 71.6 33.9 26.8 21.9 56.8 39.6 49.0 40.5 34.7 24.2 5.1 5.8 0.0 2.6 6.6 13.7 12.7 6.2 2.3 2.3 12.8 27.0 0.0 50.9 8.8 24.9 3.1 18.6 5.8 12.0 10.0 2.4 12.0 6.3 15.6 11.0 0.0 14.8 57.6 8.2 20.9 6.6 2.4 8.6 0.6 5.0 0.0 0.1 3.8 14.7 0.0 0.0 9.5 24.0 9.3 2.7 25.2 18.5 57.8 14.0 0.0 4.5 11.2 0.1 0.3 18.7 0.1 20.3 9.8 0.2 1.6 5.6 19.2 56.8 20.2 53.4 40.5 32.6 39.0 26.8 31.0 36.6 21.9 23.8 31.0 35.0 10.5 49.0 39.6 5.4 31.5 34.7 1.2 1.5 0.8 1.2 1.6 1.4 1.9 0.7 3.3 0.7 TEX14 CT113 ENSG00000121101 "Testis expressed 14, intercellular bridge forming factor" Q8IWB6 17 58556678-58692055 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "testis: 52.7" "Cell line enhanced" "Detected in some" "HDLM-2: 8.9;Karpas-707: 11.6;MCF7: 4.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030620, HPA077020" Enhanced Approved "Vesicles,Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cytosol" "Vesicles, Cell Junctions" "HPA030620: AB_10601598, HPA077020: " "unprognostic (1.21e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-1)" "unprognostic (9.49e-2)" "unprognostic (2.48e-1)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (6.17e-2)" "unprognostic (2.07e-2)" "unprognostic (1.61e-3)" "unprognostic (2.67e-2)" "unprognostic (8.10e-2)" "unprognostic (1.76e-9)" "unprognostic (1.77e-1)" "unprognostic (2.54e-1)" "unprognostic (5.00e-3)" "unprognostic (5.88e-2)" 0.1 0.1 0.2 0.1 0.3 1.5 0.1 0.9 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.5 0.2 0.0 52.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.2 0.1 0.0 0.2 2.5 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.2 0.0 0.0 0.3 0.0 0.2 8.9 1.3 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.0 0.0 0.1 11.6 0.0 4.7 0.4 0.1 0.6 0.1 0.5 0.4 1.7 0.0 0.1 1.4 0.2 0.0 0.0 0.6 0.4 0.1 0.0 0.1 0.3 0.0 0.0 2.0 0.5 1.1 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.8 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.9 0.2 0.3 0.2 0.2 0.1 0.4 0.1 TMEM141 MGC14141 ENSG00000244187 "Transmembrane protein 141" Q96I45 9 136791355-136793257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014615, HPA050244" Approved Supported "Cell Junctions,Mitochondria" Mitochondria "Cell Junctions" "HPA014615: AB_2204756, HPA050244: " "unprognostic (2.05e-1)" "unprognostic (1.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (2.00e-1)" "unprognostic (8.53e-3)" "unprognostic (1.52e-2)" "unprognostic (3.15e-2)" "unprognostic (2.38e-1)" "unprognostic (1.94e-2)" "unprognostic (2.24e-1)" "unprognostic (8.45e-2)" "prognostic favourable (6.63e-4)" "unprognostic (1.49e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-1)" "unprognostic (1.70e-1)" 10.0 15.5 15.7 23.4 15.3 15.5 22.9 11.6 28.3 17.2 54.4 21.0 22.4 21.9 9.4 31.1 35.5 22.6 27.9 22.8 15.2 12.2 38.5 43.4 14.4 23.0 19.9 19.3 13.8 46.3 20.6 23.1 31.7 22.0 49.0 51.4 12.5 32.5 27.5 13.5 22.0 25.6 10.5 19.1 14.1 23.3 16.5 13.8 16.3 28.6 26.0 15.2 16.4 16.3 11.1 42.7 9.0 19.4 12.4 11.3 12.2 16.0 11.6 10.4 6.5 13.1 10.6 22.5 9.1 14.2 11.2 9.0 15.3 14.6 15.4 14.2 9.8 23.9 4.4 26.5 3.6 11.2 8.0 8.6 6.5 17.1 19.2 8.9 10.8 10.1 45.5 8.6 24.4 16.7 8.5 8.3 14.7 32.7 12.2 6.9 5.0 13.1 10.2 11.0 45.3 25.5 9.0 17.5 7.9 9.8 37.2 10.2 66.4 8.7 11.4 8.0 6.4 14.6 5.9 5.4 8.4 8.2 12.1 12.9 11.5 6.5 13.8 9.0 11.3 19.4 10.2 8.7 7.9 8.1 11.2 11.1 10.9 10.0 3.3 12.4 16.0 42.7 7.5 12.2 15.7 15.3 11.6 28.3 15.2 12.2 19.9 19.3 22.0 13.8 TMEM164 "FLJ22679, RP13-360B22.2" ENSG00000157600 "Transmembrane protein 164" Q5U3C3 X 110002631-110182734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 69.7" "Cell line enhanced" "Detected in all" "HMC-1: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 25.9;eosinophil: 7.2;neutrophil: 8.8" "Lineage enriched" "Detected in many" 15 "granulocytes: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038784 Approved Approved "Vesicles,Cell Junctions" Vesicles "Cell Junctions" "HPA038784: AB_10670790" "unprognostic (2.14e-3)" "unprognostic (3.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.65e-3)" "unprognostic (7.94e-2)" "unprognostic (3.97e-2)" "prognostic unfavourable (8.17e-6)" "unprognostic (9.85e-3)" "unprognostic (5.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-2)" "unprognostic (3.95e-1)" "unprognostic (7.66e-2)" "prognostic favourable (3.14e-4)" "unprognostic (1.76e-1)" "unprognostic (1.81e-2)" "unprognostic (4.19e-3)" 15.0 8.6 9.2 6.1 10.9 11.1 9.2 2.6 6.8 3.9 17.0 6.0 36.3 14.5 4.5 4.1 10.5 5.5 8.8 14.7 6.6 5.9 8.4 1.7 35.8 7.6 4.6 3.5 11.9 17.2 11.1 8.7 6.6 7.0 6.2 14.8 18.7 7.6 69.7 32.0 15.2 33.1 4.6 2.9 6.9 9.9 2.2 5.1 4.5 11.4 6.0 5.8 5.0 5.1 0.4 1.4 25.9 1.7 1.1 0.9 0.8 4.7 10.9 9.0 5.8 11.1 8.2 5.5 2.4 5.6 5.1 3.3 8.5 7.5 3.8 16.3 3.7 7.0 7.7 12.6 5.0 10.5 5.3 25.9 5.9 3.5 6.6 11.4 37.1 11.3 22.3 9.1 12.7 9.9 8.0 4.6 9.0 9.5 11.9 14.5 8.0 7.9 5.5 6.9 3.2 8.1 5.0 8.4 9.4 15.3 15.1 7.0 4.4 11.4 22.0 4.3 3.2 5.0 3.4 2.7 3.4 3.1 11.3 14.3 11.5 25.9 1.7 7.2 0.3 1.5 0.9 0.1 0.4 0.3 1.4 0.4 0.2 0.3 8.8 1.1 0.9 0.2 0.5 0.8 9.2 10.9 2.6 6.8 6.6 5.9 4.6 3.5 7.0 5.1 TMEM183A C1orf37 ENSG00000163444 "Transmembrane protein 183A" Q8IXX5 1 203007386-203024848 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072607 Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA072607: " "unprognostic (2.94e-3)" "unprognostic (1.60e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-2)" "unprognostic (5.99e-2)" "prognostic unfavourable (2.62e-4)" "unprognostic (6.46e-2)" "unprognostic (3.21e-2)" "unprognostic (4.82e-3)" "unprognostic (5.28e-2)" "unprognostic (7.84e-2)" "unprognostic (4.83e-2)" "unprognostic (6.01e-3)" "unprognostic (9.55e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" 12.2 12.6 22.4 13.5 20.8 50.1 17.2 31.9 30.4 14.4 21.1 12.4 6.7 20.0 13.6 15.2 19.3 12.0 15.0 11.5 19.8 21.0 16.0 21.1 13.4 20.2 19.3 14.8 15.0 29.9 12.0 8.2 10.9 20.8 15.0 23.6 11.1 22.2 13.6 8.8 16.1 18.8 17.6 12.4 14.5 15.8 27.7 12.3 23.3 20.5 14.8 17.7 15.3 20.7 17.4 27.2 35.6 24.4 26.4 23.7 24.3 12.7 12.4 15.9 26.1 21.1 15.9 26.3 12.8 12.7 14.9 13.1 15.0 13.5 31.8 9.3 16.5 16.1 21.3 18.0 12.4 10.3 25.9 15.7 14.5 16.5 15.3 28.1 13.8 15.5 20.0 12.2 24.8 18.7 32.2 11.6 13.8 28.4 22.9 28.9 43.7 19.8 17.7 27.2 25.6 23.0 12.5 20.5 25.7 19.2 32.0 18.4 22.9 22.2 13.8 10.1 14.1 17.2 14.0 11.8 18.9 24.7 11.1 21.9 10.6 21.1 24.4 35.6 18.1 20.4 17.9 16.6 20.5 20.5 27.2 17.4 23.7 19.3 21.3 26.4 18.5 19.5 21.2 24.3 22.4 20.8 31.9 30.4 19.8 21.0 19.3 14.8 20.8 12.3 TMEM186 "C16orf51, DKFZP564K2062" ENSG00000184857 "Transmembrane protein 186" Q96B77 16 8780384-8797648 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018226, HPA063559" Uncertain Approved "Cell Junctions" "Cell Junctions" "HPA018226: AB_1845579, HPA063559: " "unprognostic (3.49e-1)" "unprognostic (1.07e-2)" "unprognostic (1.11e-2)" "unprognostic (2.98e-2)" "unprognostic (4.81e-2)" "unprognostic (1.18e-1)" "unprognostic (2.32e-2)" "unprognostic (2.08e-2)" "unprognostic (8.06e-2)" "unprognostic (9.35e-2)" "unprognostic (2.45e-1)" "unprognostic (3.99e-2)" "prognostic favourable (1.93e-8)" "unprognostic (1.06e-1)" "unprognostic (3.73e-2)" "unprognostic (1.70e-1)" "unprognostic (3.89e-2)" 6.6 12.0 8.2 6.2 10.4 1.9 11.0 5.4 13.2 7.4 10.6 8.2 9.4 10.1 11.0 14.2 9.6 10.4 9.7 11.5 7.4 7.6 9.6 15.9 6.2 8.2 9.1 12.6 9.7 11.8 16.3 11.8 8.4 7.8 8.4 12.5 10.4 14.0 8.4 16.9 8.8 9.2 15.1 10.3 10.1 9.1 11.7 6.2 7.0 11.9 7.7 11.0 10.4 6.2 14.3 10.4 11.8 13.8 9.5 17.2 8.4 6.7 10.6 7.9 10.0 13.6 7.2 7.5 7.8 8.0 10.3 8.5 10.2 11.3 20.6 6.7 5.7 13.0 14.0 11.0 11.8 11.9 13.5 8.6 13.7 21.8 15.3 9.6 7.0 8.7 18.8 11.3 16.6 9.3 14.7 11.3 5.9 18.2 7.3 9.4 10.0 9.3 15.6 10.4 22.5 10.9 5.8 12.2 11.6 10.6 15.1 9.1 18.1 7.8 5.9 7.3 10.3 18.0 6.4 10.4 11.0 10.0 11.4 17.6 5.8 11.8 10.0 7.5 9.4 9.6 12.5 14.3 10.0 10.6 10.4 12.7 17.2 13.2 4.8 9.5 13.8 8.1 13.0 8.4 8.2 10.4 5.4 13.2 7.4 7.6 9.1 12.6 7.8 6.2 TMEM251 "C14orf109, DKFZP564F1123" ENSG00000153485 "Transmembrane protein 251" Q8N6I4 14 93184951-93187089 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048559 Uncertain Approved "Golgi apparatus,Cell Junctions" "Cell Junctions" "Golgi apparatus" "HPA048559: " "unprognostic (1.21e-2)" "unprognostic (4.56e-2)" "unprognostic (4.61e-3)" "unprognostic (3.37e-2)" "unprognostic (2.14e-1)" "unprognostic (4.03e-2)" "prognostic unfavourable (6.14e-7)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (9.99e-3)" "unprognostic (5.80e-3)" "unprognostic (1.58e-1)" "prognostic favourable (1.10e-4)" "unprognostic (5.17e-2)" "unprognostic (1.61e-1)" "unprognostic (7.47e-2)" "unprognostic (6.17e-2)" 15.8 19.5 12.2 10.7 14.3 3.9 23.1 11.5 14.2 21.9 19.6 11.4 19.6 15.5 13.0 26.2 10.8 15.8 11.5 23.2 12.2 12.8 25.0 14.4 24.1 19.1 19.0 11.1 12.4 23.6 16.4 17.2 12.5 15.8 26.1 19.5 18.3 18.7 18.5 22.6 10.4 17.9 11.5 17.3 13.3 16.5 8.7 15.1 14.2 19.4 11.0 11.7 13.3 11.8 6.0 8.7 13.7 12.7 5.4 6.6 4.4 7.0 7.5 10.1 10.6 11.7 4.6 6.8 4.9 5.8 8.6 11.1 5.3 7.4 8.0 10.0 4.7 9.5 10.9 8.0 11.7 7.3 8.5 6.8 5.6 10.6 11.1 9.5 11.0 6.1 9.2 6.9 11.1 8.6 5.6 7.9 6.9 33.7 6.8 7.7 5.9 8.1 4.1 10.1 7.1 10.7 14.3 9.7 9.1 7.4 4.1 29.0 11.2 6.9 3.8 4.3 7.0 9.0 6.2 10.5 12.5 8.2 8.1 4.0 6.5 4.8 10.8 13.7 4.7 9.7 3.1 5.3 5.5 5.3 8.7 6.0 6.1 6.6 10.7 5.4 12.7 7.6 4.4 4.4 12.2 14.3 11.5 14.2 12.2 12.8 19.0 11.1 15.8 15.1 TNK1 ENSG00000174292 "Tyrosine kinase non receptor 1" Q13470 17 7380534-7389774 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 6.4;HaCaT: 10.4;HBEC3-KT: 6.9;hTCEpi: 7.8;T-47d: 8.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 6.4;cerebellum: 11.4;cerebral cortex: 4.0;pons and medulla: 4.3" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 1.6;T-cells: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA012065, HPA056452" Uncertain Approved "Cell Junctions" "Cell Junctions" "HPA012065: AB_1858165, HPA056452: " "unprognostic (4.90e-2)" "unprognostic (1.93e-1)" "unprognostic (2.95e-1)" "prognostic favourable (4.28e-4)" "unprognostic (2.84e-1)" "unprognostic (1.60e-1)" "unprognostic (1.41e-2)" "unprognostic (3.65e-1)" "unprognostic (2.20e-1)" "unprognostic (2.52e-2)" "unprognostic (2.43e-1)" "unprognostic (3.10e-1)" "prognostic favourable (6.40e-4)" "unprognostic (1.77e-3)" "unprognostic (1.61e-1)" "unprognostic (1.38e-1)" "prognostic favourable (1.52e-4)" 3.4 0.6 1.1 2.2 6.4 0.4 7.9 11.4 4.0 5.4 11.7 0.4 7.7 7.1 5.1 5.3 7.2 3.5 6.3 2.0 1.0 0.4 4.6 6.9 3.2 2.7 1.5 0.8 4.4 6.8 5.4 2.7 2.5 4.3 8.9 4.5 7.7 10.5 4.8 1.8 8.3 11.3 5.1 0.7 2.4 9.6 2.2 0.6 0.6 11.6 5.7 5.2 4.5 4.4 1.6 0.1 0.4 0.0 0.0 3.8 0.6 6.4 1.0 0.2 0.4 0.0 0.0 4.3 0.2 0.0 0.4 0.4 3.3 3.0 0.0 2.6 0.3 10.4 0.0 6.9 0.1 0.7 1.5 0.0 3.7 1.8 0.4 0.0 0.2 0.1 7.8 0.0 1.2 0.0 0.8 0.0 0.0 4.9 0.6 0.0 0.9 0.9 0.2 0.2 0.7 4.8 3.0 0.2 0.5 3.5 5.2 1.0 8.6 0.1 1.7 0.2 0.8 0.2 0.0 0.5 1.0 0.1 0.1 0.4 0.5 0.0 0.0 0.0 1.0 0.0 1.9 1.6 1.8 1.2 0.1 1.5 3.3 3.8 0.4 0.0 0.0 0.0 0.8 0.6 1.1 6.4 11.4 4.0 1.0 0.4 1.5 0.8 4.3 0.6 TPD52L1 "D53, hD53" ENSG00000111907 "Tumor protein D52 like 1" Q16890 6 125119049-125264407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 95.2;salivary gland: 104.6" "Cell line enhanced" "Detected in many" "AN3-CA: 51.4;hTCEpi: 45.3;MCF7: 67.2;RPTEC TERT1: 52.1;SK-BR-3: 36.3;T-47d: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027915, HPA027916" Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions, Cytosol" "HPA027915: AB_10602074, HPA027916: AB_10601860" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (2.76e-2)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (2.87e-2)" "unprognostic (1.38e-2)" "unprognostic (2.14e-1)" "unprognostic (7.85e-2)" "unprognostic (7.80e-2)" "unprognostic (9.42e-3)" "unprognostic (1.76e-1)" "prognostic favourable (3.26e-4)" "unprognostic (1.06e-1)" "unprognostic (6.83e-2)" "prognostic favourable (3.97e-4)" "prognostic unfavourable (5.34e-4)" 10.3 95.2 31.5 4.3 47.5 1.0 25.7 2.6 32.9 10.5 8.5 9.2 31.0 4.3 6.2 27.6 43.3 13.9 10.8 26.0 21.4 9.5 11.7 22.0 4.7 2.9 15.4 12.8 9.0 18.0 10.3 8.7 4.0 16.1 16.6 5.8 13.0 104.6 32.7 34.4 11.8 4.6 27.1 5.5 1.4 10.3 2.6 18.2 0.0 23.5 20.1 11.0 18.1 14.6 1.1 0.9 5.9 1.2 5.3 1.7 1.0 6.9 7.9 0.0 51.4 0.4 0.1 12.2 1.1 1.1 0.0 0.1 12.5 8.9 0.0 26.4 5.8 15.9 1.5 11.0 0.0 0.1 11.0 0.1 11.0 0.1 1.1 0.0 0.0 1.4 45.3 0.0 5.9 0.0 5.5 0.1 0.9 67.2 0.0 0.1 0.8 4.3 0.0 0.0 0.0 52.1 1.8 1.7 0.0 13.3 36.3 0.8 31.0 0.1 0.0 0.3 1.1 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 2.7 1.2 0.8 0.8 0.6 0.8 0.8 1.3 0.6 0.5 1.1 1.7 1.2 5.9 5.3 0.3 0.9 0.4 1.0 31.5 47.5 2.6 32.9 21.4 9.5 15.4 12.8 16.1 18.2 TRIM38 "RNF15, RORET" ENSG00000112343 "Tripartite motif containing 38" O00635 6 25962802-25991226 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA031685 Approved Approved "Plasma membrane,Cell Junctions,Centrosome" Centrosome "Plasma membrane, Cell Junctions" "HPA031685: AB_10603218" "unprognostic (6.62e-2)" "unprognostic (1.65e-3)" "unprognostic (3.34e-1)" "unprognostic (2.72e-2)" "unprognostic (1.25e-1)" "unprognostic (6.51e-2)" "unprognostic (7.79e-2)" "unprognostic (3.27e-2)" "unprognostic (2.78e-2)" "prognostic favourable (8.95e-5)" "unprognostic (2.81e-2)" "unprognostic (6.28e-2)" "unprognostic (2.73e-1)" "unprognostic (3.36e-1)" "unprognostic (4.49e-2)" "prognostic favourable (8.20e-5)" "prognostic favourable (4.94e-9)" 13.3 8.4 2.5 15.7 2.3 12.0 7.9 1.1 3.4 17.2 12.1 3.1 20.5 6.7 26.2 22.3 15.7 8.9 9.2 5.8 2.8 2.3 26.1 8.8 14.0 14.4 3.7 1.8 11.5 4.3 1.0 4.3 10.3 3.5 15.5 7.8 9.2 9.8 16.5 9.0 5.3 14.6 13.1 4.5 17.6 6.6 5.3 2.9 16.6 13.7 9.5 20.1 18.0 15.4 16.5 10.1 12.1 12.9 6.7 7.9 6.3 3.5 2.0 0.3 4.3 10.3 13.9 3.6 4.5 8.9 8.7 14.5 1.5 3.8 7.9 7.4 5.5 5.6 2.7 4.4 5.2 7.9 1.8 3.5 3.3 1.4 13.7 4.2 7.4 13.8 3.2 5.4 1.9 7.5 2.3 4.4 10.3 1.7 4.0 4.8 1.4 2.7 6.2 4.3 8.2 10.4 7.0 0.1 0.1 3.4 7.1 12.0 1.0 5.5 7.7 1.6 2.7 2.7 3.0 5.1 3.7 8.9 4.2 5.2 9.6 10.1 10.6 4.7 7.6 12.9 7.4 14.3 6.5 6.8 10.1 16.5 6.2 6.7 12.1 6.7 11.4 9.5 7.9 6.3 2.5 2.3 1.1 3.4 2.8 2.3 3.7 1.8 3.5 2.9 TRMT6 "CGI-09, GCD10, Gcd10p, MGC5029" ENSG00000089195 "TRNA methyltransferase 6" Q9UJA5 20 5937235-5950558 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047032, HPA050408" Approved Enhanced "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA047032: , HPA050408: " "unprognostic (1.78e-1)" "unprognostic (4.51e-2)" "unprognostic (1.65e-1)" "unprognostic (4.26e-2)" "unprognostic (2.11e-1)" "unprognostic (6.81e-2)" "prognostic unfavourable (4.70e-12)" "unprognostic (5.37e-2)" "unprognostic (3.53e-2)" "unprognostic (1.14e-1)" "unprognostic (6.27e-2)" "unprognostic (1.22e-1)" "unprognostic (7.65e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" 10.5 12.9 10.5 11.3 12.1 20.6 8.5 15.0 10.5 7.3 7.4 5.7 47.8 5.1 9.1 7.9 11.9 7.9 5.6 13.2 8.4 9.5 10.2 10.1 7.2 13.2 8.3 11.8 9.6 9.6 9.8 13.9 9.4 13.6 7.2 8.2 5.1 8.2 33.9 24.4 9.9 8.6 8.0 8.2 12.2 7.5 15.5 7.9 10.3 8.7 10.6 12.7 8.8 7.9 9.2 17.8 5.9 8.7 13.9 11.6 7.1 25.2 12.5 8.4 12.9 4.8 6.2 11.7 12.2 6.2 11.9 10.0 16.4 11.2 30.1 6.4 6.7 19.4 16.8 19.3 20.0 6.2 11.7 24.8 5.8 14.7 9.3 22.7 6.5 6.1 10.2 21.2 16.0 5.0 14.9 9.4 13.7 7.0 23.6 12.4 19.0 15.7 15.7 16.7 16.5 8.1 16.1 16.4 25.4 14.8 19.2 19.5 10.2 11.1 4.9 14.2 13.2 13.0 24.4 15.3 29.5 35.3 6.2 18.8 13.8 2.0 7.9 5.9 9.6 8.7 11.0 9.2 10.8 11.6 17.8 8.2 11.2 11.6 0.8 13.9 7.6 8.1 11.3 7.1 10.5 12.1 15.0 10.5 8.4 9.5 8.3 11.8 13.6 7.9 TSPAN6 "T245, TM4SF6, TSPAN-6" ENSG00000000003 "Tetraspanin 6" O43657 X 100627109-100639991 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 88.4" "Cell line enhanced" "Detected in many" "NTERA-2: 42.7;RT4: 64.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "pons and medulla: 34.2" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.6" "Lineage enriched" "Detected in single" 8 "T-cells: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004109 Approved Approved "Nucleoli fibrillar center,Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "Nucleoli fibrillar center" "HPA004109: AB_1080301" "unprognostic (7.71e-2)" "unprognostic (8.97e-2)" "unprognostic (3.56e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-3)" "unprognostic (5.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-3)" "unprognostic (2.04e-3)" "unprognostic (8.76e-2)" "unprognostic (3.83e-3)" "unprognostic (4.28e-2)" "unprognostic (1.14e-1)" "unprognostic (2.24e-1)" "unprognostic (9.54e-3)" 27.0 9.8 7.0 4.4 6.6 0.1 33.0 2.9 4.9 15.9 17.8 12.6 6.4 9.7 11.1 10.4 27.1 24.2 10.0 5.7 7.4 7.3 26.7 68.2 8.3 3.6 6.9 4.1 27.6 25.1 19.6 17.7 23.6 34.2 15.5 20.3 16.7 88.4 6.7 3.5 4.7 11.6 4.7 10.4 8.6 8.0 17.5 6.6 2.9 24.6 11.0 19.8 17.2 11.5 0.3 0.2 0.8 0.2 0.3 6.6 1.4 7.8 10.5 28.3 14.3 12.4 6.7 11.5 4.5 7.0 8.9 20.8 23.5 13.7 0.0 18.8 4.6 6.4 0.1 8.5 10.5 0.0 15.2 1.4 6.8 26.1 6.9 0.0 1.1 13.2 4.1 7.8 3.0 18.9 0.0 0.0 9.1 8.1 0.0 0.1 42.7 7.9 0.0 13.4 0.0 13.9 64.4 1.8 7.7 4.4 3.9 6.0 5.7 1.0 5.3 5.6 8.5 9.1 2.9 0.0 0.0 0.0 4.9 0.0 3.9 0.5 0.1 0.2 1.0 0.1 3.5 0.3 2.4 0.8 0.0 0.2 6.6 3.8 0.8 0.3 0.2 0.2 0.1 1.4 7.0 6.6 2.9 4.9 7.4 7.3 6.9 4.1 34.2 6.6 TSR2 "DT1P1A10, RP1-112K5.2, WGG1" ENSG00000158526 "TSR2, ribosome maturation factor" Q969E8 X 54440401-54445487 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030514 Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" "Nucleoplasm, Nucleoli" "Cell Junctions, Cytosol" "HPA030514: AB_10603457" "unprognostic (1.05e-1)" "unprognostic (1.80e-2)" "unprognostic (1.77e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-2)" "unprognostic (5.91e-2)" "unprognostic (7.15e-3)" "unprognostic (8.29e-2)" "unprognostic (4.39e-1)" "unprognostic (1.31e-1)" "unprognostic (2.94e-2)" "unprognostic (6.19e-2)" "prognostic favourable (1.21e-6)" "unprognostic (2.27e-1)" "unprognostic (1.13e-1)" "unprognostic (7.93e-3)" "unprognostic (1.80e-3)" 20.8 25.0 52.9 13.8 53.1 15.3 19.2 27.6 44.3 18.2 17.2 30.8 16.9 13.9 18.4 33.9 16.2 21.1 14.8 22.2 45.3 46.2 26.5 23.7 17.5 14.9 53.8 34.4 22.9 17.2 30.7 19.0 19.8 31.0 20.8 20.6 19.0 16.6 25.4 35.5 17.2 14.7 19.7 54.3 18.1 16.5 8.4 27.5 10.2 23.9 10.8 22.0 17.7 16.8 39.6 15.4 28.7 21.2 24.7 41.4 21.1 20.4 26.2 19.2 17.4 17.3 12.5 17.1 20.3 16.5 18.9 16.3 24.7 22.4 22.4 14.1 17.7 21.2 46.9 28.1 25.3 29.1 23.2 18.2 19.6 19.2 10.7 31.5 19.1 11.6 15.4 26.4 27.3 13.2 18.5 16.8 19.2 37.5 24.0 24.8 30.5 29.8 21.6 35.7 18.9 20.1 18.2 24.2 16.8 38.6 19.3 21.5 39.3 11.0 17.9 13.9 24.5 29.2 17.3 18.0 27.1 26.8 20.5 25.1 20.8 24.5 15.3 28.7 35.1 20.5 28.8 38.7 33.3 31.8 13.9 39.6 41.4 31.7 9.4 24.7 21.2 15.4 35.5 21.1 52.9 53.1 27.6 44.3 45.3 46.2 53.8 34.4 31.0 27.5 TSSK4 "C14orf20, STK22E" ENSG00000139908 "Testis specific serine kinase 4" Q6SA08 14 24205697-24208362 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 46.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA060660, HPA077103" Approved Approved "Cell Junctions" "Cell Junctions" "HPA060660: , HPA077103: " "unprognostic (1.95e-1)" "unprognostic (4.30e-2)" "unprognostic (1.52e-1)" "unprognostic (5.69e-2)" "unprognostic (2.36e-1)" "unprognostic (3.38e-5)" "unprognostic (1.06e-1)" "unprognostic (6.25e-3)" "unprognostic (1.64e-1)" "unprognostic (3.39e-1)" "unprognostic (7.03e-3)" "unprognostic (1.27e-3)" "unprognostic (3.42e-1)" "unprognostic (4.30e-2)" "unprognostic (6.28e-2)" "unprognostic (8.98e-2)" "unprognostic (7.26e-2)" 0.6 0.9 0.6 1.7 0.6 3.1 0.6 1.5 1.8 0.6 0.6 0.6 0.6 1.5 0.8 0.9 1.4 0.8 1.7 0.6 0.6 0.4 0.6 0.6 0.8 2.8 0.6 0.6 0.8 0.9 0.0 0.6 0.6 0.6 0.6 0.0 0.6 1.4 0.6 1.0 4.7 1.6 0.6 0.6 1.5 0.6 46.1 0.6 0.6 1.4 0.6 0.6 1.0 0.6 2.1 1.7 2.0 1.0 1.8 2.0 0.7 1.0 4.0 3.9 1.5 0.1 0.0 4.3 1.6 0.1 0.0 0.0 2.1 3.7 3.1 0.9 0.1 3.8 0.0 0.1 0.0 1.6 3.0 3.4 4.8 3.0 0.0 1.5 3.7 0.0 0.0 0.0 0.6 0.1 1.3 2.0 0.0 3.8 3.6 1.6 0.7 3.2 2.9 1.5 2.6 0.0 5.2 2.2 2.0 2.7 2.5 0.8 1.6 1.7 1.4 2.9 1.8 3.7 1.3 4.2 4.8 4.7 1.0 2.8 0.9 0.0 1.0 2.0 2.0 1.0 0.7 2.0 1.6 1.6 0.6 2.1 1.6 1.7 2.0 1.8 0.9 1.7 0.7 0.7 0.6 0.6 1.5 0.6 0.6 0.4 0.6 0.6 0.6 0.6 UBALD1 FAM100A ENSG00000153443 "UBA like domain containing 1" Q8TB05 16 4608883-4615027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066771 Approved Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA066771: " "unprognostic (7.09e-2)" "unprognostic (2.21e-2)" "unprognostic (1.55e-1)" "unprognostic (7.67e-3)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.54e-1)" "unprognostic (4.37e-3)" "unprognostic (2.63e-3)" "unprognostic (8.06e-2)" "unprognostic (1.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.99e-2)" "unprognostic (6.20e-2)" "unprognostic (1.35e-2)" 23.0 16.7 20.5 17.9 25.0 37.5 11.9 32.4 39.2 12.1 19.3 15.1 11.7 23.7 20.4 11.0 15.0 13.9 12.4 14.8 20.9 14.2 19.6 32.9 15.7 13.8 12.0 22.2 14.8 27.2 9.0 12.1 27.9 16.9 18.9 5.3 13.6 19.4 18.1 38.3 16.7 19.5 14.2 11.5 23.9 25.9 13.2 13.0 9.9 17.3 11.3 11.6 17.8 12.8 1.9 2.8 11.3 4.5 1.5 2.6 1.5 5.4 15.7 3.7 5.9 2.5 3.3 16.8 8.2 3.4 3.2 4.6 7.7 6.4 8.1 9.2 2.5 15.0 2.4 8.4 0.9 17.0 23.9 7.6 16.4 11.9 5.2 4.7 13.0 4.6 6.3 4.9 2.4 3.4 11.4 8.5 1.2 26.8 7.8 25.7 14.0 13.9 11.3 4.6 26.2 2.8 7.9 10.9 10.0 9.7 15.0 12.9 9.6 7.7 10.0 6.5 7.3 25.8 5.3 16.6 13.3 9.1 2.6 6.4 3.3 1.3 2.3 11.3 2.5 3.5 1.6 1.9 2.0 2.6 2.8 1.8 2.1 2.2 3.9 1.5 4.5 1.8 2.4 1.5 20.5 25.0 32.4 39.2 20.9 14.2 12.0 22.2 16.9 13.0 VCAM1 CD106 ENSG00000162692 "Vascular cell adhesion molecule 1" P19320 1 100719742-100739045 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "kidney: 69.6;lymphoid tissue: 129.2" "Group enriched" "Detected in some" 5 "HHSteC: 56.9;HSkMC: 38.0" "Cancer enriched" "Detected in all" 8 "renal cancer: 89.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "gdT-cell: 1.3;memory CD8 T-cell: 2.9;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 17 "T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000154, HPA034796, HPA069867" Enhanced Approved "Cell Junctions" 960000000 "Cell Junctions" "CAB000154: , HPA034796: , HPA069867: " "unprognostic (2.96e-1)" "prognostic favourable (3.82e-4)" "unprognostic (1.31e-1)" "unprognostic (7.49e-3)" "unprognostic (1.04e-1)" "prognostic favourable (7.19e-5)" "unprognostic (1.60e-2)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (1.20e-1)" "unprognostic (3.95e-2)" "unprognostic (8.23e-2)" "unprognostic (1.80e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.55e-2)" 10.9 18.1 1.5 20.2 3.2 1.3 5.2 0.9 1.1 3.7 5.0 3.3 1.4 3.3 4.9 4.5 5.3 4.9 6.8 7.2 1.7 2.3 69.6 11.8 9.8 26.8 2.8 1.7 11.1 6.6 10.6 3.5 10.9 4.2 8.3 5.5 15.3 4.9 1.1 4.7 1.8 6.3 4.2 3.7 129.2 3.0 2.5 1.6 13.3 3.5 2.8 20.9 8.2 2.8 0.0 0.1 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.2 0.1 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 8.2 0.0 0.0 0.0 0.0 56.9 0.0 0.0 38.0 0.0 10.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 2.9 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 3.2 0.9 1.1 1.7 2.3 2.8 1.7 4.2 1.6 VPS13B "CHS1, COH1" ENSG00000132549 "Vacuolar protein sorting 13 homolog B" Q7Z7G8 8 99013266-99877580 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043865 Approved "Cell Junctions" "Cell Junctions" "HPA043865: " "unprognostic (4.23e-2)" "unprognostic (1.98e-2)" "unprognostic (1.02e-1)" "unprognostic (3.60e-3)" "unprognostic (5.72e-2)" "unprognostic (6.08e-3)" "unprognostic (1.95e-1)" "unprognostic (1.62e-1)" "unprognostic (1.94e-1)" "unprognostic (1.65e-3)" "unprognostic (8.60e-2)" "unprognostic (5.95e-2)" "unprognostic (6.52e-2)" "unprognostic (5.19e-2)" "unprognostic (1.59e-1)" "unprognostic (8.93e-3)" "unprognostic (2.90e-1)" 11.3 10.5 9.6 13.8 10.4 22.1 10.3 13.4 11.8 12.4 9.3 6.6 10.8 4.8 22.4 8.0 10.4 11.6 8.8 7.9 8.7 4.7 7.9 6.2 12.3 12.5 9.9 7.4 16.5 8.1 18.3 21.2 7.9 8.5 10.0 7.5 6.5 9.9 9.6 8.4 11.0 9.6 18.4 11.0 9.8 8.8 10.7 8.4 15.6 9.5 4.9 10.7 12.5 11.8 5.0 1.0 9.8 3.3 1.0 2.9 0.8 8.0 5.8 7.0 5.2 13.2 16.0 3.5 5.2 9.5 5.2 6.9 3.4 4.1 4.4 6.8 8.8 3.7 4.8 4.8 9.5 7.2 4.4 9.7 6.1 2.6 4.3 4.6 7.2 10.3 4.5 8.3 12.0 7.4 7.3 12.0 5.9 4.9 9.6 2.7 2.2 2.1 7.8 5.0 8.4 3.5 7.6 2.1 5.8 8.0 3.9 3.9 6.9 5.3 10.2 7.8 7.3 6.9 4.4 4.9 5.5 12.1 5.9 7.6 5.4 3.5 1.9 4.3 2.1 1.7 1.9 5.0 1.8 1.6 0.8 2.9 2.9 1.9 9.8 1.0 3.3 1.0 2.1 0.8 9.6 10.4 13.4 11.8 8.7 4.7 9.9 7.4 8.5 8.4 VPS36 "C13orf9, CGI-145, Eap45" ENSG00000136100 "Vacuolar protein sorting 36 homolog" Q86VN1 13 52412602-52450628 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039734, HPA043947" Approved Supported "Vesicles,Lysosomes,Plasma membrane,Cell Junctions" "Vesicles, Lysosomes" "Plasma membrane, Cell Junctions" "HPA039734: , HPA043947: " "unprognostic (2.43e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-1)" "unprognostic (2.94e-1)" "unprognostic (1.56e-1)" "unprognostic (2.32e-1)" "unprognostic (6.57e-2)" "unprognostic (7.84e-2)" "unprognostic (3.96e-3)" "unprognostic (1.19e-2)" "unprognostic (9.37e-2)" "unprognostic (5.57e-2)" "prognostic favourable (9.91e-6)" "unprognostic (6.47e-3)" "unprognostic (1.83e-1)" "unprognostic (1.94e-1)" "unprognostic (9.83e-2)" 16.4 14.5 16.5 15.9 22.3 7.0 23.5 36.8 27.7 17.1 21.1 13.6 12.8 23.8 22.4 12.9 24.6 16.6 18.0 20.3 15.4 13.0 22.6 20.2 17.5 15.6 16.2 18.5 20.0 19.0 14.4 20.1 21.7 25.9 20.1 24.7 18.2 21.6 18.3 23.4 44.6 27.9 23.7 13.8 22.3 15.7 4.2 13.8 18.1 20.0 16.8 18.1 20.3 21.7 14.4 14.9 13.9 19.2 19.4 19.3 11.8 3.7 6.3 11.2 7.3 11.6 16.3 9.6 8.7 6.7 8.9 5.4 7.4 12.6 13.3 4.6 12.5 10.7 8.8 10.5 9.9 9.9 8.5 15.6 10.0 6.6 13.9 21.0 17.0 11.4 20.6 6.0 9.9 8.9 11.5 11.8 17.0 4.9 15.3 21.1 10.6 3.3 16.0 6.3 8.1 15.6 9.9 5.7 12.0 6.2 14.8 13.2 8.6 35.0 13.8 5.7 6.9 5.6 9.8 8.8 11.0 14.1 5.9 14.9 13.2 13.9 13.5 10.9 12.1 14.8 19.3 14.4 13.3 15.1 14.3 12.3 12.4 13.2 3.7 19.4 19.2 14.9 14.3 11.8 16.5 22.3 36.8 27.7 15.4 13.0 16.2 18.5 25.9 13.8 VTCN1 "B7-H4, B7H4, B7S1, B7X, FLJ22418" ENSG00000134258 "V-set domain containing T cell activation inhibitor 1" Q7Z7D3 1 117143587-117210960 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 72.8" "Group enriched" "Detected in many" 6 "breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054200 Approved Approved "Plasma membrane,Cell Junctions,Focal adhesion sites" "Plasma membrane" "Cell Junctions, Focal adhesion sites" "HPA054200: " "unprognostic (4.13e-1)" "unprognostic (1.71e-3)" "unprognostic (2.95e-1)" "unprognostic (3.44e-2)" "unprognostic (1.71e-3)" "unprognostic (2.56e-1)" "unprognostic (7.94e-2)" "unprognostic (4.86e-2)" "unprognostic (3.53e-1)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (5.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-1)" "unprognostic (3.07e-1)" "unprognostic (1.45e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 46.4 0.1 0.1 6.7 0.1 0.1 7.0 0.0 2.6 29.9 0.4 14.2 1.9 0.2 0.1 0.1 27.0 0.9 0.3 0.1 0.1 0.1 4.5 35.9 0.0 1.4 3.0 0.1 1.5 0.0 0.1 17.5 3.6 0.2 2.2 0.1 0.8 0.1 0.1 1.5 2.5 0.1 0.2 0.1 0.5 1.5 2.1 0.7 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.0 72.8 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 WDPCP "BBS15, C2orf86, fritz, hFrtz" ENSG00000143951 "WD repeat containing planar cell polarity effector" O95876 2 63121383-63827843 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044144 Uncertain Approved "Cell Junctions" "Cell Junctions" "HPA044144: AB_10969458" "unprognostic (3.36e-1)" "unprognostic (3.22e-2)" "unprognostic (1.95e-1)" "unprognostic (7.07e-2)" "unprognostic (2.95e-1)" "unprognostic (6.88e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-3)" "unprognostic (7.22e-2)" "unprognostic (6.48e-2)" "unprognostic (1.93e-1)" "unprognostic (4.87e-2)" "unprognostic (2.34e-3)" "unprognostic (6.02e-2)" "unprognostic (1.97e-1)" "unprognostic (2.25e-3)" "unprognostic (2.00e-1)" 7.2 7.6 7.9 5.4 13.8 15.6 6.6 10.7 14.2 6.4 4.6 7.8 5.6 3.7 8.1 9.3 4.9 8.6 5.3 10.8 7.8 7.5 8.1 5.1 5.5 6.7 7.0 10.1 9.5 5.0 6.9 17.1 5.7 9.8 5.8 4.5 10.4 4.8 4.5 9.3 6.7 3.9 8.7 9.4 6.2 6.3 13.1 8.5 7.5 7.8 4.5 6.3 5.1 4.9 5.6 4.6 8.7 4.3 6.3 7.0 1.6 6.0 5.9 4.8 5.5 5.4 5.6 5.0 6.1 2.9 3.6 3.3 4.7 3.5 6.0 5.0 3.6 4.9 2.7 2.7 4.6 8.1 4.5 7.7 5.5 3.7 2.8 6.2 5.9 3.3 2.7 3.9 2.3 3.3 3.4 9.2 4.0 7.0 8.1 6.7 5.9 2.4 7.5 5.1 6.1 2.4 4.0 6.4 8.1 4.0 5.6 7.4 5.8 5.4 6.8 7.1 10.8 5.9 5.4 7.1 4.9 11.7 7.7 6.8 6.9 8.7 4.3 2.8 3.6 2.3 7.0 3.7 3.1 4.6 3.2 5.6 4.1 6.1 3.7 6.3 1.9 4.6 2.7 1.6 7.9 13.8 10.7 14.2 7.8 7.5 7.0 10.1 9.8 8.5 ZDHHC5 "DHHC5, KIAA1748, ZNF375" ENSG00000156599 "Zinc finger DHHC-type containing 5" Q9C0B5 11 57667747-57701187 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014670 Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA014670: AB_2257442" "unprognostic (1.34e-1)" "unprognostic (3.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (5.32e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-3)" "unprognostic (1.74e-3)" "unprognostic (4.36e-2)" "unprognostic (9.78e-2)" "prognostic unfavourable (6.74e-5)" "unprognostic (1.76e-1)" "unprognostic (4.72e-3)" "unprognostic (2.16e-1)" "unprognostic (6.80e-2)" "unprognostic (2.06e-2)" "unprognostic (1.74e-3)" 19.6 18.2 6.9 14.2 16.1 13.0 17.3 12.4 19.2 20.0 18.7 14.1 20.9 14.6 19.8 15.9 45.8 16.0 19.1 18.2 8.2 8.1 27.8 24.8 18.7 18.0 8.5 8.2 16.2 21.3 31.4 13.9 31.4 12.8 15.5 18.2 19.1 29.3 18.4 31.3 33.2 25.9 15.2 8.7 21.5 16.3 35.7 7.8 26.4 25.5 23.9 39.1 23.3 26.0 9.4 13.4 15.5 11.3 6.9 13.1 9.0 27.9 31.1 12.2 12.4 27.0 20.8 23.0 26.3 31.6 22.1 16.5 18.8 34.5 18.9 34.2 31.1 39.6 19.0 31.2 19.7 23.2 8.6 16.0 14.3 16.7 30.3 30.0 27.2 29.3 28.2 32.6 33.1 24.8 21.1 23.9 27.8 16.8 16.9 8.4 14.8 18.7 16.8 24.7 23.3 25.2 41.6 8.9 11.4 24.5 27.7 25.7 29.7 17.2 29.1 28.6 14.9 30.0 18.3 17.4 21.5 16.3 21.3 15.5 24.8 15.5 8.1 9.8 11.1 10.1 13.1 9.0 10.9 9.4 8.0 9.4 11.0 11.1 10.2 6.9 11.3 13.4 9.8 9.0 6.9 16.1 12.4 19.2 8.2 8.1 8.5 8.2 12.8 7.8 ZNF236 ENSG00000130856 "Zinc finger protein 236" Q9UL36 18 76822607-76970727 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008600 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Cell Junctions" "Nucleoplasm, Cytosol" "HPA008600: AB_1080696" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "unprognostic (3.13e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (9.88e-3)" "unprognostic (5.51e-2)" "unprognostic (1.77e-1)" "unprognostic (2.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "unprognostic (2.95e-2)" "unprognostic (9.40e-2)" "unprognostic (1.74e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" 5.7 5.2 7.0 9.1 11.2 10.8 10.0 15.3 11.0 7.2 5.8 7.3 6.7 5.0 7.6 7.1 5.6 7.6 6.3 5.1 8.3 5.7 4.7 4.3 6.4 6.2 8.3 3.5 11.3 7.1 12.2 8.9 5.6 7.3 6.2 4.1 5.4 6.6 12.6 5.7 9.9 5.5 5.8 6.5 5.5 5.8 16.6 10.6 10.4 6.5 1.9 10.0 6.2 12.7 9.0 4.6 5.9 3.4 3.0 5.4 1.2 4.3 5.8 8.2 6.0 6.3 6.1 3.7 3.4 4.7 5.4 4.3 4.1 4.1 6.2 1.7 4.4 8.0 5.7 4.8 4.6 6.5 5.7 5.9 6.7 4.8 3.9 9.4 6.8 6.0 5.2 5.1 7.9 5.4 5.6 5.2 5.4 4.1 11.4 5.2 4.5 4.6 7.3 8.5 4.1 4.0 6.8 4.7 4.9 6.1 3.7 4.2 4.4 6.6 5.6 9.3 3.7 2.5 5.0 3.5 4.9 8.0 6.2 5.2 6.9 1.1 3.4 5.9 5.4 2.9 5.2 9.0 4.0 3.7 2.2 8.1 4.6 4.8 3.7 3.0 2.7 4.6 3.9 1.2 7.0 11.2 15.3 11.0 8.3 5.7 8.3 3.5 7.3 10.6 ZNF497 FLJ44773 ENSG00000174586 "Zinc finger protein 497" Q6ZNH5 19 58354357-58362848 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA047872 Uncertain Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA047872: " "unprognostic (8.24e-2)" "unprognostic (1.12e-1)" "unprognostic (2.17e-1)" "unprognostic (1.09e-3)" "unprognostic (1.02e-1)" "unprognostic (1.42e-2)" "unprognostic (2.30e-2)" "unprognostic (8.53e-2)" "unprognostic (9.45e-2)" "unprognostic (9.29e-2)" "unprognostic (4.16e-3)" "unprognostic (7.03e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "unprognostic (4.58e-2)" "unprognostic (7.28e-2)" "unprognostic (1.24e-1)" 0.8 2.3 3.3 2.8 5.5 2.3 5.0 7.5 6.2 3.3 1.7 3.1 3.0 2.0 4.1 3.7 3.6 9.1 3.1 2.0 7.2 3.3 3.7 5.0 3.2 3.8 2.0 4.5 4.5 6.0 3.8 5.9 1.8 5.8 3.2 1.2 1.4 7.7 1.9 0.8 4.6 3.1 0.6 3.5 3.6 2.8 2.3 0.6 2.5 4.9 2.0 1.5 1.4 2.1 4.7 4.8 2.3 2.8 2.1 4.8 1.9 1.6 5.8 5.2 5.1 0.2 0.1 7.0 3.1 0.0 0.0 0.0 0.4 1.9 3.4 1.7 0.0 0.8 0.6 0.4 0.0 3.6 17.4 3.1 1.6 1.0 0.3 1.2 8.1 0.4 0.8 0.1 0.6 0.0 2.5 0.5 0.1 6.0 4.2 4.3 3.2 1.8 10.6 3.9 1.8 0.5 1.4 4.1 5.8 1.7 5.2 2.8 7.1 3.5 0.5 5.8 3.1 0.5 1.0 7.6 9.1 3.0 1.6 3.5 3.1 2.3 2.8 0.9 2.4 1.1 2.6 3.8 2.8 2.9 2.7 4.7 2.9 4.8 1.0 2.1 0.9 4.8 3.1 1.9 3.3 5.5 7.5 4.2 7.2 3.3 2.0 4.5 5.8 0.6 ZNF536 KIAA0390 ENSG00000198597 "Zinc finger protein 536" O15090 19 30228290-30713538 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 44.5" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.9;HAP1: 8.7;SH-SY5Y: 23.8;U-937: 5.8;WM-115: 10.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077341 Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA077341: " "unprognostic (1.98e-1)" "unprognostic (4.11e-1)" "unprognostic (1.92e-2)" "unprognostic (1.70e-2)" "unprognostic (2.09e-1)" "unprognostic (1.03e-1)" "unprognostic (4.70e-2)" "unprognostic (4.68e-1)" "unprognostic (5.50e-2)" "unprognostic (1.74e-2)" "unprognostic (1.25e-2)" "unprognostic (4.46e-4)" "unprognostic (1.58e-1)" "unprognostic (2.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.45e-1)" 1.1 6.0 9.9 2.0 21.0 0.6 0.8 14.3 24.1 4.2 4.0 44.5 0.0 2.7 1.7 1.3 6.9 1.0 1.3 2.9 13.3 7.7 0.8 0.7 1.0 0.7 20.9 9.6 0.9 0.9 0.7 3.4 0.7 18.3 3.7 4.1 4.8 1.6 2.4 1.4 1.2 4.2 1.2 23.1 1.5 2.1 5.0 18.4 0.0 6.9 0.0 0.7 2.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 8.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 23.8 0.0 0.0 1.5 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 5.8 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.9 21.0 14.3 15.1 13.3 7.7 20.9 9.6 18.3 18.4 ZNF688 ENSG00000229809 "Zinc finger protein 688" P0C7X2 16 30569346-30572734 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048922 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" Nucleoplasm "Plasma membrane, Cell Junctions" "HPA048922: AB_2680557" "prognostic favourable (5.90e-4)" "prognostic favourable (7.74e-4)" "unprognostic (1.68e-1)" "prognostic favourable (4.58e-5)" "unprognostic (1.37e-1)" "unprognostic (1.76e-2)" "unprognostic (4.01e-1)" "prognostic favourable (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "prognostic favourable (6.61e-4)" "unprognostic (7.75e-2)" "unprognostic (5.14e-2)" "unprognostic (7.08e-2)" "unprognostic (2.48e-1)" "unprognostic (4.12e-2)" "unprognostic (4.03e-2)" 10.7 11.9 14.2 11.8 11.8 13.7 8.0 13.8 16.7 8.8 15.3 15.5 12.1 20.5 11.5 9.6 12.0 13.5 14.5 17.2 13.1 10.6 11.2 12.4 10.3 19.9 12.1 11.5 12.9 14.7 8.4 14.0 7.8 11.2 11.8 9.0 11.0 13.8 10.1 32.5 9.5 14.4 14.2 11.0 13.9 13.0 24.6 8.3 21.6 13.7 8.3 10.0 10.4 13.3 6.1 5.4 12.6 5.4 15.1 6.8 2.8 7.6 5.8 5.9 6.2 11.3 2.9 2.5 4.4 6.1 3.7 2.9 1.8 11.7 4.1 8.9 5.5 5.7 1.6 2.8 4.1 12.0 3.6 2.8 2.3 1.4 3.0 3.8 12.5 5.8 6.2 4.0 4.8 3.7 2.9 9.5 4.2 4.6 10.9 4.3 2.1 1.9 9.3 2.4 6.0 6.5 2.5 8.5 9.4 1.5 11.6 9.8 12.7 6.4 2.9 3.2 3.5 3.8 3.4 13.5 9.4 4.3 9.9 3.3 5.5 12.6 3.9 8.3 4.8 3.9 5.8 5.5 5.6 5.4 3.9 6.1 4.8 4.4 6.0 15.1 5.4 5.4 6.8 2.8 14.2 11.8 13.8 16.7 13.1 10.6 12.1 11.5 11.2 8.3